data_2k3k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 113.965 0.717 . . . . 0.0 113.965 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' LYS . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' TYR . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 N--CA 1.456 -0.723 0 N-CA-C 113.558 0.561 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.413 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' TYR . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 113.701 0.616 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 N--CA 1.458 -0.603 0 CA-C-O 121.692 0.622 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 CA-C-O 119.262 -0.744 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 CA-C-O 121.357 0.482 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 77' ' ' LYS . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' TYR . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.472 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.46 -0.462 0 CA-C-O 121.408 0.503 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.487 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 77' ' ' LYS . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' TYR . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.487 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.536 0.586 0 N-CA-C 113.743 0.632 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.611 0 CA-C-O 121.333 0.472 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 121.486 0.536 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.28 0 CA-C-O 120.196 -0.225 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.417 ' C ' ' H ' ' A' ' 77' ' ' LYS . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' TYR . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 113.639 0.592 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 114.232 0.82 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 CA-C-O 120.137 -0.257 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-O 121.523 0.551 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 77' ' ' LYS . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 75' ' ' TYR . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 N-CA-C 114.896 1.075 . . . . 0.0 114.896 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 121.502 0.542 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 CA-C-O 119.872 -0.405 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 115.338 1.246 . . . . 0.0 115.338 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.402 ' C ' ' H ' ' A' ' 77' ' ' LYS . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 75' ' ' TYR . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 112.556 0.175 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo . . . . . 0 N--CA 1.457 -0.668 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -141.27 139.39 33.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -72.38 162.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.522 0.729 . . . . 0.0 110.899 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.5 mp -115.27 144.24 31.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.29 136.86 77.64 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.888 2.392 . . . . 0.0 113.965 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.79 153.24 38.96 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -70.44 -17.8 63.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 p -68.46 148.59 50.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.753 0.821 . . . . 0.0 109.679 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.53 -36.98 67.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.513 0.725 . . . . 0.0 112.052 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -59.71 -11.9 5.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.3 mmm -137.55 27.08 2.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.152 1.381 . . . . 0.0 110.396 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -93.92 -33.14 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.436 -0.79 . . . . 0.0 111.24 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.51 -3.51 61.18 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.419 ' C ' ' H ' ' A' ' 77' ' ' LYS . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 75' ' ' TYR . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.78 141.35 30.57 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -67.09 163.26 20.48 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.098 0.475 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 78.2 mttt 63.1 26.39 15.34 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 111.416 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.4 m -163.28 47.39 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.506 2.722 . . . . 0.0 105.09 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -145.37 169.82 17.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.697 1.599 . . . . 0.0 110.493 -168.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 m -54.4 -29.33 48.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.436 1.494 . . . . 0.0 114.27 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.91 -46.49 71.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.98 1.263 . . . . 0.0 110.912 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 pt -71.02 -32.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.332 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -46.03 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.23 82.88 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.663 -0.648 . . . . 0.0 111.198 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.71 -47.49 78.11 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -70.83 -32.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 119.851 1.205 . . . . 0.0 111.576 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.75 -26.85 65.44 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.527 0.603 . . . . 0.0 111.426 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 -21.23 43.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.42 1.486 . . . . 0.0 111.414 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 p -59.41 -14.43 12.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.764 1.626 . . . . 0.0 113.46 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -54.32 -34.45 61.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.851 0.86 . . . . 0.0 111.677 169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.5 -20.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -67.02 148.71 51.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.372 0.987 . . . . 0.0 109.751 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.65 156.03 91.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.54 -29.08 44.83 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.27 1.98 . . . . 0.0 112.067 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -150.93 156.38 41.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.558 1.943 . . . . 0.0 107.076 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.433 -1.27 . . . . 0.0 110.827 -176.28 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.42 150.67 47.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.924 0.49 . . . . 0.0 109.756 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.32 148.65 40.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 169.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.86 110.83 1.49 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 111.152 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.27 125.97 16.33 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.714 2.943 . . . . 0.0 113.558 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.88 160.07 36.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.97 -15.55 60.66 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.807 -0.558 . . . . 0.0 112.394 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -60.21 151.3 27.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.124 0.969 . . . . 0.0 109.778 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.61 -25.55 62.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -58.11 -23.0 53.25 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.981 1.712 . . . . 0.0 112.574 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.44 23.0 4.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.445 1.498 . . . . 0.0 110.073 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -60.19 -33.07 71.71 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.766 -1.209 . . . . 0.0 112.959 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.83 29.07 1.57 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.698 1.142 . . . . 0.0 111.567 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.413 ' C ' ' H ' ' A' ' 77' ' ' LYS . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' TYR . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.64 143.03 57.24 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.7 p -64.14 3.94 0.38 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.43 -26.04 62.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.068 1.304 . . . . 0.0 109.703 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 35.9 -119.73 0.13 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.964 2.505 . . . . 0.0 113.39 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.29 175.86 13.46 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.796 1.238 . . . . 0.0 109.935 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 m -49.31 -24.82 2.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.739 2.015 . . . . 0.0 115.016 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.18 -45.36 92.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 119.5 1.046 . . . . 0.0 111.676 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -72.76 -29.0 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 O-C-N 121.718 -0.614 . . . . 0.0 110.315 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -62.92 -43.12 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.19 77.71 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.447 -0.783 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -59.51 -51.71 68.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.631 1.105 . . . . 0.0 110.336 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.22 -32.68 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.52 1.055 . . . . 0.0 111.825 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.19 -18.45 61.25 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.146 0.579 . . . . 0.0 111.878 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.7 57.57 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.376 0.989 . . . . 0.0 112.091 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 p -65.16 -3.71 4.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.069 1.435 . . . . 0.0 113.474 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -61.53 -21.89 64.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.136 -0.977 . . . . 0.0 110.637 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -138.14 -31.51 0.76 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.464 1.105 . . . . 0.0 112.575 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.34 157.96 30.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.917 0.78 . . . . 0.0 109.007 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -138.07 156.2 74.11 Favored Pre-proline 0 N--CA 1.465 0.285 0 C-N-CA 124.1 0.96 . . . . 0.0 109.466 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.6 -26.17 54.22 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.395 2.063 . . . . 0.0 112.034 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -138.93 140.4 38.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.627 -178.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.78 170.35 19.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.196 1.398 . . . . 0.0 108.523 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.56 152.68 38.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.981 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mp -101.14 126.56 34.43 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.12 131.05 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 113.701 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -145.92 164.42 32.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -76.75 -5.61 48.81 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -67.36 146.67 53.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.118 0.872 . . . . 0.0 109.449 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.52 -38.75 78.39 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.195 -0.94 . . . . 0.0 110.894 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -62.2 -5.7 2.53 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 mmt -130.31 22.78 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.137 1.375 . . . . 0.0 110.69 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -122.42 -21.11 5.87 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.34 1.456 . . . . 0.0 110.588 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.36 -16.05 67.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -81.04 170.28 16.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.85 -172.44 3.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.767 0.827 . . . . 0.0 110.572 -174.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.4 159.71 28.18 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 m -67.06 165.22 16.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.015 0.926 . . . . 0.0 112.09 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -42.36 -42.08 3.06 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.383 1.873 . . . . 0.0 112.231 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 m -58.28 -27.1 63.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.576 1.15 . . . . 0.0 114.039 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.14 -36.97 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.442 0.697 . . . . 0.0 111.646 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 pt -63.69 -35.97 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.28 -36.95 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.087 0.858 . . . . 0.0 109.473 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.64 93.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.736 0.698 . . . . 0.0 110.863 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -47.74 83.61 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.377 0.671 . . . . 0.0 111.047 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 pt -88.16 -20.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.719 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -143.29 -66.36 0.37 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 119.218 0.917 . . . . 0.0 110.821 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.24 -173.61 32.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -169.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.5 m 59.58 79.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -55.95 140.59 42.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 44.73 63.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.132 1.373 . . . . 0.0 110.195 -168.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.85 144.45 11.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.595 0.758 . . . . 0.0 110.415 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -142.06 82.49 13.38 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 126.178 1.791 . . . . 0.0 106.202 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.56 -36.06 97.84 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.187 1.925 . . . . 0.0 113.86 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -152.63 37.44 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 110.995 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.5 tttp . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -172.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.849 -0.056 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 58.61 178.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.222 1.809 . . . . 0.0 112.59 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -69.3 168.26 14.65 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.665 0.786 . . . . 0.0 111.505 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.84 132.86 22.11 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.95 123.32 7.22 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.681 2.921 . . . . 0.0 112.683 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt -138.44 169.06 18.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -74.5 -23.61 58.87 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.472 . . . . 0.0 110.717 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -52.3 125.39 15.83 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.733 1.613 . . . . 0.0 108.906 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.1 tp -52.14 -46.55 65.46 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.399 0.679 . . . . 0.0 111.916 -172.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.03 -16.09 39.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.9 tpt -126.97 26.55 6.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 110.79 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -117.61 -28.6 5.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.362 1.865 . . . . 0.0 108.888 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.94 -7.62 73.94 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.737 0.684 . . . . 0.0 111.393 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.09 155.37 32.48 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -72.29 86.73 1.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.538 0.685 . . . . 0.0 111.355 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -57.14 -14.36 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.911 1.284 . . . . 0.0 113.458 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -120.23 24.09 10.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.45 . . . . 0.0 110.965 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -49.61 -45.09 47.68 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.668 1.187 . . . . 0.0 112.19 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -58.98 -37.59 77.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.052 0.541 . . . . 0.0 111.729 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.47 -44.21 52.59 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 122.855 0.462 . . . . 0.0 110.939 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 pt -69.89 -35.85 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.612 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.75 -45.34 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -33.71 74.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.943 0.792 . . . . 0.0 111.659 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 39.0 ttpt -63.59 -53.09 57.04 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.012 0.525 . . . . 0.0 110.211 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.31 -32.41 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.466 0.575 . . . . 0.0 111.348 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -70.4 -39.25 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.467 0.707 . . . . 0.0 111.12 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.75 30.09 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.829 1.204 . . . . 0.0 111.685 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 p -59.31 -22.51 61.34 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.698 1.249 . . . . 0.0 112.623 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 7.2 p90 -55.6 -24.71 34.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.392 0.996 . . . . 0.0 112.764 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -125.35 -26.24 3.64 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.78 -33.38 58.04 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.821 0.737 . . . . 0.0 110.852 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -143.02 67.74 17.53 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 125.039 1.335 . . . . 0.0 109.037 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.84 -24.29 68.25 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.888 1.725 . . . . 0.0 111.931 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.98 129.64 19.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.86 -29.92 35.7 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.16 157.97 36.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.198 0.999 . . . . 0.0 110.545 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.77 149.88 66.03 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.379 1.072 . . . . 0.0 110.354 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.69 134.9 64.94 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.83 3.02 . . . . 0.0 116.279 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt -143.09 167.4 22.17 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.26 3.09 55.73 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 111.737 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 p -59.75 151.75 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.58 -42.44 74.74 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.648 -0.658 . . . . 0.0 110.986 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -59.39 -22.35 61.25 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.953 0.501 . . . . 0.0 111.966 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.8 mmm -117.92 10.87 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.993 1.317 . . . . 0.0 111.0 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -50.28 -47.98 55.19 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.27 1.028 . . . . 0.0 109.611 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.02 32.19 3.33 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.647 1.118 . . . . 0.0 111.367 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -74.32 137.03 42.58 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -63.55 155.44 29.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.515 0.674 . . . . 0.0 111.777 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -144.29 164.57 30.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.671 1.988 . . . . 0.0 106.407 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.8 m -52.79 126.31 19.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.39 0.676 . . . . 0.0 109.418 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -152.48 141.79 21.52 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.115 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 m -59.52 -15.36 17.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.74 -47.15 15.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 120.141 1.337 . . . . 0.0 111.28 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.2 -32.58 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 122.156 -0.34 . . . . 0.0 110.535 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.61 -41.07 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.83 92.61 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.49 -0.756 . . . . 0.0 111.699 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -56.74 -53.47 57.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.454 0.57 . . . . 0.0 110.293 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.6 -27.4 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.411 0.55 . . . . 0.0 111.625 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.36 -46.62 87.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.922 0.783 . . . . 0.0 109.179 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.73 -15.28 1.21 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.668 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -145.22 107.79 4.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.256 1.528 . . . . 0.0 108.64 -169.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -51.99 -39.0 58.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.773 0.829 . . . . 0.0 112.749 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.19 -32.38 73.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.659 0.784 . . . . 0.0 111.63 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.7 112.4 19.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -60.45 144.77 87.96 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.35 -34.19 31.45 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.115 2.543 . . . . 0.0 115.786 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -128.81 38.58 3.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.612 1.165 . . . . 0.0 109.962 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.277 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.819 0.343 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.77 145.35 28.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -73.3 129.46 38.08 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.74 142.51 93.88 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.395 0.678 . . . . 0.0 110.941 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.24 134.59 61.43 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.98 2.453 . . . . 0.0 111.993 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -137.09 166.86 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -69.7 -21.36 63.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.277 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -63.79 134.08 54.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.614 1.097 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.56 -40.45 65.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.186 0.595 . . . . 0.0 111.955 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.15 -21.45 32.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.984 0.914 . . . . 0.0 112.542 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.3 mmt -129.0 29.49 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.893 1.277 . . . . 0.0 110.025 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -123.75 -35.36 2.89 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.013 1.325 . . . . 0.0 110.318 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.84 -11.02 85.82 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.435 0.561 . . . . 0.0 112.104 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 77' ' ' LYS . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' TYR . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.472 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -75.13 150.6 38.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 143.8 54.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.358 0.599 . . . . 0.0 112.098 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.97 170.79 15.48 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.341 2.256 . . . . 0.0 107.034 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.6 m -54.64 146.71 16.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.849 0.86 . . . . 0.0 110.804 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.24 148.16 28.55 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.632 1.573 . . . . 0.0 107.17 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 m -52.88 -33.74 51.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.307 1.043 . . . . 0.0 113.44 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -49.36 52.05 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.399 1.0 . . . . 0.0 110.981 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.1 pt -71.42 -33.44 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.522 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.14 -46.08 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.75 82.13 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.147 0.885 . . . . 0.0 110.087 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -53.49 -51.3 63.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.614 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.45 -31.51 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 119.327 0.967 . . . . 0.0 112.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.57 -41.81 68.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 0.0 111.374 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.21 47.8 0.08 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.97 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.3 m 69.34 161.39 0.21 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.5 1.52 . . . . 0.0 110.905 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -50.98 -31.57 18.34 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.06 -1.025 . . . . 0.0 112.1 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -140.05 137.93 34.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 168.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -72.1 -32.7 67.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -62.3 151.27 82.56 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.777 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.93 -37.81 78.45 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.696 2.264 . . . . 0.0 112.703 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -158.54 163.52 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.129 1.772 . . . . 0.0 108.659 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.249 1.05 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.543 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -133.31 176.94 8.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 109.24 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -55.94 137.5 50.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.321 1.448 . . . . 0.0 111.011 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.09 150.7 97.42 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.849 0.86 . . . . 0.0 111.558 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.15 137.74 63.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.706 2.937 . . . . 0.0 112.619 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt -142.9 169.87 16.77 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -72.68 -27.3 62.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 110.965 169.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -58.48 131.03 49.54 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.437 1.495 . . . . 0.0 109.247 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -49.9 -45.75 51.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.145 0.978 . . . . 0.0 112.338 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.53 -18.76 43.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.56 0.744 . . . . 0.0 112.559 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.32 25.03 5.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.254 1.422 . . . . 0.0 110.521 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -120.41 -30.64 4.52 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.363 1.465 . . . . 0.0 109.802 169.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.67 -8.49 76.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.215 0.912 . . . . 0.0 111.07 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 77' ' ' LYS . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 75' ' ' TYR . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.487 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -66.32 160.81 23.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -54.16 129.51 35.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.508 0.723 . . . . 0.0 111.673 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -156.85 154.85 30.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.21 2.204 . . . . 0.0 106.57 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 m -143.93 10.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -142.48 -61.91 0.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.002 1.274 . . . . 0.0 112.055 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 m -59.16 -38.18 79.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.335 0.516 . . . . 0.0 111.27 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.25 -52.47 61.99 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 122.831 0.452 . . . . 0.0 111.487 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.7 pt -67.06 -33.13 61.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.426 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.2 -49.43 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.22 72.63 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.938 0.79 . . . . 0.0 111.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -67.91 -46.03 72.71 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.786 0.834 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -73.75 -34.4 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.982 0.81 . . . . 0.0 111.537 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.48 -28.07 64.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.541 0.61 . . . . 0.0 111.525 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.32 -13.68 64.27 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.907 1.241 . . . . 0.0 112.056 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -60.17 -12.46 8.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.599 1.699 . . . . 0.0 113.123 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -54.21 -38.73 66.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 111.767 169.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -158.51 -25.35 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.99 -36.79 78.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.258 0.935 . . . . 0.0 110.655 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 150.53 60.88 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.15 -39.83 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.477 1.451 . . . . 0.0 112.585 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -159.01 48.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.861 0.864 . . . . 0.0 110.471 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.248 1.001 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.16 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.62 -41.37 79.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.883 -0.511 . . . . 0.0 111.668 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -71.64 149.96 45.07 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.354 0.661 . . . . 0.0 111.297 -171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.2 mt -70.94 149.12 94.89 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.4 -2.57 10.59 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.149 2.566 . . . . 0.0 113.743 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp -148.41 166.54 27.81 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -74.74 -23.53 58.58 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.618 -0.677 . . . . 0.0 112.254 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.5 143.6 57.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.126 0.876 . . . . 0.0 109.234 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -31.52 64.06 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.517 -0.739 . . . . 0.0 111.799 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.96 -26.75 27.22 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.453 1.501 . . . . 0.0 112.454 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 mmm -136.42 32.48 2.81 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.465 1.029 . . . . 0.0 110.307 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -125.88 -27.27 3.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.966 1.306 . . . . 0.0 110.423 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.35 -5.66 89.38 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -75.25 153.22 38.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -62.25 137.7 58.3 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.579 -0.7 . . . . 0.0 111.482 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -138.21 33.62 2.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.341 1.856 . . . . 0.0 108.812 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -67.5 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.115 2.566 . . . . 0.0 115.152 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -52.06 -48.89 64.41 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.127 1.371 . . . . 0.0 112.235 -169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m -62.14 -34.96 77.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 111.559 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -75.86 -44.9 38.45 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 122.889 0.475 . . . . 0.0 110.58 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 pt -68.34 -32.82 57.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.635 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -61.48 -47.21 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.21 86.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.553 1.07 . . . . 0.0 111.295 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -55.44 -54.28 45.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.078 0.853 . . . . 0.0 110.854 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.3 pt -70.74 -29.92 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.273 0.942 . . . . 0.0 111.876 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -66.44 -31.41 72.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.141 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.2 -55.63 0.08 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.14 0.882 . . . . 0.0 112.084 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -164.55 150.82 10.7 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -58.45 -9.99 1.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -137.32 20.93 2.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.319 1.448 . . . . 0.0 111.706 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.97 136.37 38.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.029 0.831 . . . . 0.0 109.376 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -68.32 146.33 97.87 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.184 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.35 -41.39 4.84 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.79 1.66 . . . . 0.0 110.772 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -149.59 158.46 44.19 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.353 2.261 . . . . 0.0 107.226 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? . . . . . 0 C--O 1.249 1.066 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 170.03 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -138.32 -41.2 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.384 0.674 . . . . 0.0 110.189 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -119.45 143.65 47.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.852 1.661 . . . . 0.0 106.536 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.14 130.12 92.63 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 118.755 -0.641 . . . . 0.0 111.67 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.3 128.62 30.32 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.231 2.62 . . . . 0.0 113.023 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.36 167.93 22.37 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.75 -16.57 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -62.52 141.07 58.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.693 1.133 . . . . 0.0 108.996 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.2 -36.62 80.37 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 110.881 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -60.31 -11.27 6.07 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -121.85 20.67 10.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.316 1.446 . . . . 0.0 111.234 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.8 mtm105 -120.46 -29.13 4.84 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.7 1.6 . . . . 0.0 108.693 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.91 -10.57 84.88 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -76.58 171.05 15.29 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -142.81 -166.15 2.22 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.525 1.53 . . . . 0.0 108.519 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -117.58 167.13 11.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 109.159 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.6 m -55.3 140.58 38.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.65 1.18 . . . . 0.0 113.509 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -56.3 158.91 3.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.634 1.173 . . . . 0.0 111.054 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m 66.72 -42.68 0.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.587 2.355 . . . . 0.0 112.525 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.51 -51.75 39.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.559 1.072 . . . . 0.0 110.51 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 pt -62.81 -35.51 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.198 -0.429 . . . . 0.0 110.683 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -63.65 -48.63 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.01 82.99 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.76 0.709 . . . . 0.0 111.13 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -61.29 -52.26 65.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.479 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.8 pt -72.5 -31.98 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.001 0.819 . . . . 0.0 111.661 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -67.36 -30.12 69.83 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.655 0.782 . . . . 0.0 111.08 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.78 46.86 6.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -131.97 0.25 3.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.429 1.492 . . . . 0.0 111.231 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.18 -44.6 94.92 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.696 1.198 . . . . 0.0 111.69 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' C ' ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -153.34 66.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 176.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -147.71 163.22 37.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -63.14 150.52 88.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 O-C-N 122.05 -0.406 . . . . 0.0 109.988 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.83 -3.06 13.13 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.174 2.583 . . . . 0.0 111.899 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -134.28 -174.67 3.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.299 2.239 . . . . 0.0 107.626 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.248 1.01 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.727 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -150.25 140.01 21.76 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -133.46 136.99 45.5 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.6 151.39 80.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.22 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.28 134.86 66.23 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.196 2.597 . . . . 0.0 112.864 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp -144.69 160.47 41.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.06 -21.17 59.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.429 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.4 p -68.71 140.59 55.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.279 0.945 . . . . 0.0 109.018 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.58 -30.42 54.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -57.2 -16.24 7.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.867 1.267 . . . . 0.0 113.68 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.6 21.65 6.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.756 1.623 . . . . 0.0 110.41 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -105.98 -38.88 6.18 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.39 -8.69 84.05 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.396 0.522 . . . . 0.0 113.147 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.417 ' C ' ' H ' ' A' ' 77' ' ' LYS . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' TYR . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.38 144.88 28.52 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 84.94 1.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.256 0.623 . . . . 0.0 110.595 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -48.66 -51.2 29.61 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 111.325 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.0 m -151.61 157.34 42.03 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.417 1.487 . . . . 0.0 108.118 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.89 155.16 29.09 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.24 1.416 . . . . 0.0 108.304 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 m -138.02 18.66 2.81 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 111.595 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -144.13 -48.07 0.27 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.3 0.955 . . . . 0.0 113.372 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.93 -37.55 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.258 0.935 . . . . 0.0 108.613 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.17 -44.21 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.861 0.864 . . . . 0.0 108.963 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.86 94.92 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.666 -0.646 . . . . 0.0 110.927 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -48.24 82.65 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.788 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.0 pt -71.35 -29.57 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.762 0.71 . . . . 0.0 111.474 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -65.17 -42.16 93.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.781 0.718 . . . . 0.0 110.511 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.82 -67.36 0.06 OUTLIER Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.953 0.797 . . . . 0.0 111.339 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.1 p -149.86 -84.73 0.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -112.1 -11.82 13.75 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.966 1.706 . . . . 0.0 109.671 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 -175.68 4.27 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.004 2.522 . . . . 0.0 105.342 172.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.4 -7.13 5.84 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.04 145.08 99.17 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.554 1.142 . . . . 0.0 110.23 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.24 -11.75 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.857 2.371 . . . . 0.0 112.745 173.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -146.62 137.35 23.99 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.368 -174.323 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.34 170.21 19.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.003 1.321 . . . . 0.0 108.629 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -61.84 153.03 30.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.667 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.49 155.21 37.69 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.46 139.7 55.44 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.776 2.984 . . . . 0.0 113.639 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt -144.0 156.5 44.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -82.55 -6.07 59.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 p -61.96 158.19 16.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.683 0.793 . . . . 0.0 109.469 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -53.77 -36.22 62.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.808 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -51.84 -31.06 26.11 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.045 1.338 . . . . 0.0 112.968 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.3 mtp -134.49 23.22 3.71 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.34 0.973 . . . . 0.0 110.854 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -53.75 -40.05 65.84 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.44 29.14 2.62 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.601 1.096 . . . . 0.0 111.155 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -70.35 143.58 51.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 p -60.66 -28.9 68.93 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -57.01 -17.36 9.6 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.451 0.7 . . . . 0.0 112.531 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -61.96 -18.03 59.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.309 1.044 . . . . 0.0 113.374 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -129.19 116.93 19.94 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.331 1.423 . . . . 0.0 111.389 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -63.16 -26.72 68.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.589 1.156 . . . . 0.0 113.066 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -83.42 -42.46 16.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.422 1.01 . . . . 0.0 110.869 -171.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 pt -67.76 -32.92 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.896 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.8 0.727 . . . . 0.0 109.404 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.88 97.85 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.265 0.939 . . . . 0.0 111.164 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -59.68 -48.62 80.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.334 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.7 pt -72.57 -27.81 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.626 1.103 . . . . 0.0 111.662 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.81 -42.39 97.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.055 0.843 . . . . 0.0 109.156 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.08 -27.77 0.72 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.981 -0.899 . . . . 0.0 113.754 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 m -148.52 125.06 11.03 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.718 1.259 . . . . 0.0 108.534 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -59.34 -32.32 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -69.22 -31.78 70.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.076 0.95 . . . . 0.0 111.744 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.44 147.57 50.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -64.8 118.93 53.44 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.21 -39.44 13.24 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.496 1.464 . . . . 0.0 112.824 -169.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -86.25 18.66 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.581 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.8 161.44 26.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.193 0.597 . . . . 0.0 110.541 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.77 130.05 44.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.306 0.642 . . . . 0.0 110.911 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.03 132.96 90.06 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.806 0.842 . . . . 0.0 110.345 -170.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.0 125.47 19.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.224 2.616 . . . . 0.0 114.232 170.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.81 164.12 32.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.51 -22.19 62.66 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.837 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -60.77 136.96 58.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.098 0.863 . . . . 0.0 109.098 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -50.94 -43.34 60.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.935 0.894 . . . . 0.0 112.091 -170.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.19 -10.46 10.66 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -136.06 17.76 3.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.955 1.702 . . . . 0.0 110.241 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -89.63 -34.24 16.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.3 1.04 . . . . 0.0 111.479 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.5 15.53 8.06 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.133 1.825 . . . . 0.0 111.578 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -79.44 165.14 23.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -138.21 116.52 11.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.1 145.31 56.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 m -67.68 -18.93 65.1 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.21 -41.85 0.42 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.165 0.986 . . . . 0.0 111.335 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -30.13 68.2 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.91 -0.494 . . . . 0.0 111.944 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.7 -46.85 67.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.411 0.551 . . . . 0.0 111.351 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.8 pt -70.2 -33.06 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.44 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.93 -46.55 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.65 74.14 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.67 -0.644 . . . . 0.0 111.705 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 60.9 mtpt -63.02 -54.5 37.33 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.92 0.782 . . . . 0.0 110.147 174.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.38 -30.52 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 119.148 0.885 . . . . 0.0 111.803 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -77.46 -11.85 59.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.828 0.851 . . . . 0.0 112.596 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.36 -16.04 10.95 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.357 0.981 . . . . 0.0 112.904 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 p -62.1 -14.49 37.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.141 1.471 . . . . 0.0 113.425 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 4.4 p90 -58.87 -27.44 65.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.949 0.795 . . . . 0.0 112.824 172.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.37 -1.93 0.39 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -139.15 175.03 9.91 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 109.627 -170.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.73 158.78 81.93 Favored Pre-proline 0 CA--C 1.539 0.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.543 169.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.17 -31.12 53.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.322 2.681 . . . . 0.0 113.877 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -147.38 147.06 29.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.018 1.727 . . . . 0.0 106.647 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.726 170.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.92 -48.33 80.91 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.351 0.661 . . . . 0.0 110.274 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -76.07 138.1 40.6 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.907 1.283 . . . . 0.0 108.445 170.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.58 137.59 94.9 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.367 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.5 144.35 63.11 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.198 2.599 . . . . 0.0 113.83 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -145.46 172.41 13.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -69.89 -22.48 63.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.721 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -63.63 143.12 58.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.848 0.859 . . . . 0.0 109.295 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.8 tp -51.71 -43.59 62.89 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.149 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.02 -19.69 33.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.613 1.165 . . . . 0.0 112.582 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.01 18.93 8.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.374 1.469 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -106.81 -42.0 5.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.643 1.577 . . . . 0.0 108.148 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.11 -6.98 89.03 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.322 0.487 . . . . 0.0 112.674 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -67.2 162.53 22.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -59.01 141.09 54.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -138.11 41.03 2.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.945 2.098 . . . . 0.0 108.166 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -50.84 123.26 8.73 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.223 1.409 . . . . 0.0 109.39 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.34 -50.11 65.71 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 -169.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -61.33 -36.0 78.95 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.665 0.386 . . . . 0.0 111.41 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.91 -46.56 35.11 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 122.91 0.484 . . . . 0.0 110.926 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 pt -65.81 -38.32 81.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.94 -46.94 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.55 80.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.964 0.802 . . . . 0.0 111.641 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -64.78 -49.24 71.51 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.885 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.79 -33.04 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.656 1.117 . . . . 0.0 111.831 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -71.69 -29.77 64.95 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.211 0.604 . . . . 0.0 111.301 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.93 -15.38 60.75 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.946 1.26 . . . . 0.0 111.529 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -62.5 -10.43 11.82 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.586 1.554 . . . . 0.0 112.884 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.75 -27.2 64.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.276 1.03 . . . . 0.0 111.273 169.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.67 -43.22 0.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.543 1.137 . . . . 0.0 110.593 -176.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.4 164.79 15.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.166 0.587 . . . . 0.0 110.243 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -56.06 148.8 38.19 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.346 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.01 -23.4 34.24 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.579 2.186 . . . . 0.0 112.436 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -144.58 130.62 19.42 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.338 1.855 . . . . 0.0 106.934 -179.296 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.53 157.16 34.98 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.38 136.31 56.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.68 148.19 87.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.302 0.641 . . . . 0.0 110.234 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.65 133.24 56.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.996 2.464 . . . . 0.0 112.363 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -141.52 166.3 25.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -78.02 -14.8 59.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.695 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -66.33 138.62 57.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.463 1.105 . . . . 0.0 108.888 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -44.77 -55.52 5.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.895 1.278 . . . . 0.0 114.236 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -66.46 -43.58 85.1 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.198 0.908 . . . . 0.0 110.53 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.758 0.823 . . . . 0.0 112.802 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -117.03 -28.53 6.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.814 1.646 . . . . 0.0 109.97 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.57 -12.04 73.33 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.677 1.132 . . . . 0.0 111.66 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 77' ' ' LYS . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 75' ' ' TYR . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -78.36 145.07 35.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -64.93 166.5 9.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 111.839 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -176.8 3.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.889 1.676 . . . . 0.0 108.435 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -53.31 150.38 6.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.443 1.097 . . . . 0.0 110.872 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.76 -45.48 74.22 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.781 0.832 . . . . 0.0 111.874 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.59 -36.47 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.764 0.426 . . . . 0.0 111.168 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.28 -35.54 47.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.258 -0.901 . . . . 0.0 111.553 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.5 pt -67.72 -30.91 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.4 -0.813 . . . . 0.0 110.351 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.52 -41.36 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.789 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.47 -44.57 84.96 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 120.052 1.296 . . . . 0.0 111.314 171.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -60.75 -46.93 88.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.477 -0.773 . . . . 0.0 111.227 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.2 pt -71.08 -29.84 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.588 1.085 . . . . 0.0 111.523 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt 127.83 122.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 132.16 4.184 . . . . 0.0 106.717 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.67 178.58 48.68 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.0 p -60.9 -21.89 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.564 1.146 . . . . 0.0 113.672 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -66.56 -8.1 24.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.627 1.103 . . . . 0.0 113.2 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 19.85 16.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.619 1.1 . . . . 0.0 111.914 169.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -129.62 -54.04 1.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.153 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -141.8 64.38 18.06 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.92 1.688 . . . . 0.0 109.248 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.88 -38.63 28.83 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.084 1.19 . . . . 0.0 111.449 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -85.73 55.33 3.47 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.61 1.164 . . . . 0.0 108.448 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.041 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.94 143.42 28.48 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mmt -78.58 152.21 31.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.14 117.56 25.52 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.265 1.826 . . . . 0.0 106.553 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.39 126.35 21.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.428 2.752 . . . . 0.0 114.896 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt -139.58 163.93 31.26 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -80.71 -8.66 59.72 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.792 0.837 . . . . 0.0 112.246 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -59.85 151.21 26.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.111 0.964 . . . . 0.0 109.252 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.89 -25.82 63.71 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.244 -0.91 . . . . 0.0 112.966 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.56 -26.85 68.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.187 0.995 . . . . 0.0 112.07 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.1 mmm -130.32 11.18 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.027 1.331 . . . . 0.0 111.819 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -59.98 -29.73 68.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.49 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.7 25.28 2.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.998 1.285 . . . . 0.0 112.412 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -78.98 169.95 17.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -134.76 -173.56 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.712 1.205 . . . . 0.0 108.201 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.79 156.15 46.51 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -59.5 147.24 37.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.527 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -146.92 145.78 29.91 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.625 1.17 . . . . 0.0 107.927 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -53.03 -31.72 42.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.468 1.107 . . . . 0.0 113.545 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.4 -48.01 52.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.697 1.135 . . . . 0.0 111.608 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.65 -33.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.142 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.65 -45.24 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.3 89.06 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.224 0.92 . . . . 0.0 110.711 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -57.62 -51.01 71.25 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.195 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.21 -34.67 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.929 0.786 . . . . 0.0 112.096 -172.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -77.59 -32.68 53.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.132 0.573 . . . . 0.0 110.67 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -28.05 6.08 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.301 1.905 . . . . 0.0 111.595 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p -146.08 163.55 34.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.711 2.004 . . . . 0.0 106.589 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -55.64 -32.78 63.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 112.361 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.81 138.67 45.81 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -58.73 120.06 8.26 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.949 1.249 . . . . 0.0 110.231 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 36.91 75.84 0.49 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.014 2.526 . . . . 0.0 110.972 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.54 -23.75 8.19 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.323 3.349 . . . . 0.0 117.735 -169.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.28 22.47 13.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.375 0.989 . . . . 0.0 112.238 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.09 0.556 . . . . 0.0 109.792 169.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.36 163.71 33.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.401 1.08 . . . . 0.0 109.69 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -122.13 149.21 43.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.82 135.04 95.75 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.548 -0.739 . . . . 0.0 111.33 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.36 138.96 73.92 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.274 2.649 . . . . 0.0 111.869 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp -160.1 146.15 15.58 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -76.1 -8.91 58.08 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -58.75 147.44 33.23 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.548 1.067 . . . . 0.0 109.069 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.99 -41.08 46.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.954 0.902 . . . . 0.0 112.09 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -56.35 -20.27 18.43 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.6 mmm -134.65 -6.26 2.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.836 1.254 . . . . 0.0 113.051 -171.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -62.75 -26.8 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.947 1.249 . . . . 0.0 113.179 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.98 16.56 18.11 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.68 1.133 . . . . 0.0 112.457 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -71.06 158.83 35.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 159.51 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.723 1.209 . . . . 0.0 112.82 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 59.9 16.24 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.996 1.718 . . . . 0.0 113.557 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.3 m -69.36 -42.01 75.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.531 1.059 . . . . 0.0 111.427 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -167.82 -178.71 3.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.566 1.546 . . . . 0.0 108.005 -169.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m 60.55 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.908 2.883 . . . . 0.0 112.418 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.27 -44.88 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.034 0.834 . . . . 0.0 111.117 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.4 pt -65.43 -40.86 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.279 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -45.85 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.92 -38.91 83.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 110.804 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.37 -53.0 49.8 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.602 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.7 pt -70.17 -34.52 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.86 0.754 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -71.23 -48.12 53.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.276 0.489 . . . . 0.0 110.22 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.46 -23.1 4.32 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.549 1.071 . . . . 0.0 111.841 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -52.63 -21.41 3.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.663 1.585 . . . . 0.0 113.748 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.7 -32.55 65.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.324 -0.86 . . . . 0.0 111.866 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.82 1.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.436 1.094 . . . . 0.0 113.508 -170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -137.84 165.28 26.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.721 1.608 . . . . 0.0 108.745 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -59.41 141.88 87.35 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.719 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.15 -40.42 60.14 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.097 2.531 . . . . 0.0 113.868 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -155.54 150.6 26.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.205 1.402 . . . . 0.0 108.02 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--O 1.247 0.964 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -125.13 -15.37 6.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.906 0.882 . . . . 0.0 111.489 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -78.94 41.69 0.44 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.368 2.267 . . . . 0.0 113.153 -170.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.84 122.38 81.96 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.043 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.47 125.22 18.42 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.384 2.723 . . . . 0.0 115.338 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt -140.74 160.62 39.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -69.14 -23.51 63.97 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.669 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -58.57 133.19 55.63 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.973 0.806 . . . . 0.0 109.037 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -49.39 -39.85 33.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.584 1.154 . . . . 0.0 112.013 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -54.55 -21.56 10.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.9 1.28 . . . . 0.0 112.843 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.5 mmm -126.61 31.9 5.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.812 1.245 . . . . 0.0 111.261 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -117.28 -28.9 6.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.283 1.033 . . . . 0.0 109.731 168.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.23 -12.21 84.81 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.758 0.708 . . . . 0.0 112.633 170.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.402 ' C ' ' H ' ' A' ' 77' ' ' LYS . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 75' ' ' TYR . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -69.51 174.98 4.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -137.43 158.07 45.21 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.044 0.938 . . . . 0.0 109.135 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.23 32.96 1.52 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.349 1.46 . . . . 0.0 108.681 170.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 m -136.53 24.32 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 111.499 -169.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.25 -47.13 69.31 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.497 0.719 . . . . 0.0 111.415 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -61.06 -33.06 72.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.962 0.505 . . . . 0.0 111.727 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.77 -43.49 30.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 121.85 -0.531 . . . . 0.0 111.121 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.06 -36.93 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 118.492 0.587 . . . . 0.0 109.979 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.57 -46.05 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.41 -38.64 77.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.839 1.199 . . . . 0.0 111.942 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -67.75 -44.69 76.91 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.891 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.0 pt -76.65 -28.33 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.744 1.156 . . . . 0.0 111.613 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -88.47 -143.1 0.13 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.376 1.47 . . . . 0.0 107.673 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.04 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.92 0 CA-C-N 119.826 1.194 . . . . 0.0 114.184 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.4 p -72.74 -49.08 33.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.428 1.614 . . . . 0.0 109.808 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.9 t80 166.55 -39.37 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 130.164 3.386 . . . . 0.0 107.588 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -145.24 -5.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.184 0.993 . . . . 0.0 113.512 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.78 -173.92 3.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.45 1.9 . . . . 0.0 106.428 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -137.29 143.42 41.48 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.34 105.31 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 105.897 -2.386 . . . . 0.0 105.897 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -53.44 113.06 1.03 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.265 1.026 . . . . 0.0 110.625 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -129.62 172.65 11.38 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.146 0.978 . . . . 0.0 108.771 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -71.44 140.11 49.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.625 0.77 . . . . 0.0 111.461 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.75 97.34 17.29 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.41 109.37 0.29 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.019 3.146 . . . . 0.0 112.556 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -140.35 169.69 17.2 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -71.9 -30.29 65.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.669 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 p -60.75 134.66 57.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.08 0.952 . . . . 0.0 109.023 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.13 -42.75 66.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.196 0.598 . . . . 0.0 111.805 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -58.92 -21.91 58.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.303 0.641 . . . . 0.0 112.389 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.1 21.59 9.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.551 1.54 . . . . 0.0 110.703 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -118.39 -38.91 3.09 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.03 1.332 . . . . 0.0 109.674 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.73 -5.36 88.41 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.233 0.92 . . . . 0.0 111.764 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -63.84 151.61 41.91 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -63.92 150.9 44.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.418 0.687 . . . . 0.0 112.157 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -140.72 152.93 45.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.565 1.946 . . . . 0.0 106.342 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.9 m -56.63 142.03 41.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -169.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -151.58 146.28 25.74 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.752 1.621 . . . . 0.0 107.078 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 m -54.22 -32.92 57.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.984 0.913 . . . . 0.0 113.131 -173.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.93 -35.88 37.12 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 111.967 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 pt -71.75 -34.63 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.784 0.72 . . . . 0.0 110.241 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.66 -45.69 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -35.01 75.28 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.502 -0.749 . . . . 0.0 111.663 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -42.72 90.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.839 0.855 . . . . 0.0 112.117 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 pt -74.6 -31.05 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.85 0.75 . . . . 0.0 110.612 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.37 -172.84 1.89 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.136 0.974 . . . . 0.0 108.741 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -89.95 -13.27 60.95 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.286 -0.884 . . . . 0.0 111.901 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 p -65.43 -8.03 16.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.972 1.386 . . . . 0.0 114.521 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -64.33 -20.37 66.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.603 1.092 . . . . 0.0 111.633 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -136.73 -33.36 0.79 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.137 0.975 . . . . 0.0 112.429 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.59 153.93 42.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -61.21 153.72 66.05 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.004 0.922 . . . . 0.0 109.824 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.2 -36.3 55.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.189 2.593 . . . . 0.0 113.189 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -152.95 157.14 40.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.979 1.712 . . . . 0.0 107.827 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.246 0.905 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.115 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.43 164.72 35.17 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.258 1.423 . . . . 0.0 108.32 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -65.08 152.65 42.97 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 111.266 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.3 mt -123.94 145.83 49.1 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.422 1.089 . . . . 0.0 108.74 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.6 130.82 42.56 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.165 2.577 . . . . 0.0 114.175 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.18 160.13 43.91 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -70.11 -22.3 63.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.577 0.751 . . . . 0.0 112.454 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 p -65.05 144.06 57.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 109.358 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.8 tp -47.04 -45.67 21.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.458 1.103 . . . . 0.0 111.058 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -54.74 -21.96 12.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.167 1.387 . . . . 0.0 113.136 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mmm -132.49 29.16 4.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.046 1.294 . . . . 0.0 112.659 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -129.34 -18.05 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.149 0.979 . . . . 0.0 110.611 168.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.53 88.12 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' HE3' ' A' ' 85' ' ' LYS . 26.0 p90 -84.25 138.62 32.85 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -70.54 158.12 36.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' HE3' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -153.29 -32.79 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -61.24 123.06 16.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.142 0.883 . . . . 0.0 109.253 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.49 -49.46 70.09 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.85 0.86 . . . . 0.0 112.578 -169.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 m -62.31 -37.32 85.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.544 0.337 . . . . 0.0 111.007 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.61 -41.52 54.16 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.205 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.21 -38.64 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 118.786 0.721 . . . . 0.0 110.168 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.16 -44.0 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 119.113 0.87 . . . . 0.0 109.297 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.91 86.13 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.952 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.37 -43.66 80.87 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.911 1.232 . . . . 0.0 111.35 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.7 pt -74.14 -22.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.669 1.122 . . . . 0.0 112.215 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -113.04 2.21 15.64 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.964 1.256 . . . . 0.0 114.023 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.76 -131.56 1.74 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.533 1.061 . . . . 0.0 110.462 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.0 p -135.07 -59.75 0.78 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.687 0.795 . . . . 0.0 110.678 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.89 20.58 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.459 1.904 . . . . 0.0 108.946 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -151.76 147.17 26.36 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.672 2.789 . . . . 0.0 103.72 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.05 33.17 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.242 0.928 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.37 151.41 57.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.928 1.691 . . . . 0.0 107.163 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.32 -35.85 66.05 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.262 2.641 . . . . 0.0 113.287 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -148.5 147.36 29.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.084 -177.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.23 -55.91 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.455 0.702 . . . . 0.0 109.21 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -65.79 164.44 14.7 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.781 1.232 . . . . 0.0 111.417 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -122.52 130.66 24.57 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -48.69 132.49 25.85 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 114.037 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.61 153.53 34.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.36 -15.35 58.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.331 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -62.49 147.79 47.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.364 0.984 . . . . 0.0 108.832 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.0 tp -51.66 -39.19 57.74 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.248 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.2 -26.68 40.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.893 0.877 . . . . 0.0 112.605 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.3 mmm -121.07 7.71 10.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.999 1.319 . . . . 0.0 110.99 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -82.99 51.47 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.381 -1.45 . . . . 0.0 109.67 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.54 -11.31 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.67 -0.644 . . . . 0.0 112.596 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -75.12 146.01 41.73 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.8 p -76.88 -15.43 59.7 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.497 -0.752 . . . . 0.0 112.57 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.74 -29.61 62.72 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.201 1.401 . . . . 0.0 113.417 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 p -76.26 44.57 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.17 1.788 . . . . 0.0 111.255 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.9 -50.02 58.25 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.415 1.486 . . . . 0.0 112.929 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -65.0 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.788 -0.57 . . . . 0.0 111.979 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.56 -47.41 40.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.49 -0.756 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -64.99 -34.15 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 O-C-N 122.193 -0.317 . . . . 0.0 110.393 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.91 -40.52 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.62 0.646 . . . . 0.0 110.241 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.1 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.408 -0.808 . . . . 0.0 111.425 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.59 -48.13 64.96 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.789 1.177 . . . . 0.0 111.42 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.4 pt -88.17 -20.25 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -123.51 -57.69 1.64 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.832 1.196 . . . . 0.0 109.442 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.92 -52.57 0.7 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 m -58.23 148.79 25.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.244 1.418 . . . . 0.0 109.215 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -59.88 -34.53 73.29 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.336 0.654 . . . . 0.0 111.856 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -122.36 157.28 32.18 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -82.59 80.31 8.76 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -130.59 157.1 78.62 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 126.674 1.99 . . . . 0.0 106.492 174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.65 -57.39 2.3 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.858 2.372 . . . . 0.0 113.92 -170.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -150.08 38.36 0.73 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 110.151 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.983 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -171.441 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 113.965 0.717 . . . . 0.0 113.965 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 N--CA 1.456 -0.723 0 N-CA-C 113.558 0.561 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 113.701 0.616 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 N--CA 1.458 -0.603 0 CA-C-O 121.692 0.622 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 CA-C-O 119.262 -0.744 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 CA-C-O 121.357 0.482 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.46 -0.462 0 CA-C-O 121.408 0.503 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.494 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.536 0.586 0 N-CA-C 113.743 0.632 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.611 0 CA-C-O 121.333 0.472 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 121.486 0.536 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 23' ' ' LEU . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.28 0 CA-C-O 120.196 -0.225 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 113.639 0.592 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HB3' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 36' ' ' GLN . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 114.232 0.82 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' H ' HD23 ' A' ' 14' ' ' LEU . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 CA-C-O 120.137 -0.257 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-O 121.523 0.551 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 N-CA-C 114.896 1.075 . . . . 0.0 114.896 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 121.502 0.542 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 CA-C-O 119.872 -0.405 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 115.338 1.246 . . . . 0.0 115.338 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 112.556 0.175 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo . . . . . 0 N--CA 1.457 -0.668 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -141.27 139.39 33.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -72.38 162.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.522 0.729 . . . . 0.0 110.899 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.5 mp -115.27 144.24 31.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.29 136.86 77.64 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.888 2.392 . . . . 0.0 113.965 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD13 ' H ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -147.79 153.24 38.96 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' H ' HD13 ' A' ' 43' ' ' LEU . 57.1 tttm -70.44 -17.8 63.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 p -68.46 148.59 50.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.753 0.821 . . . . 0.0 109.679 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.53 -36.98 67.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.513 0.725 . . . . 0.0 112.052 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -59.71 -11.9 5.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.3 mmm -137.55 27.08 2.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.152 1.381 . . . . 0.0 110.396 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -93.92 -33.14 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.436 -0.79 . . . . 0.0 111.24 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.51 -3.51 61.18 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.78 141.35 30.57 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -67.09 163.26 20.48 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.098 0.475 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 78.2 mttt 63.1 26.39 15.34 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 111.416 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.4 m -163.28 47.39 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.506 2.722 . . . . 0.0 105.09 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -145.37 169.82 17.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.697 1.599 . . . . 0.0 110.493 -168.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 m -54.4 -29.33 48.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.436 1.494 . . . . 0.0 114.27 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.91 -46.49 71.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.98 1.263 . . . . 0.0 110.912 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 pt -71.02 -32.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.332 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -46.03 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.23 82.88 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.663 -0.648 . . . . 0.0 111.198 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.71 -47.49 78.11 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -70.83 -32.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 119.851 1.205 . . . . 0.0 111.576 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.75 -26.85 65.44 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.527 0.603 . . . . 0.0 111.426 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 -21.23 43.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.42 1.486 . . . . 0.0 111.414 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 p -59.41 -14.43 12.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.764 1.626 . . . . 0.0 113.46 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -54.32 -34.45 61.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.851 0.86 . . . . 0.0 111.677 169.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.5 -20.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -67.02 148.71 51.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.372 0.987 . . . . 0.0 109.751 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.65 156.03 91.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.54 -29.08 44.83 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.27 1.98 . . . . 0.0 112.067 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -150.93 156.38 41.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.558 1.943 . . . . 0.0 107.076 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.433 -1.27 . . . . 0.0 110.827 -176.28 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.42 150.67 47.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.924 0.49 . . . . 0.0 109.756 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.32 148.65 40.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 169.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.86 110.83 1.49 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 111.152 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.27 125.97 16.33 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.714 2.943 . . . . 0.0 113.558 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.88 160.07 36.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.97 -15.55 60.66 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.807 -0.558 . . . . 0.0 112.394 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -60.21 151.3 27.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.124 0.969 . . . . 0.0 109.778 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.61 -25.55 62.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -58.11 -23.0 53.25 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.981 1.712 . . . . 0.0 112.574 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.44 23.0 4.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.445 1.498 . . . . 0.0 110.073 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -60.19 -33.07 71.71 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.766 -1.209 . . . . 0.0 112.959 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.83 29.07 1.57 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.698 1.142 . . . . 0.0 111.567 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.64 143.03 57.24 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.7 p -64.14 3.94 0.38 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.43 -26.04 62.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.068 1.304 . . . . 0.0 109.703 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 35.9 -119.73 0.13 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.964 2.505 . . . . 0.0 113.39 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.29 175.86 13.46 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.796 1.238 . . . . 0.0 109.935 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 m -49.31 -24.82 2.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.739 2.015 . . . . 0.0 115.016 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.18 -45.36 92.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 119.5 1.046 . . . . 0.0 111.676 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -72.76 -29.0 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 O-C-N 121.718 -0.614 . . . . 0.0 110.315 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -62.92 -43.12 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.19 77.71 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.447 -0.783 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -59.51 -51.71 68.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.631 1.105 . . . . 0.0 110.336 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.22 -32.68 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.52 1.055 . . . . 0.0 111.825 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.19 -18.45 61.25 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.146 0.579 . . . . 0.0 111.878 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.7 57.57 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.376 0.989 . . . . 0.0 112.091 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 p -65.16 -3.71 4.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.069 1.435 . . . . 0.0 113.474 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -61.53 -21.89 64.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.136 -0.977 . . . . 0.0 110.637 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -138.14 -31.51 0.76 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.464 1.105 . . . . 0.0 112.575 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.34 157.96 30.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.917 0.78 . . . . 0.0 109.007 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -138.07 156.2 74.11 Favored Pre-proline 0 N--CA 1.465 0.285 0 C-N-CA 124.1 0.96 . . . . 0.0 109.466 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.6 -26.17 54.22 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.395 2.063 . . . . 0.0 112.034 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -138.93 140.4 38.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.627 -178.317 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.78 170.35 19.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.196 1.398 . . . . 0.0 108.523 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.56 152.68 38.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.981 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mp -101.14 126.56 34.43 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.12 131.05 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 113.701 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -145.92 164.42 32.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -76.75 -5.61 48.81 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -67.36 146.67 53.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.118 0.872 . . . . 0.0 109.449 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.52 -38.75 78.39 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.195 -0.94 . . . . 0.0 110.894 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -62.2 -5.7 2.53 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 mmt -130.31 22.78 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.137 1.375 . . . . 0.0 110.69 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -122.42 -21.11 5.87 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.34 1.456 . . . . 0.0 110.588 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.36 -16.05 67.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -81.04 170.28 16.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.85 -172.44 3.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.767 0.827 . . . . 0.0 110.572 -174.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.4 159.71 28.18 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 m -67.06 165.22 16.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.015 0.926 . . . . 0.0 112.09 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -42.36 -42.08 3.06 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.383 1.873 . . . . 0.0 112.231 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 m -58.28 -27.1 63.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.576 1.15 . . . . 0.0 114.039 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.14 -36.97 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.442 0.697 . . . . 0.0 111.646 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 pt -63.69 -35.97 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.28 -36.95 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.087 0.858 . . . . 0.0 109.473 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.64 93.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.736 0.698 . . . . 0.0 110.863 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -47.74 83.61 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.377 0.671 . . . . 0.0 111.047 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 pt -88.16 -20.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.719 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -143.29 -66.36 0.37 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 119.218 0.917 . . . . 0.0 110.821 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.24 -173.61 32.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -169.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.5 m 59.58 79.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -55.95 140.59 42.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 44.73 63.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.132 1.373 . . . . 0.0 110.195 -168.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.85 144.45 11.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.595 0.758 . . . . 0.0 110.415 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -142.06 82.49 13.38 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 126.178 1.791 . . . . 0.0 106.202 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.56 -36.06 97.84 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.187 1.925 . . . . 0.0 113.86 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -152.63 37.44 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 110.995 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.5 tttp . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -172.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.849 -0.056 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 58.61 178.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.222 1.809 . . . . 0.0 112.59 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -69.3 168.26 14.65 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.665 0.786 . . . . 0.0 111.505 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.84 132.86 22.11 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.95 123.32 7.22 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.681 2.921 . . . . 0.0 112.683 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt -138.44 169.06 18.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -74.5 -23.61 58.87 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.472 . . . . 0.0 110.717 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -52.3 125.39 15.83 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.733 1.613 . . . . 0.0 108.906 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.1 tp -52.14 -46.55 65.46 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.399 0.679 . . . . 0.0 111.916 -172.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.03 -16.09 39.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.9 tpt -126.97 26.55 6.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 110.79 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -117.61 -28.6 5.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.362 1.865 . . . . 0.0 108.888 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.94 -7.62 73.94 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.737 0.684 . . . . 0.0 111.393 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.09 155.37 32.48 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -72.29 86.73 1.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.538 0.685 . . . . 0.0 111.355 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -57.14 -14.36 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.911 1.284 . . . . 0.0 113.458 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -120.23 24.09 10.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.45 . . . . 0.0 110.965 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -49.61 -45.09 47.68 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.668 1.187 . . . . 0.0 112.19 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -58.98 -37.59 77.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.052 0.541 . . . . 0.0 111.729 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.47 -44.21 52.59 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 122.855 0.462 . . . . 0.0 110.939 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 pt -69.89 -35.85 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.612 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.75 -45.34 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -33.71 74.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.943 0.792 . . . . 0.0 111.659 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 39.0 ttpt -63.59 -53.09 57.04 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.012 0.525 . . . . 0.0 110.211 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.31 -32.41 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.466 0.575 . . . . 0.0 111.348 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -70.4 -39.25 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.467 0.707 . . . . 0.0 111.12 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.75 30.09 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.829 1.204 . . . . 0.0 111.685 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 p -59.31 -22.51 61.34 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.698 1.249 . . . . 0.0 112.623 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 7.2 p90 -55.6 -24.71 34.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.392 0.996 . . . . 0.0 112.764 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -125.35 -26.24 3.64 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.78 -33.38 58.04 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.821 0.737 . . . . 0.0 110.852 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -143.02 67.74 17.53 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 125.039 1.335 . . . . 0.0 109.037 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.84 -24.29 68.25 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.888 1.725 . . . . 0.0 111.931 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.98 129.64 19.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.508 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.86 -29.92 35.7 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.16 157.97 36.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.198 0.999 . . . . 0.0 110.545 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.77 149.88 66.03 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.379 1.072 . . . . 0.0 110.354 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.69 134.9 64.94 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.83 3.02 . . . . 0.0 116.279 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt -143.09 167.4 22.17 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.26 3.09 55.73 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 111.737 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 p -59.75 151.75 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.58 -42.44 74.74 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.648 -0.658 . . . . 0.0 110.986 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -59.39 -22.35 61.25 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.953 0.501 . . . . 0.0 111.966 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.8 mmm -117.92 10.87 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.993 1.317 . . . . 0.0 111.0 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -50.28 -47.98 55.19 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.27 1.028 . . . . 0.0 109.611 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.02 32.19 3.33 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.647 1.118 . . . . 0.0 111.367 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -74.32 137.03 42.58 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -63.55 155.44 29.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.515 0.674 . . . . 0.0 111.777 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -144.29 164.57 30.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.671 1.988 . . . . 0.0 106.407 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.8 m -52.79 126.31 19.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.39 0.676 . . . . 0.0 109.418 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -152.48 141.79 21.52 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.115 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 m -59.52 -15.36 17.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.74 -47.15 15.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 120.141 1.337 . . . . 0.0 111.28 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.2 -32.58 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 122.156 -0.34 . . . . 0.0 110.535 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.61 -41.07 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.83 92.61 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.49 -0.756 . . . . 0.0 111.699 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -56.74 -53.47 57.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.454 0.57 . . . . 0.0 110.293 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.6 -27.4 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.411 0.55 . . . . 0.0 111.625 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.36 -46.62 87.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.922 0.783 . . . . 0.0 109.179 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.73 -15.28 1.21 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.668 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -145.22 107.79 4.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.256 1.528 . . . . 0.0 108.64 -169.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -51.99 -39.0 58.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.773 0.829 . . . . 0.0 112.749 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.19 -32.38 73.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.659 0.784 . . . . 0.0 111.63 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.7 112.4 19.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -60.45 144.77 87.96 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.35 -34.19 31.45 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.115 2.543 . . . . 0.0 115.786 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -128.81 38.58 3.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.612 1.165 . . . . 0.0 109.962 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.277 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.819 0.343 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.77 145.35 28.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -73.3 129.46 38.08 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.74 142.51 93.88 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.395 0.678 . . . . 0.0 110.941 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.24 134.59 61.43 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.98 2.453 . . . . 0.0 111.993 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -137.09 166.86 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -69.7 -21.36 63.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.277 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -63.79 134.08 54.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.614 1.097 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.56 -40.45 65.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.186 0.595 . . . . 0.0 111.955 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.15 -21.45 32.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.984 0.914 . . . . 0.0 112.542 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.3 mmt -129.0 29.49 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.893 1.277 . . . . 0.0 110.025 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -123.75 -35.36 2.89 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.013 1.325 . . . . 0.0 110.318 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.84 -11.02 85.82 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.435 0.561 . . . . 0.0 112.104 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -75.13 150.6 38.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 143.8 54.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.358 0.599 . . . . 0.0 112.098 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.97 170.79 15.48 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.341 2.256 . . . . 0.0 107.034 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.6 m -54.64 146.71 16.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.849 0.86 . . . . 0.0 110.804 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.24 148.16 28.55 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.632 1.573 . . . . 0.0 107.17 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 m -52.88 -33.74 51.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.307 1.043 . . . . 0.0 113.44 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -49.36 52.05 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.399 1.0 . . . . 0.0 110.981 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.1 pt -71.42 -33.44 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.522 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.14 -46.08 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.75 82.13 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.147 0.885 . . . . 0.0 110.087 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -53.49 -51.3 63.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.614 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.45 -31.51 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 119.327 0.967 . . . . 0.0 112.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.57 -41.81 68.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 0.0 111.374 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.21 47.8 0.08 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.97 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.3 m 69.34 161.39 0.21 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.5 1.52 . . . . 0.0 110.905 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -50.98 -31.57 18.34 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.06 -1.025 . . . . 0.0 112.1 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.9 mmpt? -140.05 137.93 34.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 168.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -72.1 -32.7 67.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -62.3 151.27 82.56 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.777 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.93 -37.81 78.45 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.696 2.264 . . . . 0.0 112.703 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -158.54 163.52 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.129 1.772 . . . . 0.0 108.659 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.249 1.05 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.543 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -133.31 176.94 8.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 109.24 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -55.94 137.5 50.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.321 1.448 . . . . 0.0 111.011 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.09 150.7 97.42 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.849 0.86 . . . . 0.0 111.558 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.15 137.74 63.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.706 2.937 . . . . 0.0 112.619 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt -142.9 169.87 16.77 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -72.68 -27.3 62.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 110.965 169.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -58.48 131.03 49.54 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.437 1.495 . . . . 0.0 109.247 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -49.9 -45.75 51.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.145 0.978 . . . . 0.0 112.338 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.53 -18.76 43.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.56 0.744 . . . . 0.0 112.559 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.32 25.03 5.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.254 1.422 . . . . 0.0 110.521 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -120.41 -30.64 4.52 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.363 1.465 . . . . 0.0 109.802 169.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.67 -8.49 76.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.215 0.912 . . . . 0.0 111.07 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -66.32 160.81 23.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -54.16 129.51 35.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.508 0.723 . . . . 0.0 111.673 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -156.85 154.85 30.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.21 2.204 . . . . 0.0 106.57 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 m -143.93 10.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -142.48 -61.91 0.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.002 1.274 . . . . 0.0 112.055 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 m -59.16 -38.18 79.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.335 0.516 . . . . 0.0 111.27 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.25 -52.47 61.99 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 122.831 0.452 . . . . 0.0 111.487 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.7 pt -67.06 -33.13 61.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.426 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.2 -49.43 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.22 72.63 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.938 0.79 . . . . 0.0 111.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -67.91 -46.03 72.71 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.786 0.834 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -73.75 -34.4 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.982 0.81 . . . . 0.0 111.537 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.48 -28.07 64.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.541 0.61 . . . . 0.0 111.525 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.32 -13.68 64.27 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.907 1.241 . . . . 0.0 112.056 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -60.17 -12.46 8.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.599 1.699 . . . . 0.0 113.123 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -54.21 -38.73 66.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 111.767 169.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -158.51 -25.35 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.99 -36.79 78.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.258 0.935 . . . . 0.0 110.655 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 150.53 60.88 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.15 -39.83 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.477 1.451 . . . . 0.0 112.585 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -159.01 48.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.861 0.864 . . . . 0.0 110.471 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.248 1.001 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.16 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.62 -41.37 79.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.883 -0.511 . . . . 0.0 111.668 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -71.64 149.96 45.07 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.354 0.661 . . . . 0.0 111.297 -171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.2 mt -70.94 149.12 94.89 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.4 -2.57 10.59 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.149 2.566 . . . . 0.0 113.743 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp -148.41 166.54 27.81 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -74.74 -23.53 58.58 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.618 -0.677 . . . . 0.0 112.254 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.5 143.6 57.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.126 0.876 . . . . 0.0 109.234 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -31.52 64.06 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.517 -0.739 . . . . 0.0 111.799 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.96 -26.75 27.22 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.453 1.501 . . . . 0.0 112.454 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 mmm -136.42 32.48 2.81 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.465 1.029 . . . . 0.0 110.307 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -125.88 -27.27 3.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.966 1.306 . . . . 0.0 110.423 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.35 -5.66 89.38 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -75.25 153.22 38.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -62.25 137.7 58.3 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.579 -0.7 . . . . 0.0 111.482 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -138.21 33.62 2.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.341 1.856 . . . . 0.0 108.812 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -67.5 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.115 2.566 . . . . 0.0 115.152 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -52.06 -48.89 64.41 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.127 1.371 . . . . 0.0 112.235 -169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m -62.14 -34.96 77.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 111.559 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -75.86 -44.9 38.45 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 122.889 0.475 . . . . 0.0 110.58 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 pt -68.34 -32.82 57.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.635 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -61.48 -47.21 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.21 86.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.553 1.07 . . . . 0.0 111.295 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -55.44 -54.28 45.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.078 0.853 . . . . 0.0 110.854 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.3 pt -70.74 -29.92 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.273 0.942 . . . . 0.0 111.876 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -66.44 -31.41 72.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.141 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.2 -55.63 0.08 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.14 0.882 . . . . 0.0 112.084 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -164.55 150.82 10.7 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -58.45 -9.99 1.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -137.32 20.93 2.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.319 1.448 . . . . 0.0 111.706 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.97 136.37 38.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.029 0.831 . . . . 0.0 109.376 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -68.32 146.33 97.87 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.184 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.35 -41.39 4.84 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.79 1.66 . . . . 0.0 110.772 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -149.59 158.46 44.19 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.353 2.261 . . . . 0.0 107.226 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? . . . . . 0 C--O 1.249 1.066 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 170.03 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -138.32 -41.2 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.384 0.674 . . . . 0.0 110.189 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -119.45 143.65 47.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.852 1.661 . . . . 0.0 106.536 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.14 130.12 92.63 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 118.755 -0.641 . . . . 0.0 111.67 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.3 128.62 30.32 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.231 2.62 . . . . 0.0 113.023 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.36 167.93 22.37 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.75 -16.57 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -62.52 141.07 58.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.693 1.133 . . . . 0.0 108.996 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.2 -36.62 80.37 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 110.881 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -60.31 -11.27 6.07 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -121.85 20.67 10.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.316 1.446 . . . . 0.0 111.234 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.8 mtm105 -120.46 -29.13 4.84 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.7 1.6 . . . . 0.0 108.693 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.91 -10.57 84.88 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -76.58 171.05 15.29 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -142.81 -166.15 2.22 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.525 1.53 . . . . 0.0 108.519 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -117.58 167.13 11.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 109.159 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.6 m -55.3 140.58 38.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.65 1.18 . . . . 0.0 113.509 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -56.3 158.91 3.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.634 1.173 . . . . 0.0 111.054 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m 66.72 -42.68 0.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.587 2.355 . . . . 0.0 112.525 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.51 -51.75 39.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.559 1.072 . . . . 0.0 110.51 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 pt -62.81 -35.51 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.198 -0.429 . . . . 0.0 110.683 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -63.65 -48.63 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.01 82.99 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.76 0.709 . . . . 0.0 111.13 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -61.29 -52.26 65.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.479 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.8 pt -72.5 -31.98 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.001 0.819 . . . . 0.0 111.661 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -67.36 -30.12 69.83 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.655 0.782 . . . . 0.0 111.08 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.78 46.86 6.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -131.97 0.25 3.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.429 1.492 . . . . 0.0 111.231 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.18 -44.6 94.92 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.696 1.198 . . . . 0.0 111.69 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -153.34 66.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 176.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -147.71 163.22 37.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -63.14 150.52 88.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 O-C-N 122.05 -0.406 . . . . 0.0 109.988 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.83 -3.06 13.13 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.174 2.583 . . . . 0.0 111.899 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -134.28 -174.67 3.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.299 2.239 . . . . 0.0 107.626 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.248 1.01 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.727 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -150.25 140.01 21.76 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -133.46 136.99 45.5 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.6 151.39 80.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.22 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.28 134.86 66.23 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.196 2.597 . . . . 0.0 112.864 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 23' ' ' LEU . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp -144.69 160.47 41.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.06 -21.17 59.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.429 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.4 p -68.71 140.59 55.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.279 0.945 . . . . 0.0 109.018 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.58 -30.42 54.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -57.2 -16.24 7.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.867 1.267 . . . . 0.0 113.68 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.6 21.65 6.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.756 1.623 . . . . 0.0 110.41 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -105.98 -38.88 6.18 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.39 -8.69 84.05 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.396 0.522 . . . . 0.0 113.147 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.38 144.88 28.52 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 84.94 1.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.256 0.623 . . . . 0.0 110.595 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -48.66 -51.2 29.61 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 111.325 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.0 m -151.61 157.34 42.03 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.417 1.487 . . . . 0.0 108.118 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.89 155.16 29.09 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.24 1.416 . . . . 0.0 108.304 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 m -138.02 18.66 2.81 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 111.595 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -144.13 -48.07 0.27 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.3 0.955 . . . . 0.0 113.372 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.93 -37.55 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.258 0.935 . . . . 0.0 108.613 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.17 -44.21 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.861 0.864 . . . . 0.0 108.963 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.86 94.92 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.666 -0.646 . . . . 0.0 110.927 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -48.24 82.65 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.788 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.0 pt -71.35 -29.57 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.762 0.71 . . . . 0.0 111.474 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -65.17 -42.16 93.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.781 0.718 . . . . 0.0 110.511 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.82 -67.36 0.06 OUTLIER Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.953 0.797 . . . . 0.0 111.339 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.1 p -149.86 -84.73 0.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -112.1 -11.82 13.75 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.966 1.706 . . . . 0.0 109.671 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 -175.68 4.27 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.004 2.522 . . . . 0.0 105.342 172.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.4 -7.13 5.84 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.04 145.08 99.17 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.554 1.142 . . . . 0.0 110.23 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.24 -11.75 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.857 2.371 . . . . 0.0 112.745 173.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -146.62 137.35 23.99 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.368 -174.323 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.34 170.21 19.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.003 1.321 . . . . 0.0 108.629 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -61.84 153.03 30.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.667 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.49 155.21 37.69 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.46 139.7 55.44 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.776 2.984 . . . . 0.0 113.639 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HB3' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt -144.0 156.5 44.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -82.55 -6.07 59.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 p -61.96 158.19 16.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.683 0.793 . . . . 0.0 109.469 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -53.77 -36.22 62.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.808 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -51.84 -31.06 26.11 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.045 1.338 . . . . 0.0 112.968 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.3 mtp -134.49 23.22 3.71 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.34 0.973 . . . . 0.0 110.854 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -53.75 -40.05 65.84 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.44 29.14 2.62 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.601 1.096 . . . . 0.0 111.155 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 36' ' ' GLN . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -70.35 143.58 51.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 p -60.66 -28.9 68.93 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -57.01 -17.36 9.6 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.451 0.7 . . . . 0.0 112.531 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -61.96 -18.03 59.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.309 1.044 . . . . 0.0 113.374 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -129.19 116.93 19.94 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.331 1.423 . . . . 0.0 111.389 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -63.16 -26.72 68.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.589 1.156 . . . . 0.0 113.066 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -83.42 -42.46 16.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.422 1.01 . . . . 0.0 110.869 -171.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 pt -67.76 -32.92 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.896 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.8 0.727 . . . . 0.0 109.404 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.88 97.85 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.265 0.939 . . . . 0.0 111.164 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -59.68 -48.62 80.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.334 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.7 pt -72.57 -27.81 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.626 1.103 . . . . 0.0 111.662 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.81 -42.39 97.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.055 0.843 . . . . 0.0 109.156 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.08 -27.77 0.72 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.981 -0.899 . . . . 0.0 113.754 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 m -148.52 125.06 11.03 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.718 1.259 . . . . 0.0 108.534 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -59.34 -32.32 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -69.22 -31.78 70.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.076 0.95 . . . . 0.0 111.744 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.44 147.57 50.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -64.8 118.93 53.44 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.21 -39.44 13.24 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.496 1.464 . . . . 0.0 112.824 -169.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -86.25 18.66 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.581 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.8 161.44 26.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.193 0.597 . . . . 0.0 110.541 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.77 130.05 44.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.306 0.642 . . . . 0.0 110.911 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.03 132.96 90.06 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.806 0.842 . . . . 0.0 110.345 -170.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.0 125.47 19.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.224 2.616 . . . . 0.0 114.232 170.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' H ' HD23 ' A' ' 14' ' ' LEU . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.81 164.12 32.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.51 -22.19 62.66 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.837 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -60.77 136.96 58.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.098 0.863 . . . . 0.0 109.098 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -50.94 -43.34 60.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.935 0.894 . . . . 0.0 112.091 -170.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.19 -10.46 10.66 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -136.06 17.76 3.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.955 1.702 . . . . 0.0 110.241 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -89.63 -34.24 16.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.3 1.04 . . . . 0.0 111.479 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.5 15.53 8.06 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.133 1.825 . . . . 0.0 111.578 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -79.44 165.14 23.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -138.21 116.52 11.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.1 145.31 56.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 m -67.68 -18.93 65.1 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.21 -41.85 0.42 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.165 0.986 . . . . 0.0 111.335 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -30.13 68.2 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.91 -0.494 . . . . 0.0 111.944 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.7 -46.85 67.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.411 0.551 . . . . 0.0 111.351 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.8 pt -70.2 -33.06 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.44 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.93 -46.55 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.65 74.14 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.67 -0.644 . . . . 0.0 111.705 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 60.9 mtpt -63.02 -54.5 37.33 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.92 0.782 . . . . 0.0 110.147 174.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.38 -30.52 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 119.148 0.885 . . . . 0.0 111.803 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -77.46 -11.85 59.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.828 0.851 . . . . 0.0 112.596 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.36 -16.04 10.95 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.357 0.981 . . . . 0.0 112.904 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 p -62.1 -14.49 37.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.141 1.471 . . . . 0.0 113.425 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 4.4 p90 -58.87 -27.44 65.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.949 0.795 . . . . 0.0 112.824 172.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.37 -1.93 0.39 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -139.15 175.03 9.91 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 109.627 -170.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.73 158.78 81.93 Favored Pre-proline 0 CA--C 1.539 0.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.543 169.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.17 -31.12 53.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.322 2.681 . . . . 0.0 113.877 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -147.38 147.06 29.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.018 1.727 . . . . 0.0 106.647 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.726 170.466 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.92 -48.33 80.91 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.351 0.661 . . . . 0.0 110.274 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -76.07 138.1 40.6 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.907 1.283 . . . . 0.0 108.445 170.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.58 137.59 94.9 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.367 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.5 144.35 63.11 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.198 2.599 . . . . 0.0 113.83 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -145.46 172.41 13.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -69.89 -22.48 63.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.721 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -63.63 143.12 58.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.848 0.859 . . . . 0.0 109.295 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.8 tp -51.71 -43.59 62.89 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.149 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.02 -19.69 33.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.613 1.165 . . . . 0.0 112.582 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.01 18.93 8.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.374 1.469 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -106.81 -42.0 5.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.643 1.577 . . . . 0.0 108.148 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.11 -6.98 89.03 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.322 0.487 . . . . 0.0 112.674 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -67.2 162.53 22.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -59.01 141.09 54.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -138.11 41.03 2.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.945 2.098 . . . . 0.0 108.166 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -50.84 123.26 8.73 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.223 1.409 . . . . 0.0 109.39 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.34 -50.11 65.71 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 -169.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -61.33 -36.0 78.95 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.665 0.386 . . . . 0.0 111.41 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.91 -46.56 35.11 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 122.91 0.484 . . . . 0.0 110.926 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 pt -65.81 -38.32 81.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.94 -46.94 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.55 80.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.964 0.802 . . . . 0.0 111.641 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -64.78 -49.24 71.51 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.885 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.79 -33.04 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.656 1.117 . . . . 0.0 111.831 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -71.69 -29.77 64.95 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.211 0.604 . . . . 0.0 111.301 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.93 -15.38 60.75 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.946 1.26 . . . . 0.0 111.529 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -62.5 -10.43 11.82 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.586 1.554 . . . . 0.0 112.884 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.75 -27.2 64.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.276 1.03 . . . . 0.0 111.273 169.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.67 -43.22 0.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.543 1.137 . . . . 0.0 110.593 -176.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.4 164.79 15.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.166 0.587 . . . . 0.0 110.243 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -56.06 148.8 38.19 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.346 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.01 -23.4 34.24 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.579 2.186 . . . . 0.0 112.436 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -144.58 130.62 19.42 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.338 1.855 . . . . 0.0 106.934 -179.296 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.53 157.16 34.98 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.38 136.31 56.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.68 148.19 87.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.302 0.641 . . . . 0.0 110.234 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.65 133.24 56.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.996 2.464 . . . . 0.0 112.363 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -141.52 166.3 25.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -78.02 -14.8 59.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.695 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -66.33 138.62 57.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.463 1.105 . . . . 0.0 108.888 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -44.77 -55.52 5.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.895 1.278 . . . . 0.0 114.236 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -66.46 -43.58 85.1 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.198 0.908 . . . . 0.0 110.53 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.758 0.823 . . . . 0.0 112.802 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -117.03 -28.53 6.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.814 1.646 . . . . 0.0 109.97 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.57 -12.04 73.33 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.677 1.132 . . . . 0.0 111.66 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -78.36 145.07 35.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -64.93 166.5 9.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 111.839 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -176.8 3.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.889 1.676 . . . . 0.0 108.435 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -53.31 150.38 6.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.443 1.097 . . . . 0.0 110.872 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.76 -45.48 74.22 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.781 0.832 . . . . 0.0 111.874 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.59 -36.47 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.764 0.426 . . . . 0.0 111.168 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.28 -35.54 47.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.258 -0.901 . . . . 0.0 111.553 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.5 pt -67.72 -30.91 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.4 -0.813 . . . . 0.0 110.351 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.52 -41.36 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.789 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . . . -57.47 -44.57 84.96 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 120.052 1.296 . . . . 0.0 111.314 171.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -60.75 -46.93 88.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.477 -0.773 . . . . 0.0 111.227 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.2 pt -71.08 -29.84 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.588 1.085 . . . . 0.0 111.523 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt 127.83 122.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 132.16 4.184 . . . . 0.0 106.717 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.67 178.58 48.68 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.0 p -60.9 -21.89 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.564 1.146 . . . . 0.0 113.672 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . 15.9 t80 -66.56 -8.1 24.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.627 1.103 . . . . 0.0 113.2 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 19.85 16.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.619 1.1 . . . . 0.0 111.914 169.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -129.62 -54.04 1.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.153 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -141.8 64.38 18.06 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.92 1.688 . . . . 0.0 109.248 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.88 -38.63 28.83 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.084 1.19 . . . . 0.0 111.449 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -85.73 55.33 3.47 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.61 1.164 . . . . 0.0 108.448 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.041 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.94 143.42 28.48 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mmt -78.58 152.21 31.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.14 117.56 25.52 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.265 1.826 . . . . 0.0 106.553 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.39 126.35 21.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.428 2.752 . . . . 0.0 114.896 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt -139.58 163.93 31.26 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -80.71 -8.66 59.72 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.792 0.837 . . . . 0.0 112.246 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -59.85 151.21 26.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.111 0.964 . . . . 0.0 109.252 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.89 -25.82 63.71 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.244 -0.91 . . . . 0.0 112.966 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.56 -26.85 68.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.187 0.995 . . . . 0.0 112.07 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.1 mmm -130.32 11.18 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.027 1.331 . . . . 0.0 111.819 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -59.98 -29.73 68.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.49 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.7 25.28 2.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.998 1.285 . . . . 0.0 112.412 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -78.98 169.95 17.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -134.76 -173.56 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.712 1.205 . . . . 0.0 108.201 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.79 156.15 46.51 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -59.5 147.24 37.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.527 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -146.92 145.78 29.91 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.625 1.17 . . . . 0.0 107.927 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -53.03 -31.72 42.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.468 1.107 . . . . 0.0 113.545 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.4 -48.01 52.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.697 1.135 . . . . 0.0 111.608 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.65 -33.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.142 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.65 -45.24 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.3 89.06 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.224 0.92 . . . . 0.0 110.711 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -57.62 -51.01 71.25 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.195 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.21 -34.67 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.929 0.786 . . . . 0.0 112.096 -172.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -77.59 -32.68 53.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.132 0.573 . . . . 0.0 110.67 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -28.05 6.08 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.301 1.905 . . . . 0.0 111.595 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p -146.08 163.55 34.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.711 2.004 . . . . 0.0 106.589 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -55.64 -32.78 63.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 112.361 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -133.81 138.67 45.81 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -58.73 120.06 8.26 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.949 1.249 . . . . 0.0 110.231 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 36.91 75.84 0.49 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.014 2.526 . . . . 0.0 110.972 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.54 -23.75 8.19 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.323 3.349 . . . . 0.0 117.735 -169.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.28 22.47 13.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.375 0.989 . . . . 0.0 112.238 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.09 0.556 . . . . 0.0 109.792 169.921 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.36 163.71 33.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.401 1.08 . . . . 0.0 109.69 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -122.13 149.21 43.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.82 135.04 95.75 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.548 -0.739 . . . . 0.0 111.33 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.36 138.96 73.92 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.274 2.649 . . . . 0.0 111.869 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp -160.1 146.15 15.58 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -76.1 -8.91 58.08 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -58.75 147.44 33.23 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.548 1.067 . . . . 0.0 109.069 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.99 -41.08 46.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.954 0.902 . . . . 0.0 112.09 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -56.35 -20.27 18.43 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.6 mmm -134.65 -6.26 2.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.836 1.254 . . . . 0.0 113.051 -171.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -62.75 -26.8 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.947 1.249 . . . . 0.0 113.179 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.98 16.56 18.11 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.68 1.133 . . . . 0.0 112.457 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -71.06 158.83 35.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 159.51 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.723 1.209 . . . . 0.0 112.82 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 59.9 16.24 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.996 1.718 . . . . 0.0 113.557 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.3 m -69.36 -42.01 75.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.531 1.059 . . . . 0.0 111.427 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -167.82 -178.71 3.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.566 1.546 . . . . 0.0 108.005 -169.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m 60.55 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.908 2.883 . . . . 0.0 112.418 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.27 -44.88 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.034 0.834 . . . . 0.0 111.117 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.4 pt -65.43 -40.86 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.279 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -45.85 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.92 -38.91 83.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 110.804 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.37 -53.0 49.8 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.602 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.7 pt -70.17 -34.52 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.86 0.754 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -71.23 -48.12 53.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.276 0.489 . . . . 0.0 110.22 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.46 -23.1 4.32 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.549 1.071 . . . . 0.0 111.841 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -52.63 -21.41 3.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.663 1.585 . . . . 0.0 113.748 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.7 -32.55 65.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.324 -0.86 . . . . 0.0 111.866 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.82 1.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.436 1.094 . . . . 0.0 113.508 -170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -137.84 165.28 26.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.721 1.608 . . . . 0.0 108.745 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -59.41 141.88 87.35 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.719 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.15 -40.42 60.14 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.097 2.531 . . . . 0.0 113.868 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -155.54 150.6 26.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.205 1.402 . . . . 0.0 108.02 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--O 1.247 0.964 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -125.13 -15.37 6.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.906 0.882 . . . . 0.0 111.489 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -78.94 41.69 0.44 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.368 2.267 . . . . 0.0 113.153 -170.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.84 122.38 81.96 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.043 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.47 125.22 18.42 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.384 2.723 . . . . 0.0 115.338 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt -140.74 160.62 39.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -69.14 -23.51 63.97 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.669 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -58.57 133.19 55.63 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.973 0.806 . . . . 0.0 109.037 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -49.39 -39.85 33.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.584 1.154 . . . . 0.0 112.013 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -54.55 -21.56 10.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.9 1.28 . . . . 0.0 112.843 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.5 mmm -126.61 31.9 5.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.812 1.245 . . . . 0.0 111.261 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -117.28 -28.9 6.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.283 1.033 . . . . 0.0 109.731 168.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.23 -12.21 84.81 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.758 0.708 . . . . 0.0 112.633 170.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -69.51 174.98 4.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -137.43 158.07 45.21 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.044 0.938 . . . . 0.0 109.135 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.23 32.96 1.52 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.349 1.46 . . . . 0.0 108.681 170.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 m -136.53 24.32 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 111.499 -169.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.25 -47.13 69.31 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.497 0.719 . . . . 0.0 111.415 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -61.06 -33.06 72.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.962 0.505 . . . . 0.0 111.727 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.77 -43.49 30.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 121.85 -0.531 . . . . 0.0 111.121 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.06 -36.93 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 118.492 0.587 . . . . 0.0 109.979 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.57 -46.05 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.41 -38.64 77.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.839 1.199 . . . . 0.0 111.942 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -67.75 -44.69 76.91 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.891 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.0 pt -76.65 -28.33 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.744 1.156 . . . . 0.0 111.613 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -88.47 -143.1 0.13 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.376 1.47 . . . . 0.0 107.673 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.04 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.92 0 CA-C-N 119.826 1.194 . . . . 0.0 114.184 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.4 p -72.74 -49.08 33.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.428 1.614 . . . . 0.0 109.808 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.9 t80 166.55 -39.37 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 130.164 3.386 . . . . 0.0 107.588 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -145.24 -5.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.184 0.993 . . . . 0.0 113.512 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.78 -173.92 3.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.45 1.9 . . . . 0.0 106.428 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -137.29 143.42 41.48 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.34 105.31 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 105.897 -2.386 . . . . 0.0 105.897 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -53.44 113.06 1.03 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.265 1.026 . . . . 0.0 110.625 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -129.62 172.65 11.38 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.146 0.978 . . . . 0.0 108.771 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -71.44 140.11 49.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.625 0.77 . . . . 0.0 111.461 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.75 97.34 17.29 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.41 109.37 0.29 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.019 3.146 . . . . 0.0 112.556 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -140.35 169.69 17.2 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -71.9 -30.29 65.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.669 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 p -60.75 134.66 57.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.08 0.952 . . . . 0.0 109.023 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.13 -42.75 66.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.196 0.598 . . . . 0.0 111.805 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -58.92 -21.91 58.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.303 0.641 . . . . 0.0 112.389 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.1 21.59 9.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.551 1.54 . . . . 0.0 110.703 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -118.39 -38.91 3.09 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.03 1.332 . . . . 0.0 109.674 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.73 -5.36 88.41 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.233 0.92 . . . . 0.0 111.764 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -63.84 151.61 41.91 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -63.92 150.9 44.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.418 0.687 . . . . 0.0 112.157 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -140.72 152.93 45.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.565 1.946 . . . . 0.0 106.342 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.9 m -56.63 142.03 41.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -169.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -151.58 146.28 25.74 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.752 1.621 . . . . 0.0 107.078 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 m -54.22 -32.92 57.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.984 0.913 . . . . 0.0 113.131 -173.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.93 -35.88 37.12 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 111.967 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 pt -71.75 -34.63 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.784 0.72 . . . . 0.0 110.241 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.66 -45.69 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -35.01 75.28 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.502 -0.749 . . . . 0.0 111.663 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -42.72 90.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.839 0.855 . . . . 0.0 112.117 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 pt -74.6 -31.05 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.85 0.75 . . . . 0.0 110.612 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.37 -172.84 1.89 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.136 0.974 . . . . 0.0 108.741 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -89.95 -13.27 60.95 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.286 -0.884 . . . . 0.0 111.901 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 p -65.43 -8.03 16.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.972 1.386 . . . . 0.0 114.521 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -64.33 -20.37 66.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.603 1.092 . . . . 0.0 111.633 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -136.73 -33.36 0.79 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.137 0.975 . . . . 0.0 112.429 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.59 153.93 42.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -61.21 153.72 66.05 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.004 0.922 . . . . 0.0 109.824 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.2 -36.3 55.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.189 2.593 . . . . 0.0 113.189 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -152.95 157.14 40.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.979 1.712 . . . . 0.0 107.827 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.246 0.905 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.115 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.43 164.72 35.17 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.258 1.423 . . . . 0.0 108.32 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -65.08 152.65 42.97 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 111.266 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.3 mt -123.94 145.83 49.1 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.422 1.089 . . . . 0.0 108.74 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.6 130.82 42.56 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.165 2.577 . . . . 0.0 114.175 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.18 160.13 43.91 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -70.11 -22.3 63.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.577 0.751 . . . . 0.0 112.454 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 p -65.05 144.06 57.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 109.358 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.8 tp -47.04 -45.67 21.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.458 1.103 . . . . 0.0 111.058 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -54.74 -21.96 12.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.167 1.387 . . . . 0.0 113.136 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mmm -132.49 29.16 4.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.046 1.294 . . . . 0.0 112.659 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -129.34 -18.05 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.149 0.979 . . . . 0.0 110.611 168.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.53 88.12 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' HE3' ' A' ' 85' ' ' LYS . 26.0 p90 -84.25 138.62 32.85 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -70.54 158.12 36.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -153.29 -32.79 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -61.24 123.06 16.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.142 0.883 . . . . 0.0 109.253 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.49 -49.46 70.09 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.85 0.86 . . . . 0.0 112.578 -169.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 m -62.31 -37.32 85.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.544 0.337 . . . . 0.0 111.007 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.61 -41.52 54.16 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.205 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.21 -38.64 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 118.786 0.721 . . . . 0.0 110.168 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.16 -44.0 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 119.113 0.87 . . . . 0.0 109.297 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.91 86.13 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.952 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.37 -43.66 80.87 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.911 1.232 . . . . 0.0 111.35 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.7 pt -74.14 -22.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.669 1.122 . . . . 0.0 112.215 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -113.04 2.21 15.64 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.964 1.256 . . . . 0.0 114.023 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.76 -131.56 1.74 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.533 1.061 . . . . 0.0 110.462 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.0 p -135.07 -59.75 0.78 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.687 0.795 . . . . 0.0 110.678 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.89 20.58 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.459 1.904 . . . . 0.0 108.946 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -151.76 147.17 26.36 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.672 2.789 . . . . 0.0 103.72 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.05 33.17 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.242 0.928 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.37 151.41 57.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.928 1.691 . . . . 0.0 107.163 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.32 -35.85 66.05 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.262 2.641 . . . . 0.0 113.287 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -148.5 147.36 29.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.084 -177.854 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.23 -55.91 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.455 0.702 . . . . 0.0 109.21 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -65.79 164.44 14.7 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.781 1.232 . . . . 0.0 111.417 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -122.52 130.66 24.57 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -48.69 132.49 25.85 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 114.037 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.61 153.53 34.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.36 -15.35 58.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.331 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -62.49 147.79 47.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.364 0.984 . . . . 0.0 108.832 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.0 tp -51.66 -39.19 57.74 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.248 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.2 -26.68 40.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.893 0.877 . . . . 0.0 112.605 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.3 mmm -121.07 7.71 10.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.999 1.319 . . . . 0.0 110.99 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -82.99 51.47 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.381 -1.45 . . . . 0.0 109.67 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.54 -11.31 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.67 -0.644 . . . . 0.0 112.596 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -75.12 146.01 41.73 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.8 p -76.88 -15.43 59.7 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.497 -0.752 . . . . 0.0 112.57 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.74 -29.61 62.72 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.201 1.401 . . . . 0.0 113.417 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 p -76.26 44.57 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.17 1.788 . . . . 0.0 111.255 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.9 -50.02 58.25 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.415 1.486 . . . . 0.0 112.929 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -65.0 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.788 -0.57 . . . . 0.0 111.979 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.56 -47.41 40.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.49 -0.756 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -64.99 -34.15 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 O-C-N 122.193 -0.317 . . . . 0.0 110.393 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.91 -40.52 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.62 0.646 . . . . 0.0 110.241 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.1 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.408 -0.808 . . . . 0.0 111.425 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.59 -48.13 64.96 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.789 1.177 . . . . 0.0 111.42 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.4 pt -88.17 -20.25 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -123.51 -57.69 1.64 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.832 1.196 . . . . 0.0 109.442 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.92 -52.57 0.7 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 m -58.23 148.79 25.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.244 1.418 . . . . 0.0 109.215 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -59.88 -34.53 73.29 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.336 0.654 . . . . 0.0 111.856 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -122.36 157.28 32.18 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -82.59 80.31 8.76 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -130.59 157.1 78.62 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 126.674 1.99 . . . . 0.0 106.492 174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.65 -57.39 2.3 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.858 2.372 . . . . 0.0 113.92 -170.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -150.08 38.36 0.73 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 110.151 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.983 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -171.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 113.965 0.717 . . . . 0.0 113.965 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 . . . . . 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo . . . . . 0 N--CA 1.456 -0.723 0 N-CA-C 113.558 0.561 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.961 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 113.701 0.616 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo . . . . . 0 N--CA 1.458 -0.603 0 CA-C-O 121.692 0.622 . . . . 0.0 112.683 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.594 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 N-CA-C 116.279 1.607 . . . . 0.0 116.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.742 0 CA-C-O 119.262 -0.744 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 . . . . . 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 N--CA 1.457 -0.618 0 CA-C-O 121.357 0.482 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.488 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 N--CA 1.46 -0.462 0 CA-C-O 121.408 0.503 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.454 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.494 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 CA--C 1.536 0.586 0 N-CA-C 113.743 0.632 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.611 0 CA-C-O 121.333 0.472 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 121.486 0.536 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 23' ' ' LEU . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.28 0 CA-C-O 120.196 -0.225 . . . . 0.0 113.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 113.639 0.592 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HB3' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.913 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 36' ' ' GLN . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 N-CA-C 114.232 0.82 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.429 ' H ' HD23 ' A' ' 14' ' ' LEU . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.457 -0.657 0 N-CA-C 113.83 0.665 . . . . 0.0 113.83 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.042 0 CA-C-O 120.137 -0.257 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.456 -0.695 0 CA-C-O 121.523 0.551 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo . . . . . 0 N--CA 1.459 -0.541 0 N-CA-C 114.896 1.075 . . . . 0.0 114.896 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 120.001 -0.333 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.459 -0.537 0 CA-C-O 121.502 0.542 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 CA-C-O 119.872 -0.405 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 . . . . . 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 N--CA 1.459 -0.555 0 N-CA-C 115.338 1.246 . . . . 0.0 115.338 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.347 0 N-CA-C 112.633 -0.187 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 CA--C 1.537 0.662 0 N-CA-C 112.556 0.175 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 N-CA-C 114.175 0.798 . . . . 0.0 114.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 8' ' ' THR . 37.2 t30 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.402 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.0 p90 . . . . . 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo . . . . . 0 N--CA 1.457 -0.668 0 N-CA-C 114.037 0.745 . . . . 0.0 114.037 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.516 -0.602 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 ttp . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -141.27 139.39 33.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -72.38 162.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.522 0.729 . . . . 0.0 110.899 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.5 mp -115.27 144.24 31.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.29 136.86 77.64 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.888 2.392 . . . . 0.0 113.965 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -157.23 147.84 21.31 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.537 2.335 . . . . 0.0 104.959 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -69.59 -14.91 63.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.73 1.15 . . . . 0.0 112.216 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.0 m -120.64 147.94 44.57 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.18 0.992 . . . . 0.0 108.362 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.3 pt -127.63 157.15 39.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -125.32 132.07 52.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.102 1.761 . . . . 0.0 106.498 -173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.7 mt -118.78 137.45 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -144.12 17.76 1.75 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -142.35 40.16 1.59 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.173 0.897 . . . . 0.0 112.7 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.4 mt -63.71 152.64 38.64 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 169.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -71.28 120.43 16.84 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 169.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -60.23 -17.27 40.55 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.602 1.161 . . . . 0.0 113.985 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -64.07 -28.46 69.8 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.123 1.329 . . . . 0.0 112.257 175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.09 123.37 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.771 1.228 . . . . 0.0 109.08 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -69.86 165.77 20.87 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.099 0.96 . . . . 0.0 110.074 175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -56.06 -45.82 79.15 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.923 0.489 . . . . 0.0 110.383 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.72 -41.55 97.78 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.135 0.574 . . . . 0.0 110.321 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -69.15 -41.14 77.67 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.09 -47.44 83.21 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.094 0.957 . . . . 0.0 109.587 171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.54 -49.37 77.81 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.708 -0.62 . . . . 0.0 110.04 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -63.59 -45.36 90.75 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.967 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 p -65.03 -38.03 89.54 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.67 1.123 . . . . 0.0 111.665 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -49.67 74.37 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.082 0.553 . . . . 0.0 110.292 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -60.06 -39.03 84.57 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.173 0.442 . . . . 0.0 111.062 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -41.69 79.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.995 0.918 . . . . 0.0 112.089 -176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -117.87 -51.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 118.944 0.793 . . . . 0.0 111.377 -169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -63.6 -34.31 77.53 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.577 1.08 . . . . 0.0 111.605 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -63.39 -26.98 68.99 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 119.135 0.879 . . . . 0.0 112.76 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -64.92 -14.4 59.73 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.949 1.25 . . . . 0.0 111.492 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.73 13.26 17.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.308 1.443 . . . . 0.0 111.875 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.76 0.01 0.04 OUTLIER Glycine 0 CA--C 1.531 1.086 0 N-CA-C 117.163 1.625 . . . . 0.0 117.163 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 57.57 111.42 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.237 2.215 . . . . 0.0 112.957 -169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.5 mt -67.04 154.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.773 173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.6 tp -115.96 -37.58 3.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.381 1.872 . . . . 0.0 110.454 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -157.73 162.45 38.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 120.022 1.283 . . . . 0.0 111.204 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.4 mt -139.31 142.63 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.095 1.758 . . . . 0.0 107.68 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.94 111.67 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.565 1.146 . . . . 0.0 108.986 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.5 174.31 11.52 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.077 2.151 . . . . 0.0 106.508 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 HD13 ' H ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -147.79 153.24 38.96 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -175.155 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' H ' HD13 ' A' ' 43' ' ' LEU . 57.1 tttm -70.44 -17.8 63.0 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 p -68.46 148.59 50.4 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.753 0.821 . . . . 0.0 109.679 175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -55.53 -36.98 67.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.513 0.725 . . . . 0.0 112.052 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -59.71 -11.9 5.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.3 mmm -137.55 27.08 2.8 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.152 1.381 . . . . 0.0 110.396 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -93.92 -33.14 13.6 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.436 -0.79 . . . . 0.0 111.24 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -95.51 -3.51 61.18 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -132.36 147.07 52.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.353 1.861 . . . . 0.0 109.067 -169.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.58 164.66 37.06 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.448 1.099 . . . . 0.0 109.457 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -128.35 150.62 50.01 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.97 136.75 10.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.79 138.83 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -120.03 169.07 10.53 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.624 1.17 . . . . 0.0 111.464 -170.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -52.08 -52.13 53.21 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.012 1.325 . . . . 0.0 111.887 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -147.29 159.05 44.11 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.315 1.446 . . . . 0.0 107.78 -174.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 pt -63.67 -32.85 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.677 0.791 . . . . 0.0 112.3 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.11 -38.7 63.49 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.1 m -67.04 -40.88 87.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.334 0.653 . . . . 0.0 110.304 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.79 -47.51 82.35 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.726 0.811 . . . . 0.0 110.124 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.8 m -59.81 -43.66 94.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.064 0.546 . . . . 0.0 111.298 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -63.03 -48.34 79.14 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 122.857 0.463 . . . . 0.0 110.672 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.07 -51.77 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.798 0.839 . . . . 0.0 110.078 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.67 -60.22 3.59 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.286 1.034 . . . . 0.0 109.434 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 -64.93 -38.98 92.77 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 119.233 -0.413 . . . . 0.0 110.661 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.4 m -67.18 -41.93 85.09 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.354 0.524 . . . . 0.0 110.432 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.4 mmm -87.17 -10.57 52.35 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -54.91 125.96 22.41 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.832 0.853 . . . . 0.0 109.422 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.76 -0.61 35.17 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.266 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -69.73 139.66 88.74 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.678 1.739 . . . . 0.0 109.544 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.41 73.23 4.62 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.622 2.882 . . . . 0.0 110.198 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -65.07 -29.89 70.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.426 1.09 . . . . 0.0 110.32 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -141.26 -163.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.985 2.514 . . . . 0.0 105.8 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -66.97 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.192 1.397 . . . . 0.0 113.414 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -139.44 139.72 23.46 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 125.374 1.469 . . . . 0.0 107.586 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.84 132.29 24.49 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.385 2.056 . . . . 0.0 108.563 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.0 mmm -61.77 151.62 33.59 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.158 0.583 . . . . 0.0 110.42 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -132.3 126.08 32.5 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.99 152.95 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -169.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.19 166.49 24.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.104 1.761 . . . . 0.0 108.165 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -84.78 141.35 30.57 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.3 m -67.09 163.26 20.48 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.098 0.475 . . . . 0.0 111.065 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 78.2 mttt 63.1 26.39 15.34 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.185 1.394 . . . . 0.0 111.416 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.4 m -163.28 47.39 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.506 2.722 . . . . 0.0 105.09 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -145.37 169.82 17.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.697 1.599 . . . . 0.0 110.493 -168.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 m -54.4 -29.33 48.57 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.436 1.494 . . . . 0.0 114.27 -170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.91 -46.49 71.43 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.98 1.263 . . . . 0.0 110.912 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 8.3 pt -71.02 -32.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.06 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.332 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -46.03 97.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.04 -36.23 82.88 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.663 -0.648 . . . . 0.0 111.198 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.71 -47.49 78.11 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 121.219 -0.926 . . . . 0.0 111.241 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -70.83 -32.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 119.851 1.205 . . . . 0.0 111.576 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -68.75 -26.85 65.44 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.527 0.603 . . . . 0.0 111.426 171.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.07 -21.23 43.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.42 1.486 . . . . 0.0 111.414 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 p -59.41 -14.43 12.12 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.764 1.626 . . . . 0.0 113.46 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -54.32 -34.45 61.04 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.851 0.86 . . . . 0.0 111.677 169.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.5 -20.58 0.47 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -172.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -67.02 148.71 51.59 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.372 0.987 . . . . 0.0 109.751 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -68.65 156.03 91.73 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -66.54 -29.08 44.83 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.27 1.98 . . . . 0.0 112.067 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -150.93 156.38 41.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.558 1.943 . . . . 0.0 107.076 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.248 0.976 0 CA-C-O 117.433 -1.27 . . . . 0.0 110.827 -176.28 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.42 150.67 47.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.924 0.49 . . . . 0.0 109.756 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.32 148.65 40.61 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 169.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.86 110.83 1.49 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 125.102 1.361 . . . . 0.0 111.152 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.27 125.97 16.33 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.714 2.943 . . . . 0.0 113.558 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -153.67 145.57 23.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.854 2.062 . . . . 0.0 105.641 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -66.77 -12.07 57.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.363 0.983 . . . . 0.0 112.966 -170.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -130.7 145.65 51.99 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.137 1.375 . . . . 0.0 108.014 -171.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -128.27 165.9 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.821 1.248 . . . . 0.0 107.714 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -132.18 127.55 36.11 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.831 1.652 . . . . 0.0 106.829 -176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.7 mt -109.95 126.8 67.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -133.31 15.09 4.14 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -168.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.82 41.87 2.67 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.583 0.753 . . . . 0.0 109.689 169.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.37 135.09 45.77 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -68.43 112.68 5.42 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.52 -24.18 54.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -20.03 63.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.101 0.864 . . . . 0.0 112.939 -178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.32 127.34 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.56 151.72 43.83 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -63.0 -33.13 74.77 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.877 -1.139 . . . . 0.0 112.175 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -66.19 -39.46 89.71 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.044 0.537 . . . . 0.0 110.867 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -67.21 -40.28 86.4 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.408 0.549 . . . . 0.0 110.058 175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -56.58 -52.17 65.86 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.472 1.109 . . . . 0.0 109.372 174.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -59.27 -49.67 76.95 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.158 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -55.8 -48.36 75.51 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.952 0.501 . . . . 0.0 110.193 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 m -64.99 -43.84 91.26 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.367 0.667 . . . . 0.0 111.077 -174.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.82 -51.19 70.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.009 0.524 . . . . 0.0 110.097 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -62.95 -32.26 73.54 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.532 0.605 . . . . 0.0 111.719 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.46 78.23 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.941 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.8 pt -129.01 -41.71 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -60.85 -38.06 84.23 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 121.208 1.822 . . . . 0.0 111.113 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.3 m -59.48 -28.17 66.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 118.202 -0.904 . . . . 0.0 113.235 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -65.37 -10.97 37.72 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 120.16 1.346 . . . . 0.0 112.181 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -122.07 13.99 10.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.672 1.189 . . . . 0.0 111.642 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 173.73 -2.83 0.03 OUTLIER Glycine 0 CA--C 1.532 1.097 0 N-CA-C 117.062 1.585 . . . . 0.0 117.062 173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 49.7 109.92 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.038 2.535 . . . . 0.0 113.007 -169.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.63 147.17 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.578 175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 tt -109.3 -45.76 3.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.561 2.344 . . . . 0.0 107.299 171.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -154.03 162.0 41.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.299 0.954 . . . . 0.0 111.535 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -137.89 141.97 37.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 126.217 1.807 . . . . 0.0 107.206 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.67 101.05 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.325 1.05 . . . . 0.0 108.709 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.21 139.28 30.21 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -131.88 160.07 36.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.298 1.039 . . . . 0.0 109.418 -172.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -74.97 -15.55 60.66 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.807 -0.558 . . . . 0.0 112.394 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -60.21 151.3 27.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.124 0.969 . . . . 0.0 109.778 178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -58.61 -25.55 62.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -58.11 -23.0 53.25 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.981 1.712 . . . . 0.0 112.574 175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.44 23.0 4.38 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.445 1.498 . . . . 0.0 110.073 -174.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -60.19 -33.07 71.71 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.766 -1.209 . . . . 0.0 112.959 -172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.83 29.07 1.57 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.698 1.142 . . . . 0.0 111.567 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.47 161.8 41.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.11 1.364 . . . . 0.0 108.379 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.59 166.97 31.88 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.513 1.125 . . . . 0.0 109.906 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -125.68 153.3 44.06 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.35 142.67 15.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.17 140.26 42.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 128.028 2.531 . . . . 0.0 105.401 -169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -125.76 178.04 5.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.6 1.56 . . . . 0.0 110.704 -173.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -53.3 -45.29 68.88 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.45 162.08 40.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -169.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 pt -55.18 -38.74 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.876 1.27 . . . . 0.0 112.359 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.41 -44.45 58.75 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -59.78 -42.3 93.03 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.824 0.85 . . . . 0.0 110.41 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.02 -52.55 64.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.672 0.789 . . . . 0.0 110.757 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -65.99 -29.08 69.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.048 0.84 . . . . 0.0 112.721 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -66.0 -44.82 83.69 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.049 0.84 . . . . 0.0 110.571 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.67 68.73 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.965 0.906 . . . . 0.0 109.771 173.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.1 tt -51.01 -57.73 7.86 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.931 1.292 . . . . 0.0 109.546 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 -62.36 -48.15 81.06 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.129 -0.462 . . . . 0.0 110.506 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.0 m -64.74 -33.74 76.68 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.537 0.608 . . . . 0.0 110.632 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -91.74 -7.78 48.74 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.358 0.663 . . . . 0.0 112.25 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -57.75 124.56 19.56 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.071 0.948 . . . . 0.0 109.04 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.41 0.96 41.07 Favored Glycine 0 CA--C 1.533 1.198 0 CA-C-O 118.655 -1.08 . . . . 0.0 114.096 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -69.8 137.56 87.82 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 119.716 1.758 . . . . 0.0 109.423 -177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.45 76.17 3.66 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.557 2.838 . . . . 0.0 110.229 173.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.21 -39.13 78.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.699 1.2 . . . . 0.0 109.848 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -145.28 -155.33 0.6 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.91 2.484 . . . . 0.0 105.554 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -67.5 22.44 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.624 1.569 . . . . 0.0 113.809 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -139.23 134.51 16.68 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 125.766 1.626 . . . . 0.0 107.77 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.02 129.35 17.17 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.04 1.827 . . . . 0.0 107.543 169.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -62.38 150.93 38.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.991 0.424 . . . . 0.0 110.137 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -130.59 126.68 37.32 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -139.85 152.23 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -169.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.62 170.1 18.87 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.448 1.499 . . . . 0.0 108.583 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.64 143.03 57.24 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 169.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.7 p -64.14 3.94 0.38 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.43 -26.04 62.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.068 1.304 . . . . 0.0 109.703 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m 35.9 -119.73 0.13 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.964 2.505 . . . . 0.0 113.39 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -157.29 175.86 13.46 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.796 1.238 . . . . 0.0 109.935 -169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.7 m -49.31 -24.82 2.02 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.739 2.015 . . . . 0.0 115.016 -170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.18 -45.36 92.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-N 119.5 1.046 . . . . 0.0 111.676 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.5 pt -72.76 -29.0 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 O-C-N 121.718 -0.614 . . . . 0.0 110.315 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 96.7 t -62.92 -43.12 98.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.19 77.71 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.447 -0.783 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -59.51 -51.71 68.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.631 1.105 . . . . 0.0 110.336 173.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.22 -32.68 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 119.52 1.055 . . . . 0.0 111.825 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -73.19 -18.45 61.25 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.146 0.579 . . . . 0.0 111.878 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.18 -15.7 57.57 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.376 0.989 . . . . 0.0 112.091 -175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.1 p -65.16 -3.71 4.14 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.069 1.435 . . . . 0.0 113.474 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -61.53 -21.89 64.65 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.136 -0.977 . . . . 0.0 110.637 168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -138.14 -31.51 0.76 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.464 1.105 . . . . 0.0 112.575 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.34 157.96 30.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.917 0.78 . . . . 0.0 109.007 171.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -138.07 156.2 74.11 Favored Pre-proline 0 N--CA 1.465 0.285 0 C-N-CA 124.1 0.96 . . . . 0.0 109.466 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.6 -26.17 54.22 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.395 2.063 . . . . 0.0 112.034 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -138.93 140.4 38.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.627 -178.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.78 170.35 19.47 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.196 1.398 . . . . 0.0 108.523 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -63.56 152.68 38.02 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.981 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.6 mp -101.14 126.56 34.43 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -52.12 131.05 37.71 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.731 2.287 . . . . 0.0 113.701 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -153.68 154.67 34.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 169.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -66.88 -18.02 65.18 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.633 0.651 . . . . 0.0 112.374 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -115.15 148.54 38.89 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.381 1.472 . . . . 0.0 109.517 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 pt -130.01 161.45 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.588 1.155 . . . . 0.0 108.354 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -129.87 119.75 23.82 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 127.544 2.338 . . . . 0.0 105.595 -171.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.2 mt -103.93 134.93 43.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -176.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -140.0 14.43 2.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -139.42 40.18 2.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.893 0.854 . . . . 0.0 110.2 169.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.58 143.74 51.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 107.533 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -74.77 115.63 14.58 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.467 -0.771 . . . . 0.0 109.791 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.07 -17.51 26.54 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -63.24 -24.76 68.02 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.666 1.121 . . . . 0.0 112.566 176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mm -68.95 160.16 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.279 1.032 . . . . 0.0 108.959 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -128.35 162.79 26.26 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.376 2.27 . . . . 0.0 106.757 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -56.95 -45.31 82.92 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.965 1.257 . . . . 0.0 111.637 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -63.25 -43.63 97.45 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.625 0.37 . . . . 0.0 110.009 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -69.12 -36.9 77.98 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.782 0.433 . . . . 0.0 110.994 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -59.63 -52.33 65.97 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.622 1.169 . . . . 0.0 109.15 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -59.46 -48.8 80.27 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 123.052 0.541 . . . . 0.0 109.747 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.7 -50.39 65.97 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.318 1.047 . . . . 0.0 110.326 175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -65.72 -42.47 91.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.935 0.789 . . . . 0.0 111.51 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.2 mt -61.17 -49.28 77.85 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.21 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -64.91 -31.07 72.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.896 0.771 . . . . 0.0 111.928 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.68 72.28 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.51 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.99 -43.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -61.48 -38.91 89.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 121.063 1.756 . . . . 0.0 111.445 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 m -59.02 -34.07 71.46 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.168 0.894 . . . . 0.0 112.518 173.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.57 1.95 10.87 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.96 0.8 . . . . 0.0 111.587 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -125.39 8.95 7.82 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.973 1.309 . . . . 0.0 112.107 172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.05 11.08 0.02 OUTLIER Glycine 0 CA--C 1.531 1.041 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 36.49 106.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 129.066 2.946 . . . . 0.0 115.402 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.6 152.73 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.441 1.096 . . . . 0.0 110.444 174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.0 tp -120.07 -37.67 3.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.472 2.309 . . . . 0.0 109.578 170.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -156.3 161.67 40.18 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.635 1.107 . . . . 0.0 111.011 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.9 mt -137.82 144.66 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 126.249 1.82 . . . . 0.0 106.888 -174.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.8 t -136.22 101.82 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.78 166.73 25.03 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.696 1.999 . . . . 0.0 106.863 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.3 mt -145.92 164.42 32.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.789 1.636 . . . . 0.0 106.827 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -76.75 -5.61 48.81 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -67.36 146.67 53.83 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.118 0.872 . . . . 0.0 109.449 172.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.3 tt -58.52 -38.75 78.39 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.195 -0.94 . . . . 0.0 110.894 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -62.2 -5.7 2.53 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.4 mmt -130.31 22.78 5.19 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.137 1.375 . . . . 0.0 110.69 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -122.42 -21.11 5.87 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.34 1.456 . . . . 0.0 110.588 170.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.36 -16.05 67.54 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.82 163.97 37.37 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.778 2.031 . . . . 0.0 108.211 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 171.66 15.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.194 1.798 . . . . 0.0 108.699 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -131.21 156.3 45.59 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -153.56 146.74 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.07 141.56 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 127.696 2.398 . . . . 0.0 104.931 -169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -124.92 174.63 7.84 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.403 1.081 . . . . 0.0 110.843 -171.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -64.18 -30.88 71.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 118.383 -0.818 . . . . 0.0 112.766 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.15 158.98 39.81 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.443 1.02 . . . . 0.0 109.468 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -65.03 -35.71 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.928 0.891 . . . . 0.0 111.977 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.83 -37.09 65.99 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -67.79 -42.81 81.06 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.957 0.903 . . . . 0.0 109.844 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.56 -46.93 83.33 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.766 0.826 . . . . 0.0 110.433 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 m -61.82 -40.52 95.57 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.683 0.393 . . . . 0.0 111.477 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -64.54 -44.22 91.5 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.854 0.462 . . . . 0.0 110.668 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -51.23 70.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.608 0.763 . . . . 0.0 109.759 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.3 tt -53.38 -56.11 19.43 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 124.688 1.195 . . . . 0.0 109.455 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -60.9 -50.45 73.36 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.215 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.3 m -66.27 -34.02 77.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.373 0.533 . . . . 0.0 110.497 -171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.45 -9.25 50.85 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.203 0.601 . . . . 0.0 112.184 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.42 124.15 17.13 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.39 0.995 . . . . 0.0 108.981 174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.12 0.84 46.61 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.543 -1.143 . . . . 0.0 114.263 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -68.42 135.9 90.92 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 119.818 1.809 . . . . 0.0 109.377 -177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.12 82.11 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.445 2.763 . . . . 0.0 110.357 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -66.14 -45.36 81.29 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 110.789 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -147.38 70.45 1.18 Allowed 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 t70 65.9 -37.74 0.27 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.849 2.86 . . . . 0.0 114.148 -173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -70.16 128.79 91.25 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.941 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.61 120.96 7.86 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.025 1.817 . . . . 0.0 107.548 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 17.4 mmm -60.08 152.65 23.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.06 0.544 . . . . 0.0 110.333 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -130.21 127.13 39.02 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.1 149.56 24.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.35 167.39 22.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.406 1.882 . . . . 0.0 108.537 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -81.04 170.28 16.42 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.314 0.645 . . . . 0.0 109.33 172.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.85 -172.44 3.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.767 0.827 . . . . 0.0 110.572 -174.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -78.4 159.71 28.18 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.1 m -67.06 165.22 16.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.015 0.926 . . . . 0.0 112.09 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -42.36 -42.08 3.06 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.383 1.873 . . . . 0.0 112.231 170.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 m -58.28 -27.1 63.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.576 1.15 . . . . 0.0 114.039 -177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -111.14 -36.97 5.47 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.442 0.697 . . . . 0.0 111.646 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.9 pt -63.69 -35.97 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.098 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.28 -36.95 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.087 0.858 . . . . 0.0 109.473 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.33 -39.64 93.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.736 0.698 . . . . 0.0 110.863 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -47.74 83.61 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.377 0.671 . . . . 0.0 111.047 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.8 pt -88.16 -20.84 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.719 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -143.29 -66.36 0.37 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 119.218 0.917 . . . . 0.0 110.821 -173.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.24 -173.61 32.06 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -169.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.5 m 59.58 79.06 0.24 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.078 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -55.95 140.59 42.51 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 169.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.664 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER 44.73 63.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.132 1.373 . . . . 0.0 110.195 -168.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -51.85 144.45 11.42 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.595 0.758 . . . . 0.0 110.415 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -142.06 82.49 13.38 Favored Pre-proline 0 C--O 1.233 0.216 0 C-N-CA 126.178 1.791 . . . . 0.0 106.202 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.56 -36.06 97.84 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.187 1.925 . . . . 0.0 113.86 -170.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -152.63 37.44 0.52 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.978 1.311 . . . . 0.0 110.995 -174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.5 tttp . . . . . 0 C--O 1.245 0.843 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -172.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.483 1.22 0 N-CA-C 110.849 -0.056 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 58.61 178.69 0.07 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.222 1.809 . . . . 0.0 112.59 -173.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -69.3 168.26 14.65 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.665 0.786 . . . . 0.0 111.505 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.1 mt -112.84 132.86 22.11 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.95 123.32 7.22 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.681 2.921 . . . . 0.0 112.683 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -159.21 141.89 14.09 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 -174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -70.35 -13.08 62.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.866 1.212 . . . . 0.0 112.507 -173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -130.27 149.24 52.06 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.099 0.96 . . . . 0.0 108.55 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.76 161.76 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -127.92 116.12 19.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.355 1.862 . . . . 0.0 106.014 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.75 132.21 43.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.3 5.32 3.77 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -168.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -138.52 42.27 2.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.074 0.852 . . . . 0.0 110.143 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -66.2 136.97 56.64 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.823 1.249 . . . . 0.0 107.72 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -67.89 107.04 2.5 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -12.21 22.96 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -172.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.28 -25.94 67.44 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.735 1.607 . . . . 0.0 112.179 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.0 mm -71.39 119.87 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.394 1.078 . . . . 0.0 108.096 -176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.41 164.0 19.6 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.437 1.095 . . . . 0.0 109.988 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -55.42 -46.37 76.67 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.238 -0.914 . . . . 0.0 111.703 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -65.38 -38.87 91.31 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.174 -0.329 . . . . 0.0 110.312 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -69.5 -36.83 76.85 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.384 0.674 . . . . 0.0 109.925 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.4 -51.14 70.75 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.188 1.395 . . . . 0.0 108.809 173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.56 -49.04 77.67 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 117.952 0.342 . . . . 0.0 110.193 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -57.79 -46.88 84.0 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 123.216 0.606 . . . . 0.0 110.419 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.5 m -65.21 -43.68 90.78 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.572 0.624 . . . . 0.0 111.275 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -61.12 -46.49 90.38 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 121.8 -0.563 . . . . 0.0 109.882 176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.93 -26.25 68.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.988 0.515 . . . . 0.0 112.287 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.68 -38.74 21.09 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.996 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -129.53 -43.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -169.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -60.08 -36.65 77.86 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.55 1.523 . . . . 0.0 110.086 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 p -48.49 -36.63 15.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.253 1.421 . . . . 0.0 113.188 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.96 -12.16 61.11 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.144 0.977 . . . . 0.0 111.591 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -124.22 -16.68 6.38 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.277 1.031 . . . . 0.0 112.323 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.07 112.42 0.52 Allowed Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 106.225 -2.75 . . . . 0.0 106.225 169.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -57.39 123.89 17.03 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.765 0.793 . . . . 0.0 109.877 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.0 mm -60.76 148.73 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 127.279 2.232 . . . . 0.0 109.69 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.0 tp -125.58 -38.55 2.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.603 1.561 . . . . 0.0 109.344 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -157.47 163.76 38.14 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.517 1.053 . . . . 0.0 110.207 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -141.42 143.28 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 126.184 1.794 . . . . 0.0 107.031 -173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.4 t -139.99 112.41 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 123.905 0.882 . . . . 0.0 108.999 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.41 167.86 23.32 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.349 2.26 . . . . 0.0 106.054 169.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.7 mt -138.44 169.06 18.47 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.674 1.189 . . . . 0.0 108.566 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -74.5 -23.61 58.87 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.944 -0.472 . . . . 0.0 110.717 169.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -52.3 125.39 15.83 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.733 1.613 . . . . 0.0 108.906 173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.1 tp -52.14 -46.55 65.46 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.399 0.679 . . . . 0.0 111.916 -172.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -61.03 -16.09 39.57 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.9 tpt -126.97 26.55 6.11 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.53 1.132 . . . . 0.0 110.79 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -117.61 -28.6 5.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.362 1.865 . . . . 0.0 108.888 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -87.94 -7.62 73.94 Favored Glycine 0 CA--C 1.539 1.594 0 C-N-CA 123.737 0.684 . . . . 0.0 111.393 168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -138.0 147.9 44.64 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.502 1.921 . . . . 0.0 106.181 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.89 166.72 32.64 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.294 0.952 . . . . 0.0 110.118 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -123.25 154.16 39.17 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.56 138.14 14.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 170.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.84 139.56 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 128.591 2.756 . . . . 0.0 103.954 -171.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -121.47 168.62 11.51 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.343 1.057 . . . . 0.0 110.725 -171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -59.7 -34.36 72.79 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.823 -0.608 . . . . 0.0 112.322 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -154.14 152.8 30.83 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -169.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -60.26 -31.6 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.365 1.066 . . . . 0.0 112.426 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.44 -42.13 56.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.7 m -62.56 -42.95 99.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.17 -49.85 75.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.317 0.647 . . . . 0.0 110.582 174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.7 m -61.21 -41.57 97.09 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.687 0.395 . . . . 0.0 111.303 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -70.47 -41.03 73.29 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 119.37 -0.348 . . . . 0.0 111.42 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.98 -51.18 70.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 109.558 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.6 tt -54.99 -55.16 33.93 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.661 0.784 . . . . 0.0 109.268 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.1 ttm105 -60.74 -47.69 85.18 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.362 0.528 . . . . 0.0 110.599 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.8 m -65.13 -38.38 90.46 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.911 0.323 . . . . 0.0 110.372 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.3 mmm -90.74 -8.55 49.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.932 0.493 . . . . 0.0 111.912 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -57.27 124.09 17.65 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.268 1.027 . . . . 0.0 109.086 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.81 0.37 32.95 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.107 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -69.51 137.54 88.51 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 119.556 1.678 . . . . 0.0 109.541 -174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.34 71.76 6.24 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.713 2.942 . . . . 0.0 110.875 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -52.96 -47.9 67.79 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.652 1.581 . . . . 0.0 112.051 -175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -149.49 77.43 1.34 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.86 1.264 . . . . 0.0 107.671 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 t70 52.68 29.16 7.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.825 1.65 . . . . 0.0 113.423 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.8 ttmm -151.28 129.78 6.14 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.13 123.67 10.55 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.105 1.87 . . . . 0.0 109.107 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -62.68 153.97 30.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -134.69 130.85 36.95 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.83 150.81 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.08 164.99 28.78 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.243 1.817 . . . . 0.0 107.941 173.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -77.09 155.37 32.48 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.3 m -72.29 86.73 1.11 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.538 0.685 . . . . 0.0 111.355 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -57.14 -14.36 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.911 1.284 . . . . 0.0 113.458 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -120.23 24.09 10.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.326 1.45 . . . . 0.0 110.965 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -49.61 -45.09 47.68 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.668 1.187 . . . . 0.0 112.19 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -58.98 -37.59 77.17 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.052 0.541 . . . . 0.0 111.729 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -74.47 -44.21 52.59 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 122.855 0.462 . . . . 0.0 110.939 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.3 pt -69.89 -35.85 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.612 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -63.75 -45.34 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -33.71 74.71 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.943 0.792 . . . . 0.0 111.659 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.426 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 39.0 ttpt -63.59 -53.09 57.04 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.012 0.525 . . . . 0.0 110.211 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.31 -32.41 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 118.466 0.575 . . . . 0.0 111.348 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -70.4 -39.25 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.467 0.707 . . . . 0.0 111.12 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.28 -15.75 30.09 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.829 1.204 . . . . 0.0 111.685 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 p -59.31 -22.51 61.34 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.698 1.249 . . . . 0.0 112.623 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 7.2 p90 -55.6 -24.71 34.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.392 0.996 . . . . 0.0 112.764 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -125.35 -26.24 3.64 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.78 -33.38 58.04 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.821 0.737 . . . . 0.0 110.852 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -143.02 67.74 17.53 Favored Pre-proline 0 N--CA 1.47 0.536 0 C-N-CA 125.039 1.335 . . . . 0.0 109.037 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.84 -24.29 68.25 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 121.888 1.725 . . . . 0.0 111.931 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -143.98 129.64 19.19 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.86 -29.92 35.7 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -169.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -72.16 157.97 36.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.198 0.999 . . . . 0.0 110.545 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.5 pp -137.77 149.88 66.03 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.379 1.072 . . . . 0.0 110.354 -173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -54.69 134.9 64.94 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.83 3.02 . . . . 0.0 116.279 -172.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -160.01 151.17 19.39 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 128.021 2.528 . . . . 0.0 105.094 169.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.21 -14.78 62.78 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.309 1.413 . . . . 0.0 112.723 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -132.17 146.35 51.97 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.085 0.954 . . . . 0.0 108.52 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -125.68 160.4 32.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.37 119.18 24.53 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.5 mt -102.98 128.06 56.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 -173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -120.38 1.59 10.72 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -143.19 43.34 1.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.022 1.283 . . . . 0.0 111.854 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 148.93 50.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.631 1.172 . . . . 0.0 108.759 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -82.89 113.72 20.7 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 170.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -61.25 -16.32 44.15 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.39 -25.14 67.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.655 1.116 . . . . 0.0 111.657 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.07 114.45 9.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -69.52 165.76 20.33 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -38.65 82.86 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.307 -0.871 . . . . 0.0 112.156 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -63.11 -42.83 99.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.411 0.684 . . . . 0.0 110.299 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.2 -38.19 81.7 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.489 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.97 -55.56 33.02 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.215 1.006 . . . . 0.0 108.892 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -57.77 -49.3 77.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.034 0.379 . . . . 0.0 110.067 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -56.15 -43.92 78.74 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.935 -0.555 . . . . 0.0 110.651 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -66.81 -41.89 86.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.703 0.683 . . . . 0.0 111.713 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -63.87 -45.17 90.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -62.47 -33.71 75.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.538 0.608 . . . . 0.0 111.424 175.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.02 73.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.023 -0.989 . . . . 0.0 112.564 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 pt -127.65 -51.07 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 117.459 -1.258 . . . . 0.0 114.291 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -54.99 -44.27 74.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 120.476 1.489 . . . . 0.0 110.899 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.2 m -54.77 -34.72 62.98 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -76.4 -4.73 43.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.897 0.771 . . . . 0.0 112.493 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -135.98 22.44 3.29 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.773 1.229 . . . . 0.0 110.628 170.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 166.99 91.02 0.08 OUTLIER Glycine 0 C--N 1.336 0.561 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -58.67 125.13 22.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 118.124 0.962 . . . . 0.0 110.585 -172.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.6 mt -70.99 152.46 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 125.538 1.535 . . . . 0.0 109.571 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.4 tt -111.49 -48.7 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.636 1.975 . . . . 0.0 107.773 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -153.58 161.96 41.71 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.168 0.894 . . . . 0.0 111.176 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mt -138.65 141.2 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.74 1.616 . . . . 0.0 106.846 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -140.03 106.0 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.16 0.984 . . . . 0.0 108.445 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.51 148.53 49.21 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 169.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.8 mt -143.09 167.4 22.17 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.89 0.876 . . . . 0.0 109.643 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -91.26 3.09 55.73 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 111.737 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.4 p -59.75 151.75 24.49 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -55.58 -42.44 74.74 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.648 -0.658 . . . . 0.0 110.986 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -59.39 -22.35 61.25 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.953 0.501 . . . . 0.0 111.966 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 93.8 mmm -117.92 10.87 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.993 1.317 . . . . 0.0 111.0 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -50.28 -47.98 55.19 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.27 1.028 . . . . 0.0 109.611 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.02 32.19 3.33 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.647 1.118 . . . . 0.0 111.367 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.69 159.55 41.96 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.378 1.089 . . . . 0.0 109.923 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.92 164.13 38.91 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.957 1.303 . . . . 0.0 109.216 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -126.27 152.19 46.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 169.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.92 136.32 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.7 138.04 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 128.308 2.643 . . . . 0.0 104.091 -173.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -119.32 166.36 13.11 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.07 0.948 . . . . 0.0 110.438 -173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -63.01 -34.08 76.8 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.798 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.58 155.08 43.47 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.258 1.023 . . . . 0.0 108.698 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.8 pt -63.38 -29.31 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.876 0.871 . . . . 0.0 111.779 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.93 66.47 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m -64.34 -43.53 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 117.587 0.694 . . . . 0.0 110.08 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.66 -49.52 76.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.137 0.575 . . . . 0.0 110.546 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.7 m -59.16 -42.9 91.86 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.033 0.533 . . . . 0.0 111.361 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.61 -44.06 75.06 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.994 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.4 -49.67 75.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.238 1.015 . . . . 0.0 109.839 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 tt -54.66 -57.81 10.01 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 124.249 1.02 . . . . 0.0 109.369 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -62.95 -45.55 91.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 118.261 0.482 . . . . 0.0 110.902 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 81.2 m -59.56 -36.54 76.38 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 0.0 110.387 -177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mmm -99.31 -7.85 25.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -58.14 123.18 15.08 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.137 0.975 . . . . 0.0 109.197 174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.16 -0.85 36.95 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 118.761 -1.022 . . . . 0.0 113.981 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -72.92 136.03 80.15 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.519 1.659 . . . . 0.0 109.83 -173.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.04 76.64 3.36 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.6 2.866 . . . . 0.0 110.262 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -56.8 -40.96 76.91 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.247 . . . . 0.0 110.066 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -145.31 -153.01 0.45 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.414 2.285 . . . . 0.0 105.632 169.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.24 24.29 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.566 1.546 . . . . 0.0 113.832 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -139.79 137.07 17.96 Favored Pre-proline 0 C--O 1.235 0.336 0 C-N-CA 125.054 1.342 . . . . 0.0 108.292 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.4 127.34 13.2 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 N-CA-C 106.811 -2.034 . . . . 0.0 106.811 169.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.2 mmm -63.23 149.67 44.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -131.66 129.03 40.26 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mt -138.76 153.22 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.15 33.96 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.565 1.546 . . . . 0.0 108.41 171.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -74.32 137.03 42.58 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -63.55 155.44 29.48 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.515 0.674 . . . . 0.0 111.777 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -144.29 164.57 30.37 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.671 1.988 . . . . 0.0 106.407 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.8 m -52.79 126.31 19.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.39 0.676 . . . . 0.0 109.418 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -152.48 141.79 21.52 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.514 1.126 . . . . 0.0 108.115 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.9 m -59.52 -15.36 17.48 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -173.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.74 -47.15 15.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 120.141 1.337 . . . . 0.0 111.28 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 32.3 pt -75.2 -32.58 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 O-C-N 122.156 -0.34 . . . . 0.0 110.535 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.61 -41.07 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.62 -38.83 92.61 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.49 -0.756 . . . . 0.0 111.699 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -56.74 -53.47 57.4 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.454 0.57 . . . . 0.0 110.293 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.6 -27.4 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.411 0.55 . . . . 0.0 111.625 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -62.36 -46.62 87.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.922 0.783 . . . . 0.0 109.179 171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.73 -15.28 1.21 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.51 -1.161 . . . . 0.0 114.668 169.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.9 m -145.22 107.79 4.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.256 1.528 . . . . 0.0 108.64 -169.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -51.99 -39.0 58.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.773 0.829 . . . . 0.0 112.749 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -66.19 -32.38 73.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.659 0.784 . . . . 0.0 111.63 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -82.7 112.4 19.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.6 mmp_? -60.45 144.77 87.96 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 171.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.35 -34.19 31.45 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.115 2.543 . . . . 0.0 115.786 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -128.81 38.58 3.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.612 1.165 . . . . 0.0 109.962 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.277 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.819 0.343 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.77 145.35 28.77 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 169.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -73.3 129.46 38.08 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.74 142.51 93.88 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.395 0.678 . . . . 0.0 110.941 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.24 134.59 61.43 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.98 2.453 . . . . 0.0 111.993 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -158.61 150.77 21.51 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.928 2.091 . . . . 0.0 105.429 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.12 -6.17 40.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.082 1.31 . . . . 0.0 112.792 -174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.4 m -133.17 142.8 48.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.555 1.142 . . . . 0.0 108.11 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 pt -124.02 157.96 30.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -123.68 110.59 15.16 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.223 2.209 . . . . 0.0 106.741 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -98.9 140.7 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -144.7 168.28 20.55 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.659 1.984 . . . . 0.0 108.121 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.7 t30 54.53 28.41 9.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.042 1.337 . . . . 0.0 112.138 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -70.21 133.15 46.76 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -65.54 113.44 4.19 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.315 0.507 . . . . 0.0 109.876 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.0 -10.51 10.01 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -66.26 -26.59 67.42 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 120.484 1.493 . . . . 0.0 112.032 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -76.53 117.24 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 124.689 1.196 . . . . 0.0 107.982 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -76.58 173.17 11.88 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 118.067 0.394 . . . . 0.0 110.499 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -55.46 -47.37 76.18 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.135 0.974 . . . . 0.0 111.221 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -61.57 -44.04 97.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.299 0.64 . . . . 0.0 110.393 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -67.52 -38.98 85.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.927 0.491 . . . . 0.0 110.331 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.21 -50.73 72.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.931 1.292 . . . . 0.0 109.428 175.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -59.11 -49.2 78.78 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.477 0.58 . . . . 0.0 110.128 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -56.98 -49.46 75.65 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.797 -0.62 . . . . 0.0 109.675 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 m -61.81 -46.56 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.444 0.565 . . . . 0.0 111.345 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.1 mt -58.32 -51.8 68.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 O-C-N 121.929 -0.482 . . . . 0.0 110.151 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -65.89 -30.27 70.84 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.035 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.52 -26.24 57.92 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.025 -1.464 . . . . 0.0 113.423 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.9 pt -135.34 -41.62 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.66 -35.21 77.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 120.886 1.675 . . . . 0.0 111.51 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 m -58.81 -30.01 67.3 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -63.75 -11.75 29.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 120.146 1.339 . . . . 0.0 112.557 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -111.39 7.44 20.9 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.434 1.094 . . . . 0.0 112.089 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 165.84 3.41 0.04 OUTLIER Glycine 0 CA--C 1.531 1.073 0 N-CA-C 117.151 1.62 . . . . 0.0 117.151 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 59.37 109.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.664 2.386 . . . . 0.0 113.007 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.9 mm -58.37 138.82 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -109.9 -37.46 5.62 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.488 1.115 . . . . 0.0 110.104 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -156.55 164.95 37.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.086 0.857 . . . . 0.0 110.207 173.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.5 mt -139.24 140.05 38.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.754 1.621 . . . . 0.0 107.188 -170.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.88 97.42 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.032 1.333 . . . . 0.0 107.602 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.9 160.96 40.47 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.536 1.934 . . . . 0.0 106.704 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -137.09 166.86 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.173 1.389 . . . . 0.0 107.837 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -69.7 -21.36 63.5 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.277 171.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 p -63.79 134.08 54.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.614 1.097 . . . . 0.0 108.732 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.7 tp -53.56 -40.45 65.58 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.186 0.595 . . . . 0.0 111.955 -171.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -57.15 -21.45 32.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.984 0.914 . . . . 0.0 112.542 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 1.3 mmt -129.0 29.49 5.19 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.893 1.277 . . . . 0.0 110.025 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -123.75 -35.36 2.89 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 125.013 1.325 . . . . 0.0 110.318 172.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.84 -11.02 85.82 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 118.435 0.561 . . . . 0.0 112.104 170.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.84 163.28 38.45 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.531 1.933 . . . . 0.0 107.733 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.5 171.45 19.9 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.294 1.437 . . . . 0.0 109.02 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -128.55 145.11 51.22 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.39 135.55 40.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.5 140.25 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.74 170.09 9.06 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 110.745 -173.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -52.27 -46.07 65.68 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.49 1.116 . . . . 0.0 112.62 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.51 162.86 39.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 -171.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.5 pt -63.24 -33.41 60.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.209 0.604 . . . . 0.0 112.107 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.21 -38.4 59.03 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -64.79 -43.97 91.46 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.88 0.872 . . . . 0.0 109.698 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.12 -47.58 82.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.449 1.1 . . . . 0.0 110.441 174.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 m -59.62 -45.62 91.42 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.951 0.501 . . . . 0.0 110.857 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.42 -47.38 84.33 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.599 0.36 . . . . 0.0 110.671 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.99 67.6 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.581 0.752 . . . . 0.0 110.759 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.18 -57.81 9.2 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.827 1.251 . . . . 0.0 109.483 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -67.93 -36.41 80.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.637 -170.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 m -73.41 -42.19 62.37 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.664 0.665 . . . . 0.0 110.67 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -84.79 -12.86 52.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.851 0.46 . . . . 0.0 112.165 -173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 2.0 mm-40 -52.96 125.08 15.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.008 0.822 . . . . 0.0 109.558 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.77 -2.87 58.07 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.727 1.156 . . . . 0.0 114.163 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -70.14 136.74 86.91 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 119.691 1.746 . . . . 0.0 109.625 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.77 78.88 2.98 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.433 2.755 . . . . 0.0 110.125 172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -56.61 -38.39 71.99 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.69 1.196 . . . . 0.0 110.033 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -145.64 -157.42 0.8 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.128 2.571 . . . . 0.0 105.122 169.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -66.89 21.77 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.401 1.48 . . . . 0.0 113.982 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -138.48 138.16 21.8 Favored Pre-proline 0 C--O 1.235 0.332 0 C-N-CA 125.183 1.393 . . . . 0.0 108.088 171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -69.88 132.69 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.217 1.944 . . . . 0.0 108.815 171.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -64.58 150.13 47.48 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.011 0.524 . . . . 0.0 109.976 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -126.22 132.0 51.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.488 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.7 mt -143.76 144.69 22.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -169.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.77 174.75 10.53 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.244 1.818 . . . . 0.0 108.174 174.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -75.13 150.6 38.72 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 169.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.1 m -61.1 143.8 54.75 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.358 0.599 . . . . 0.0 112.098 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.97 170.79 15.48 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 127.341 2.256 . . . . 0.0 107.034 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.6 m -54.64 146.71 16.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.849 0.86 . . . . 0.0 110.804 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.24 148.16 28.55 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.632 1.573 . . . . 0.0 107.17 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.6 m -52.88 -33.74 51.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.307 1.043 . . . . 0.0 113.44 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -49.36 52.05 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.399 1.0 . . . . 0.0 110.981 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.1 pt -71.42 -33.44 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.522 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -63.14 -46.08 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.75 82.13 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 119.147 0.885 . . . . 0.0 110.087 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -53.49 -51.3 63.21 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 118.055 -0.974 . . . . 0.0 111.614 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.1 pt -70.45 -31.51 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 119.327 0.967 . . . . 0.0 112.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -71.57 -41.81 68.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.919 0.781 . . . . 0.0 111.374 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.21 47.8 0.08 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.97 -173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.3 m 69.34 161.39 0.21 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.5 1.52 . . . . 0.0 110.905 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -50.98 -31.57 18.34 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.06 -1.025 . . . . 0.0 112.1 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 5.9 mmpt? -140.05 137.93 34.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 168.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -72.1 -32.7 67.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -62.3 151.27 82.56 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.615 -0.707 . . . . 0.0 109.777 170.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.93 -37.81 78.45 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.696 2.264 . . . . 0.0 112.703 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -158.54 163.52 36.96 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.129 1.772 . . . . 0.0 108.659 174.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 C--O 1.249 1.05 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 169.543 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -133.31 176.94 8.08 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.661 1.184 . . . . 0.0 109.24 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -55.94 137.5 50.53 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.321 1.448 . . . . 0.0 111.011 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 80.6 mt -69.09 150.7 97.42 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.849 0.86 . . . . 0.0 111.558 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.15 137.74 63.14 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.706 2.937 . . . . 0.0 112.619 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -158.89 137.41 10.88 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -62.7 -18.49 62.56 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.723 1.147 . . . . 0.0 111.972 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.0 m -118.14 135.94 53.92 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 107.878 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.56 166.9 12.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -136.22 119.86 17.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 -169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -98.64 134.58 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -126.17 -5.36 6.7 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -167.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -135.15 39.59 2.92 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.179 0.9 . . . . 0.0 110.377 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.12 139.78 58.18 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -68.07 113.54 5.82 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -62.78 -11.87 20.59 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -69.6 -28.05 65.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 120.44 1.473 . . . . 0.0 111.94 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.35 135.71 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 123.572 0.749 . . . . 0.0 109.651 -169.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -73.11 154.18 40.48 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.177 . . . . 0.0 108.967 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -54.52 -45.15 73.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.437 0.695 . . . . 0.0 110.843 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -62.23 -40.87 97.59 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.452 0.701 . . . . 0.0 110.593 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -72.39 -36.14 68.6 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.146 0.43 . . . . 0.0 110.606 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.14 -51.99 67.66 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.31 1.044 . . . . 0.0 109.382 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -60.36 -46.56 89.52 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 122.756 0.422 . . . . 0.0 109.903 -177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -58.05 -48.98 78.46 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.137 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -63.83 -43.57 95.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 119.184 0.902 . . . . 0.0 111.262 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.6 mt -59.54 -51.51 69.55 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -61.38 -34.42 75.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.51 70.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.068 0.947 . . . . 0.0 111.851 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -128.72 -36.97 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 115.818 1.784 . . . . 0.0 115.818 -169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -60.24 -34.42 73.67 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.652 1.569 . . . . 0.0 110.63 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 m -52.41 -26.67 13.21 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.418 1.087 . . . . 0.0 113.748 176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -66.31 -23.55 66.39 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.578 0.751 . . . . 0.0 111.719 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -122.7 -24.13 4.95 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.402 1.081 . . . . 0.0 112.119 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.79 110.94 0.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 105.77 -2.932 . . . . 0.0 105.77 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -56.44 123.03 13.32 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.49 0.662 . . . . 0.0 109.557 174.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.9 mm -59.01 147.04 8.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 126.818 2.047 . . . . 0.0 109.499 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.57 -38.42 2.4 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.99 1.716 . . . . 0.0 109.252 169.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -158.02 162.96 38.17 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.623 1.101 . . . . 0.0 110.235 172.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -141.18 143.54 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.161 1.784 . . . . 0.0 107.15 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.4 t -140.47 116.44 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.286 1.034 . . . . 0.0 109.073 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.04 167.58 23.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.477 2.311 . . . . 0.0 105.955 168.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt -142.9 169.87 16.77 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.231 1.412 . . . . 0.0 108.745 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -72.68 -27.3 62.0 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 110.965 169.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.8 m -58.48 131.03 49.54 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.437 1.495 . . . . 0.0 109.247 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -49.9 -45.75 51.15 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.145 0.978 . . . . 0.0 112.338 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -59.53 -18.76 43.21 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.56 0.744 . . . . 0.0 112.559 -176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -128.32 25.03 5.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.254 1.422 . . . . 0.0 110.521 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -120.41 -30.64 4.52 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.363 1.465 . . . . 0.0 109.802 169.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.67 -8.49 76.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.215 0.912 . . . . 0.0 111.07 169.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.72 164.32 28.16 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.776 2.03 . . . . 0.0 107.533 173.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.74 168.51 26.02 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.608 1.163 . . . . 0.0 108.764 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -125.09 152.2 44.68 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 169.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.49 142.98 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -124.2 170.67 10.51 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.03 0.932 . . . . 0.0 110.55 -171.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -61.43 -32.75 72.72 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 118.842 -0.599 . . . . 0.0 112.571 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -155.17 156.32 35.51 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.9 pt -60.95 -31.98 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.797 0.839 . . . . 0.0 111.802 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.82 -36.5 66.03 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 m -67.4 -43.48 81.19 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.457 0.703 . . . . 0.0 109.329 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -46.39 87.98 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.414 0.686 . . . . 0.0 110.615 174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -59.89 -44.82 94.0 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.131 0.573 . . . . 0.0 111.082 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -68.79 -40.71 79.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.217 -0.42 . . . . 0.0 110.824 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.44 -53.19 61.15 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.421 0.688 . . . . 0.0 110.321 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -53.0 -56.06 18.9 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.955 1.302 . . . . 0.0 109.531 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.9 mtp-105 -69.36 -38.2 77.98 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.28 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 m -69.33 -42.51 75.25 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.025 0.829 . . . . 0.0 110.222 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mmm -89.32 -12.24 41.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 119.162 -0.447 . . . . 0.0 112.169 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.494 ' NE2' ' H ' ' A' ' 81' ' ' ILE . 1.7 mm-40 -53.11 127.15 23.14 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.311 0.959 . . . . 0.0 109.541 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.48 -4.33 43.11 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.744 1.164 . . . . 0.0 114.46 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -70.24 139.6 87.39 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 119.827 1.813 . . . . 0.0 109.777 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 74.41 4.28 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.772 2.981 . . . . 0.0 110.291 172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -60.1 -34.78 73.95 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.695 1.198 . . . . 0.0 110.428 177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.95 -159.23 0.99 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.065 2.546 . . . . 0.0 105.245 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.62 23.59 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.462 1.505 . . . . 0.0 113.672 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -138.9 137.56 19.86 Favored Pre-proline 0 C--O 1.234 0.28 0 C-N-CA 125.139 1.375 . . . . 0.0 107.82 170.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -69.2 131.0 21.06 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.002 1.802 . . . . 0.0 107.997 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.31 155.01 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -134.34 131.05 37.86 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 102.778 -3.045 . . . . 0.0 102.778 169.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.494 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 2.8 mt -145.82 146.07 19.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -169.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.6 175.18 11.4 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.558 1.943 . . . . 0.0 108.743 176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -66.32 160.81 23.75 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -54.16 129.51 35.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.508 0.723 . . . . 0.0 111.673 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -156.85 154.85 30.5 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 127.21 2.204 . . . . 0.0 106.57 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 m -143.93 10.48 1.56 Allowed 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -142.48 -61.91 0.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.002 1.274 . . . . 0.0 112.055 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.3 m -59.16 -38.18 79.13 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.335 0.516 . . . . 0.0 111.27 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.25 -52.47 61.99 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 122.831 0.452 . . . . 0.0 111.487 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.7 pt -67.06 -33.13 61.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.102 0 CA-C-O 118.788 -0.625 . . . . 0.0 110.426 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.2 -49.43 84.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 173.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.22 72.63 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.938 0.79 . . . . 0.0 111.836 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -67.91 -46.03 72.71 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 123.786 0.834 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.6 pt -73.75 -34.4 40.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.982 0.81 . . . . 0.0 111.537 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -70.48 -28.07 64.7 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 118.541 0.61 . . . . 0.0 111.525 176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.32 -13.68 64.27 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.907 1.241 . . . . 0.0 112.056 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -60.17 -12.46 8.66 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.599 1.699 . . . . 0.0 113.123 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -54.21 -38.73 66.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 111.767 169.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -158.51 -25.35 0.08 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.99 -36.79 78.24 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.258 0.935 . . . . 0.0 110.655 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 150.53 60.88 Favored Pre-proline 0 N--CA 1.464 0.241 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 169.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -72.15 -39.83 2.82 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 121.477 1.451 . . . . 0.0 112.585 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -159.01 48.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.861 0.864 . . . . 0.0 110.471 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt . . . . . 0 C--O 1.248 1.001 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 177.16 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.669 0.271 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -68.62 -41.37 79.59 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.883 -0.511 . . . . 0.0 111.668 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -71.64 149.96 45.07 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.354 0.661 . . . . 0.0 111.297 -171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.2 mt -70.94 149.12 94.89 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -83.4 -2.57 10.59 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 123.149 2.566 . . . . 0.0 113.743 -171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -44.67 133.35 5.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.666 1.187 . . . . 0.0 112.04 -171.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -66.4 -14.06 61.59 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.16 125.94 38.01 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 pt -122.28 159.93 24.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.072 0.949 . . . . 0.0 109.181 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -131.8 124.77 30.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.967 2.107 . . . . 0.0 106.302 -169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -114.76 140.32 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.49 172.19 13.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.586 1.554 . . . . 0.0 109.421 -174.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.3 t30 51.91 30.72 7.51 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.645 1.178 . . . . 0.0 111.493 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.57 136.35 51.19 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -65.91 107.19 1.76 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -63.62 -10.8 20.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.401 1.48 . . . . 0.0 113.851 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -65.76 -25.8 67.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 120.409 1.459 . . . . 0.0 111.854 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.7 mm -69.38 122.58 21.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.322 1.049 . . . . 0.0 108.305 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -64.63 158.62 23.93 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.616 1.166 . . . . 0.0 109.466 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -53.02 -45.11 67.81 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.792 0.837 . . . . 0.0 111.106 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.66 -43.75 98.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.065 0.946 . . . . 0.0 110.44 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -68.95 -36.82 78.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.009 0.524 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.7 -51.2 70.79 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.78 1.232 . . . . 0.0 109.018 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -60.46 -47.85 84.31 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 118.463 0.574 . . . . 0.0 109.949 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.28 -47.75 78.01 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.364 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 m -61.7 -47.01 87.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.289 0.636 . . . . 0.0 110.838 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.35 -46.39 88.9 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 121.881 -0.512 . . . . 0.0 110.686 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -65.29 -31.34 72.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.806 0.73 . . . . 0.0 111.574 175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.95 74.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.132 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.68 -47.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.32 -38.13 88.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.574 1.533 . . . . 0.0 111.57 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.0 m -59.73 -22.6 62.27 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.527 1.058 . . . . 0.0 113.419 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -64.01 -20.26 65.78 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.577 1.535 . . . . 0.0 111.526 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -87.91 -6.04 58.26 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.142 0.977 . . . . 0.0 112.388 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.4 32.88 0.04 OUTLIER Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.278 -1.29 . . . . 0.0 115.714 169.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 61.43 109.73 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.795 2.438 . . . . 0.0 114.851 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mt -64.18 146.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.0 tp -103.23 -41.08 6.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.105 1.762 . . . . 0.0 110.058 172.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -156.0 163.96 39.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.438 1.017 . . . . 0.0 111.596 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mt -142.4 145.81 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.862 1.665 . . . . 0.0 107.72 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.8 t -138.76 110.61 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.247 1.019 . . . . 0.0 108.972 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.5 167.02 23.19 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.251 2.22 . . . . 0.0 105.933 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 tp -148.41 166.54 27.81 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.707 0.803 . . . . 0.0 109.116 -172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -74.74 -23.53 58.58 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.618 -0.677 . . . . 0.0 112.254 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.5 143.6 57.8 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.126 0.876 . . . . 0.0 109.234 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -31.52 64.06 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.517 -0.739 . . . . 0.0 111.799 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -53.96 -26.75 27.22 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 125.453 1.501 . . . . 0.0 112.454 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.0 mmm -136.42 32.48 2.81 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.465 1.029 . . . . 0.0 110.307 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.7 ttp85 -125.88 -27.27 3.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.966 1.306 . . . . 0.0 110.423 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.35 -5.66 89.38 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.25 161.5 41.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.329 2.252 . . . . 0.0 107.715 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.37 168.49 27.17 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.791 1.636 . . . . 0.0 108.799 -173.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -128.35 154.18 46.25 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -144.43 153.21 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.1 mp -129.18 122.64 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -95.82 162.83 13.42 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.512 0.725 . . . . 0.0 109.876 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -61.4 -31.12 71.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -146.71 154.42 41.41 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.207 1.003 . . . . 0.0 109.0 -169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.61 -37.31 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.351 0.66 . . . . 0.0 111.893 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.08 -34.34 89.67 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 120.625 -1.297 . . . . 0.0 111.391 178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -71.98 -43.95 64.31 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.455 0.702 . . . . 0.0 110.109 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.17 -44.55 92.14 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 119.206 -0.426 . . . . 0.0 110.795 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -54.44 -53.79 49.51 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.703 0.801 . . . . 0.0 110.076 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.74 -47.96 82.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.377 0.671 . . . . 0.0 111.1 -176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.2 -54.59 45.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.542 0.737 . . . . 0.0 110.595 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 tt -55.09 -60.78 2.91 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 124.66 1.184 . . . . 0.0 108.624 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -58.07 -45.85 86.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.09 0.556 . . . . 0.0 110.282 -171.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.0 m -80.0 -29.71 39.49 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.282 -171.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 99.5 mmm -87.08 -11.66 49.53 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.147 0.885 . . . . 0.0 112.924 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -49.36 127.14 14.53 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.518 1.054 . . . . 0.0 110.544 169.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 0.37 67.21 Favored Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.187 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -62.8 134.91 95.67 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.561 1.68 . . . . 0.0 109.504 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.79 96.79 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.439 2.093 . . . . 0.0 109.895 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -65.85 -59.52 3.78 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.079 0.552 . . . . 0.0 110.251 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -155.24 83.66 1.06 Allowed 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.3 t70 57.23 21.29 6.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.558 1.543 . . . . 0.0 114.121 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -141.77 134.97 14.26 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 125.202 1.401 . . . . 0.0 107.52 170.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.03 130.74 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.063 1.842 . . . . 0.0 108.956 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.0 mtp -63.85 148.44 49.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -126.42 132.38 51.51 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.39 161.56 34.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -165.29 174.38 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.98 2.512 . . . . 0.0 107.476 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -75.25 153.22 38.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 168.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -62.25 137.7 58.3 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.579 -0.7 . . . . 0.0 111.482 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -138.21 33.62 2.33 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.341 1.856 . . . . 0.0 108.812 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 m -67.5 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 128.115 2.566 . . . . 0.0 115.152 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -52.06 -48.89 64.41 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.127 1.371 . . . . 0.0 112.235 -169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m -62.14 -34.96 77.35 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.777 0.431 . . . . 0.0 111.559 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -75.86 -44.9 38.45 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 122.889 0.475 . . . . 0.0 110.58 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.3 pt -68.34 -32.82 57.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.635 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.3 t -61.48 -47.21 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.21 86.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.553 1.07 . . . . 0.0 111.295 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -55.44 -54.28 45.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.078 0.853 . . . . 0.0 110.854 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.3 pt -70.74 -29.92 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.273 0.942 . . . . 0.0 111.876 -176.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -66.44 -31.41 72.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.141 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.2 -55.63 0.08 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 119.14 0.882 . . . . 0.0 112.084 169.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.0 m -164.55 150.82 10.7 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -58.45 -9.99 1.91 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -137.32 20.93 2.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.319 1.448 . . . . 0.0 111.706 -175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -136.97 136.37 38.47 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.029 0.831 . . . . 0.0 109.376 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -68.32 146.33 97.87 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-O 118.78 -0.629 . . . . 0.0 110.184 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.35 -41.39 4.84 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.79 1.66 . . . . 0.0 110.772 169.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -149.59 158.46 44.19 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.353 2.261 . . . . 0.0 107.226 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? . . . . . 0 C--O 1.249 1.066 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 170.03 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -138.32 -41.2 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.384 0.674 . . . . 0.0 110.189 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -119.45 143.65 47.39 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.852 1.661 . . . . 0.0 106.536 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.14 130.12 92.63 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 118.755 -0.641 . . . . 0.0 111.67 -169.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.3 128.62 30.32 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.231 2.62 . . . . 0.0 113.023 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -162.91 153.36 16.48 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 127.57 2.348 . . . . 0.0 105.268 169.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -61.86 -25.58 67.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.729 1.15 . . . . 0.0 112.645 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.9 m -104.79 145.14 30.79 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.362 0.983 . . . . 0.0 109.631 -174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.69 164.42 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.196 1.398 . . . . 0.0 108.076 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -128.63 137.54 51.72 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.902 2.081 . . . . 0.0 106.752 -173.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.1 mt -125.7 145.18 33.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.0 168.88 21.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.65 1.98 . . . . 0.0 108.821 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.9 t30 49.23 34.6 6.31 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.319 1.047 . . . . 0.0 111.168 -169.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.81 147.62 43.22 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 170.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.34 110.45 5.3 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.077 -1.015 . . . . 0.0 109.351 176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.1 -35.79 0.25 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.391 2.276 . . . . 0.0 114.893 169.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.8 -20.74 63.45 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -68.56 126.37 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -67.14 156.09 37.08 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.31 1.044 . . . . 0.0 109.365 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -54.29 -44.03 71.58 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.586 -0.696 . . . . 0.0 110.804 174.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -61.57 -43.07 99.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.994 0.917 . . . . 0.0 110.661 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -67.73 -41.82 82.87 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.829 0.452 . . . . 0.0 110.333 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -57.19 -51.18 70.37 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.549 1.139 . . . . 0.0 109.375 173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -60.2 -47.39 86.17 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -59.97 -47.17 86.92 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.433 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.8 m -61.13 -48.26 82.47 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.73 0.695 . . . . 0.0 110.759 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.19 -51.53 69.19 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 123.376 0.67 . . . . 0.0 109.81 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -61.33 -36.41 80.08 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.929 0.331 . . . . 0.0 111.427 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.81 -35.67 72.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.304 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.1 mt -119.92 -53.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.684 1.129 . . . . 0.0 111.61 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -63.81 -31.1 72.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.836 1.198 . . . . 0.0 110.841 -173.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 73.5 m -60.19 -35.21 74.87 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.54 1.063 . . . . 0.0 112.537 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -65.52 -14.73 61.67 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.709 1.14 . . . . 0.0 111.689 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -112.81 2.97 16.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 0.0 112.333 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.04 11.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 N-CA-C 117.715 1.846 . . . . 0.0 117.715 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 37.84 100.49 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.013 2.525 . . . . 0.0 114.707 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 65.1 mt -55.72 150.78 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.435 173.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.7 tp -121.06 -34.39 3.52 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.014 2.525 . . . . 0.0 109.617 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -158.07 162.64 38.09 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.873 1.215 . . . . 0.0 111.006 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 95.8 mt -138.25 144.07 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.351 1.861 . . . . 0.0 107.086 -175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -139.06 112.66 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.061 0.944 . . . . 0.0 109.546 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.32 164.42 34.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.023 2.529 . . . . 0.0 105.672 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.36 167.93 22.37 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.836 1.255 . . . . 0.0 108.242 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.75 -16.57 62.21 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.5 p -62.52 141.07 58.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.693 1.133 . . . . 0.0 108.996 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.2 -36.62 80.37 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 110.881 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -60.31 -11.27 6.07 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -121.85 20.67 10.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.316 1.446 . . . . 0.0 111.234 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 39.8 mtm105 -120.46 -29.13 4.84 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 125.7 1.6 . . . . 0.0 108.693 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.91 -10.57 84.88 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -141.06 161.28 38.23 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.717 2.007 . . . . 0.0 108.027 -178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.63 173.23 16.9 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.761 1.224 . . . . 0.0 109.016 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -135.81 155.8 49.78 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.86 146.11 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -122.28 140.5 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -126.25 166.97 16.12 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.513 1.525 . . . . 0.0 110.346 -173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -60.83 -34.99 75.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -150.05 153.41 36.42 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.32 1.048 . . . . 0.0 108.225 -170.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 pt -64.09 -33.88 65.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.324 0.65 . . . . 0.0 112.313 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.05 -38.76 59.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -68.58 -40.88 80.35 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.253 0.621 . . . . 0.0 110.132 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.74 77.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.187 0.595 . . . . 0.0 110.066 171.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 m -59.68 -40.82 89.11 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.008 0.523 . . . . 0.0 111.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -64.49 -47.14 80.05 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 119.183 -0.437 . . . . 0.0 110.699 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.16 -51.19 70.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.53 0.732 . . . . 0.0 110.033 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tt -53.98 -57.1 12.27 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.339 1.455 . . . . 0.0 109.621 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 ttp85 -70.49 -39.23 74.31 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.994 -0.526 . . . . 0.0 110.939 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.9 m -65.89 -40.36 91.48 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.647 0.658 . . . . 0.0 110.176 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.2 mmm -89.9 -7.17 54.81 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -53.21 126.27 20.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.715 0.806 . . . . 0.0 109.972 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.92 0.46 51.18 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.818 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -71.87 135.53 83.03 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.009 -172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.72 73.76 4.06 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 124.085 3.19 . . . . 0.0 110.294 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -69.31 -25.86 64.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.89 0.876 . . . . 0.0 110.977 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.4 ' C ' ' H ' ' A' ' 77' ' ' LYS . 65.4 m-85 -138.33 -156.79 0.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.284 2.234 . . . . 0.0 106.341 174.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.08 19.15 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.814 1.246 . . . . 0.0 112.697 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' TYR . 51.1 mttm -144.49 137.17 13.57 Favored Pre-proline 0 C--O 1.235 0.335 0 C-N-CA 126.178 1.791 . . . . 0.0 108.493 -177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.36 113.74 3.71 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.523 2.149 . . . . 0.0 107.026 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.9 mtm -69.42 149.62 48.14 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -117.62 140.81 49.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.3 mt -137.58 150.16 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -169.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.32 168.82 19.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.526 1.53 . . . . 0.0 108.692 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -76.58 171.05 15.29 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.309 0.576 . . . . 0.0 110.209 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -142.81 -166.15 2.22 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.525 1.53 . . . . 0.0 108.519 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -117.58 167.13 11.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.491 0.716 . . . . 0.0 109.159 172.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.6 m -55.3 140.58 38.85 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.65 1.18 . . . . 0.0 113.509 -168.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -56.3 158.91 3.85 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.634 1.173 . . . . 0.0 111.054 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m 66.72 -42.68 0.41 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.587 2.355 . . . . 0.0 112.525 -169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.51 -51.75 39.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.559 1.072 . . . . 0.0 110.51 177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.7 pt -62.81 -35.51 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.198 -0.429 . . . . 0.0 110.683 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -63.65 -48.63 85.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.01 82.99 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.76 0.709 . . . . 0.0 111.13 178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -61.29 -52.26 65.47 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.479 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.8 pt -72.5 -31.98 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 119.001 0.819 . . . . 0.0 111.661 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -67.36 -30.12 69.83 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.655 0.782 . . . . 0.0 111.08 177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.78 46.86 6.54 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -174.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.1 p -131.97 0.25 3.84 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.429 1.492 . . . . 0.0 111.231 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.18 -44.6 94.92 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.696 1.198 . . . . 0.0 111.69 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -153.34 66.86 0.77 Allowed 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 176.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -147.71 163.22 37.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -63.14 150.52 88.6 Favored Pre-proline 0 CA--C 1.535 0.399 0 O-C-N 122.05 -0.406 . . . . 0.0 109.988 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.83 -3.06 13.13 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.174 2.583 . . . . 0.0 111.899 169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -134.28 -174.67 3.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.299 2.239 . . . . 0.0 107.626 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--O 1.248 1.01 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.727 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -150.25 140.01 21.76 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -133.46 136.99 45.5 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.6 151.39 80.11 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 119.19 -0.433 . . . . 0.0 111.22 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.28 134.86 66.23 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.196 2.597 . . . . 0.0 112.864 169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -161.79 150.79 15.77 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.275 2.23 . . . . 0.0 105.226 169.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -68.59 -16.32 63.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.853 1.206 . . . . 0.0 112.102 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.6 m -127.68 143.91 51.12 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.628 1.171 . . . . 0.0 109.012 -172.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 pt -123.21 161.45 24.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.648 1.179 . . . . 0.0 107.918 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.2 134.41 51.26 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 126.582 1.953 . . . . 0.0 105.972 -177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.32 144.78 29.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -169.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.51 170.41 18.12 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.64 1.976 . . . . 0.0 108.353 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 t30 50.38 28.72 3.42 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.79 1.236 . . . . 0.0 112.352 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.565 HD11 HD23 ' A' ' 23' ' ' LEU . 1.7 tt -69.3 146.19 52.42 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 169.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -66.54 114.99 5.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.429 1.013 . . . . 0.0 108.712 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.34 -12.88 23.64 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -68.71 -35.24 76.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 120.25 1.386 . . . . 0.0 111.963 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.5 mm -56.98 112.65 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.447 1.499 . . . . 0.0 109.631 -169.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -65.84 162.87 18.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.989 0.915 . . . . 0.0 109.482 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -54.66 -45.14 73.81 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.782 0.833 . . . . 0.0 111.295 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.24 -42.15 99.18 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.079 0.551 . . . . 0.0 110.428 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -67.84 -40.75 83.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.733 0.413 . . . . 0.0 110.092 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 HD23 HD11 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -57.06 -49.65 75.2 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.842 1.257 . . . . 0.0 108.862 172.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -59.74 -47.92 83.75 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.853 0.461 . . . . 0.0 110.086 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -60.38 -46.16 90.95 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.624 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -64.1 -41.86 97.11 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.106 0.866 . . . . 0.0 111.053 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.4 mt -61.69 -50.3 73.02 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.266 0.626 . . . . 0.0 110.018 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -61.4 -37.95 85.33 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.061 0.391 . . . . 0.0 111.029 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.2 75.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.12 -0.943 . . . . 0.0 112.08 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.6 mt -123.63 -55.89 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 119.294 0.952 . . . . 0.0 111.446 -169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -64.32 -35.09 79.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.878 1.217 . . . . 0.0 111.325 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 m -60.36 -33.39 72.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.603 1.092 . . . . 0.0 112.421 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -65.22 -13.56 58.59 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.312 0.96 . . . . 0.0 111.656 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.15 5.4 11.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.948 1.299 . . . . 0.0 112.111 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 178.43 10.92 0.02 OUTLIER Glycine 0 CA--C 1.53 0.987 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 37.37 103.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.132 2.573 . . . . 0.0 114.816 -170.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 77.1 mt -58.28 152.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.281 1.032 . . . . 0.0 110.737 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -118.21 -41.59 2.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 127.466 2.306 . . . . 0.0 108.592 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.66 162.41 40.6 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.543 1.065 . . . . 0.0 111.039 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.9 142.78 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.109 1.764 . . . . 0.0 107.065 -173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.32 107.04 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 108.618 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 170.94 16.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.279 2.232 . . . . 0.0 106.465 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tp -144.69 160.47 41.15 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.903 0.881 . . . . 0.0 109.119 -171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -75.06 -21.17 59.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.429 -174.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.4 p -68.71 140.59 55.4 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.279 0.945 . . . . 0.0 109.018 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.58 -30.42 54.3 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -57.2 -16.24 7.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.867 1.267 . . . . 0.0 113.68 174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.6 21.65 6.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.756 1.623 . . . . 0.0 110.41 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -105.98 -38.88 6.18 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 168.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.39 -8.69 84.05 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.396 0.522 . . . . 0.0 113.147 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -153.32 160.49 42.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.036 1.734 . . . . 0.0 108.312 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.75 172.34 15.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.759 1.623 . . . . 0.0 108.782 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.68 156.17 49.24 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.805 1.242 . . . . 0.0 107.722 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.9 140.83 11.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.42 140.99 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 128.007 2.523 . . . . 0.0 104.54 -171.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.41 173.13 7.84 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 124.122 0.969 . . . . 0.0 112.024 -172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -51.07 -47.09 61.88 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.697 1.599 . . . . 0.0 112.491 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.43 157.16 33.44 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -61.13 -32.79 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.711 0.804 . . . . 0.0 112.645 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.49 58.05 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -67.28 -40.58 86.17 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.669 0.788 . . . . 0.0 109.857 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.72 80.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.6 0.76 . . . . 0.0 110.12 171.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.4 m -58.56 -43.25 89.3 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 122.939 0.496 . . . . 0.0 111.104 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -64.28 -45.96 85.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.199 -0.429 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.56 -52.45 65.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.542 0.737 . . . . 0.0 109.851 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.0 -57.25 11.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.214 1.405 . . . . 0.0 109.516 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -71.09 -36.85 72.36 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 118.756 -0.64 . . . . 0.0 111.247 -171.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -65.91 -40.88 91.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.87 0.759 . . . . 0.0 110.081 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -88.05 -10.42 50.29 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -55.36 124.46 17.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.855 0.862 . . . . 0.0 109.123 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.05 0.68 44.98 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 118.687 -1.063 . . . . 0.0 114.054 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -72.09 138.15 81.92 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 119.671 1.736 . . . . 0.0 109.729 -175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.61 75.36 3.99 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.722 2.948 . . . . 0.0 110.305 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -60.83 -34.91 75.27 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.599 1.16 . . . . 0.0 110.095 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -142.23 -159.45 0.97 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.03 2.532 . . . . 0.0 105.667 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.02 21.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.534 1.534 . . . . 0.0 113.764 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -140.63 138.94 19.14 Favored Pre-proline 0 C--O 1.234 0.282 0 C-N-CA 125.83 1.652 . . . . 0.0 108.008 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.82 129.34 17.36 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.291 1.994 . . . . 0.0 108.721 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.5 mmm -62.71 147.27 50.11 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.94 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -122.09 129.96 52.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 169.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.1 mt -137.31 149.66 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 166.65 24.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.79 1.636 . . . . 0.0 108.028 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -84.38 144.88 28.52 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -72.93 84.94 1.25 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.256 0.623 . . . . 0.0 110.595 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -48.66 -51.2 29.61 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.644 1.578 . . . . 0.0 111.325 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.0 m -151.61 157.34 42.03 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.417 1.487 . . . . 0.0 108.118 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -157.89 155.16 29.09 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.24 1.416 . . . . 0.0 108.304 170.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 m -138.02 18.66 2.81 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.816 1.246 . . . . 0.0 111.595 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -144.13 -48.07 0.27 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.3 0.955 . . . . 0.0 113.372 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.93 -37.55 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.258 0.935 . . . . 0.0 108.613 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.17 -44.21 94.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.861 0.864 . . . . 0.0 108.963 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.53 -39.86 94.92 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.666 -0.646 . . . . 0.0 110.927 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -48.24 82.65 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.788 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.0 pt -71.35 -29.57 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 118.762 0.71 . . . . 0.0 111.474 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -65.17 -42.16 93.96 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.781 0.718 . . . . 0.0 110.511 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.82 -67.36 0.06 OUTLIER Glycine 0 CA--C 1.524 0.597 0 CA-C-N 118.953 0.797 . . . . 0.0 111.339 175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.1 p -149.86 -84.73 0.09 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.179 0.992 . . . . 0.0 109.346 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -112.1 -11.82 13.75 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.966 1.706 . . . . 0.0 109.671 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -139.46 -175.68 4.27 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.004 2.522 . . . . 0.0 105.342 172.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -63.4 -7.13 5.84 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -65.04 145.08 99.17 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 124.554 1.142 . . . . 0.0 110.23 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.24 -11.75 25.11 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.857 2.371 . . . . 0.0 112.745 173.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -146.62 137.35 23.99 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.368 -174.323 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.483 -0.294 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.34 170.21 19.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.003 1.321 . . . . 0.0 108.629 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -61.84 153.03 30.0 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.667 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.49 155.21 37.69 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.46 139.7 55.44 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.776 2.984 . . . . 0.0 113.639 170.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -162.53 145.91 11.41 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 127.662 2.385 . . . . 0.0 104.947 169.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.51 -16.35 63.58 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 120.41 1.459 . . . . 0.0 112.989 -171.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.0 m -133.3 143.58 49.14 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.83 160.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -132.06 121.68 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.15 134.11 49.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -135.89 19.93 3.26 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -144.37 41.62 1.36 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.166 0.894 . . . . 0.0 111.766 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.5 mt -75.62 140.31 42.53 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -71.47 125.98 28.46 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.41 -27.46 47.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -19.61 65.36 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -65.44 119.45 10.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -62.27 142.72 57.58 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -73.59 -19.92 60.75 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.02 -1.05 . . . . 0.0 111.525 -171.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -69.25 -32.84 72.32 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.66 -0.65 . . . . 0.0 110.152 169.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -71.24 -35.53 71.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.494 1.043 . . . . 0.0 109.794 174.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.59 -49.51 76.15 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 169.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -57.78 -52.64 64.64 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.029 0.532 . . . . 0.0 110.476 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -60.13 -42.67 95.3 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-O 118.537 -0.744 . . . . 0.0 110.894 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.7 m -63.23 -43.01 99.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 119.073 0.851 . . . . 0.0 110.953 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.73 -49.91 75.59 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -30.21 71.03 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.362 177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.44 -42.68 29.27 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.02 0.827 . . . . 0.0 112.699 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -124.07 -39.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -169.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -60.08 -36.15 76.76 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 120.368 1.44 . . . . 0.0 110.536 173.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 66.7 m -50.92 -31.07 16.48 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.55 -10.04 59.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.443 0.697 . . . . 0.0 111.879 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.87 -20.74 3.46 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.57 1.148 . . . . 0.0 112.388 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.55 105.8 0.27 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 106.229 -2.748 . . . . 0.0 106.229 169.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HB3' ' HE2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -60.01 133.28 55.95 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.258 1.028 . . . . 0.0 109.835 177.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mm -70.87 160.55 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.379 2.272 . . . . 0.0 110.09 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.47 -39.28 1.68 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.982 1.313 . . . . 0.0 109.971 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -158.69 162.48 37.21 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.64 1.109 . . . . 0.0 110.63 173.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.45 141.76 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.713 1.605 . . . . 0.0 107.448 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 t -140.17 107.95 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.606 1.163 . . . . 0.0 108.819 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.48 150.69 36.93 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.402 1.881 . . . . 0.0 106.32 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.0 mt -144.0 156.5 44.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.762 1.225 . . . . 0.0 108.608 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -82.55 -6.07 59.12 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 p -61.96 158.19 16.88 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.683 0.793 . . . . 0.0 109.469 172.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 tt -53.77 -36.22 62.16 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.808 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -51.84 -31.06 26.11 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.045 1.338 . . . . 0.0 112.968 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.3 mtp -134.49 23.22 3.71 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.34 0.973 . . . . 0.0 110.854 -173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -53.75 -40.05 65.84 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.44 29.14 2.62 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.601 1.096 . . . . 0.0 111.155 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -146.32 152.93 39.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.376 1.07 . . . . 0.0 108.749 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.65 159.06 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.501 1.52 . . . . 0.0 108.214 -169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -135.53 153.13 51.82 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 169.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.4 p -147.37 139.33 18.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -170.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -112.61 139.92 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 127.805 2.442 . . . . 0.0 104.49 -169.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -122.5 170.85 9.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.652 1.181 . . . . 0.0 109.192 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 36' ' ' GLN . 38.4 mttm -71.42 -29.14 64.55 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.604 -0.685 . . . . 0.0 112.146 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -146.61 154.38 41.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.373 1.069 . . . . 0.0 109.157 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.4 pt -62.0 -34.07 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.584 0.754 . . . . 0.0 111.799 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.24 -45.16 72.13 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.7 m -60.74 -44.61 96.47 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.947 0.899 . . . . 0.0 110.541 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.86 88.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.58 0.352 . . . . 0.0 110.983 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.6 t -62.2 -44.73 95.92 Favored 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.095 0.407 . . . . 0.0 110.349 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -64.68 -42.8 95.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.306 0.242 . . . . 0.0 110.597 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.74 -54.93 40.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.898 0.879 . . . . 0.0 110.023 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.4 tt -52.66 -58.72 5.92 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.664 1.186 . . . . 0.0 109.575 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -73.11 -27.4 61.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.828 -169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.0 m -70.67 -42.2 71.05 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.674 1.124 . . . . 0.0 110.217 171.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.6 mmm -90.04 -10.91 43.1 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -54.05 122.71 10.72 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.569 1.148 . . . . 0.0 109.334 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.82 4.98 63.43 Favored Glycine 0 CA--C 1.535 1.312 0 CA-C-O 118.77 -1.016 . . . . 0.0 114.534 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -68.38 143.46 95.56 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 119.643 1.721 . . . . 0.0 109.915 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.62 78.82 3.39 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.965 2.444 . . . . 0.0 110.515 172.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.91 -38.29 90.56 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.915 0.886 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -146.95 -156.24 0.7 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.271 2.628 . . . . 0.0 105.231 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -60.33 5.67 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.205 1.802 . . . . 0.0 114.817 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -129.87 124.41 21.59 Favored Pre-proline 0 C--O 1.236 0.357 0 C-N-CA 124.84 1.256 . . . . 0.0 107.792 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.94 138.19 85.01 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.738 2.292 . . . . 0.0 109.946 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.4 mtp -65.83 151.03 47.58 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 121.899 -0.501 . . . . 0.0 110.203 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -133.99 123.14 24.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 169.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mt -137.58 152.81 27.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.72 169.65 19.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.023 1.729 . . . . 0.0 108.205 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -70.35 143.58 51.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 p -60.66 -28.9 68.93 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -170.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -57.01 -17.36 9.6 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.451 0.7 . . . . 0.0 112.531 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -61.96 -18.03 59.0 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.309 1.044 . . . . 0.0 113.374 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -129.19 116.93 19.94 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.331 1.423 . . . . 0.0 111.389 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -63.16 -26.72 68.94 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.589 1.156 . . . . 0.0 113.066 -173.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -83.42 -42.46 16.95 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.422 1.01 . . . . 0.0 110.869 -171.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 pt -67.76 -32.92 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 118.934 -0.555 . . . . 0.0 109.896 170.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.6 t -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.8 0.727 . . . . 0.0 109.404 172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.88 97.85 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.265 0.939 . . . . 0.0 111.164 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -59.68 -48.62 80.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 118.177 -0.916 . . . . 0.0 111.334 176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 25.7 pt -72.57 -27.81 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 119.626 1.103 . . . . 0.0 111.662 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -60.81 -42.39 97.57 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.055 0.843 . . . . 0.0 109.156 169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.08 -27.77 0.72 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-O 118.981 -0.899 . . . . 0.0 113.754 169.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 m -148.52 125.06 11.03 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.718 1.259 . . . . 0.0 108.534 -169.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -59.34 -32.32 69.98 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -69.22 -31.78 70.58 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.076 0.95 . . . . 0.0 111.744 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -69.44 147.57 50.76 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -64.8 118.93 53.44 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.21 -39.44 13.24 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.496 1.464 . . . . 0.0 112.824 -169.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -86.25 18.66 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -169.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.4 mttt . . . . . 0 C--O 1.25 1.105 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 169.581 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.8 161.44 26.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.193 0.597 . . . . 0.0 110.541 173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.77 130.05 44.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.306 0.642 . . . . 0.0 110.911 -169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -69.03 132.96 90.06 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.806 0.842 . . . . 0.0 110.345 -170.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.0 125.47 19.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.224 2.616 . . . . 0.0 114.232 170.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -160.53 147.48 15.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -71.47 12.98 0.28 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -168.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.0 m -137.02 145.93 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.88 1.218 . . . . 0.0 108.277 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.0 pt -136.29 166.67 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.644 1.177 . . . . 0.0 108.307 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -129.44 116.97 19.79 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 126.703 2.001 . . . . 0.0 106.436 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.9 mt -97.54 128.16 49.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -131.43 12.39 4.98 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -168.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -139.79 51.11 1.73 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.683 0.754 . . . . 0.0 110.172 170.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -71.2 157.49 38.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.429 ' H ' HD23 ' A' ' 14' ' ' LEU . 49.2 t-20 -90.62 111.6 22.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 172.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -53.45 -29.3 34.89 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.766 1.226 . . . . 0.0 113.352 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -65.3 -25.0 67.43 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -67.22 129.93 32.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -61.28 150.59 34.33 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -32.12 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.608 -0.683 . . . . 0.0 110.512 176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.37 -44.73 90.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.24 1.016 . . . . 0.0 111.404 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -66.47 -40.1 89.18 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 122.942 0.497 . . . . 0.0 110.109 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.82 -51.02 70.61 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.287 1.435 . . . . 0.0 109.382 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -58.54 -50.07 75.1 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.176 0.444 . . . . 0.0 110.513 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -58.52 -45.84 88.01 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-O 119.047 -0.501 . . . . 0.0 110.429 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 45.2 m -64.15 -45.8 86.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.464 0.575 . . . . 0.0 111.013 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 mt -58.14 -50.86 72.03 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.959 -0.463 . . . . 0.0 109.773 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -63.0 -29.73 71.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.24 -44.79 35.92 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.312 -0.852 . . . . 0.0 112.373 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -118.38 -41.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -169.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.76 -40.36 92.18 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.951 1.705 . . . . 0.0 109.733 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.9 m -60.56 -15.65 29.87 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 176.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -71.15 -17.29 62.55 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.078 1.308 . . . . 0.0 111.554 173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -125.86 -20.19 4.67 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.436 1.095 . . . . 0.0 112.111 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.01 106.86 0.29 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 106.666 -2.573 . . . . 0.0 106.666 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -48.72 114.58 1.01 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.64 0.776 . . . . 0.0 110.571 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -61.24 145.83 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.6 tp -120.84 -35.99 3.24 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.02 1.728 . . . . 0.0 109.96 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -154.07 163.33 40.27 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.482 1.037 . . . . 0.0 110.526 172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.7 mt -143.34 138.7 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 126.27 1.828 . . . . 0.0 107.155 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.2 t -140.86 97.63 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.544 1.138 . . . . 0.0 108.491 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.48 149.13 42.14 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 168.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.3 mt -145.81 164.12 32.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.944 0.793 . . . . 0.0 109.623 -169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.51 -22.19 62.66 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.837 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -60.77 136.96 58.23 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.098 0.863 . . . . 0.0 109.098 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.3 tp -50.94 -43.34 60.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.935 0.894 . . . . 0.0 112.091 -170.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.19 -10.46 10.66 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -136.06 17.76 3.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.955 1.702 . . . . 0.0 110.241 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -89.63 -34.24 16.37 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.3 1.04 . . . . 0.0 111.479 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.5 15.53 8.06 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 126.133 1.825 . . . . 0.0 111.578 -174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 157.32 40.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.774 2.43 . . . . 0.0 105.953 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.17 157.05 38.26 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.04 0.936 . . . . 0.0 109.368 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -114.18 139.3 49.47 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.38 143.29 34.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.63 146.8 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -129.97 167.59 18.01 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 126.026 1.731 . . . . 0.0 109.81 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -64.56 -33.39 75.81 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -149.33 157.81 43.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.893 0.877 . . . . 0.0 109.717 -169.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.1 pt -63.19 -35.17 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.011 0.924 . . . . 0.0 111.887 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.23 -42.39 75.76 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.9 m -63.0 -45.22 93.45 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.39 0.595 . . . . 0.0 110.551 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.73 71.77 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.126 0.421 . . . . 0.0 111.515 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.2 p -66.69 -38.74 87.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 122.226 -0.296 . . . . 0.0 111.403 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.78 -42.72 90.47 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.133 -0.354 . . . . 0.0 111.281 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.82 -53.51 57.05 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.114 0.966 . . . . 0.0 109.338 172.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -52.26 -59.46 4.37 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 124.374 1.069 . . . . 0.0 109.375 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -64.01 -37.08 86.13 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.484 -172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.8 m -68.8 -41.55 78.52 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.822 0.737 . . . . 0.0 110.363 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.3 mmm -89.19 -8.91 52.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.367 0.667 . . . . 0.0 112.029 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -56.38 121.69 10.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.009 1.323 . . . . 0.0 108.747 174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.34 -0.18 64.71 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.299 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -67.09 137.06 94.27 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 119.782 1.791 . . . . 0.0 110.061 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.75 73.56 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.742 2.961 . . . . 0.0 111.265 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.08 -49.2 76.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.302 1.041 . . . . 0.0 112.089 -172.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -154.6 80.1 1.09 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.682 1.193 . . . . 0.0 108.729 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 54.35 28.06 8.9 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.342 1.457 . . . . 0.0 113.035 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -149.52 133.5 8.83 Favored Pre-proline 0 C--O 1.235 0.3 0 C-N-CA 126.023 1.729 . . . . 0.0 107.554 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.9 122.67 8.68 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 N-CA-C 106.758 -2.055 . . . . 0.0 106.758 169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.8 mmm -60.97 149.02 37.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -130.2 128.03 40.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.68 151.5 24.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.98 161.22 38.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.014 1.726 . . . . 0.0 108.144 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -79.44 165.14 23.37 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -138.21 116.52 11.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -65.1 145.31 56.46 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.3 m -67.68 -18.93 65.1 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -140.21 -41.85 0.42 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.165 0.986 . . . . 0.0 111.335 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -30.13 68.2 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.91 -0.494 . . . . 0.0 111.944 -177.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.7 -46.85 67.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.411 0.551 . . . . 0.0 111.351 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 47.8 pt -70.2 -33.06 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 119.322 -0.371 . . . . 0.0 110.44 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.93 -46.55 96.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.65 74.14 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.67 -0.644 . . . . 0.0 111.705 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 98' ' ' PHE . 60.9 mtpt -63.02 -54.5 37.33 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.92 0.782 . . . . 0.0 110.147 174.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 pt -67.38 -30.52 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 119.148 0.885 . . . . 0.0 111.803 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -77.46 -11.85 59.89 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.828 0.851 . . . . 0.0 112.596 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.36 -16.04 10.95 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.357 0.981 . . . . 0.0 112.904 -174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.6 p -62.1 -14.49 37.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.141 1.471 . . . . 0.0 113.425 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 93' ' ' LYS . 4.4 p90 -58.87 -27.44 65.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.949 0.795 . . . . 0.0 112.824 172.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.37 -1.93 0.39 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -139.15 175.03 9.91 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 109.627 -170.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.73 158.78 81.93 Favored Pre-proline 0 CA--C 1.539 0.54 0 O-C-N 121.551 -0.718 . . . . 0.0 109.543 169.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.17 -31.12 53.66 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.322 2.681 . . . . 0.0 113.877 170.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -147.38 147.06 29.89 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.018 1.727 . . . . 0.0 106.647 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 117.626 -1.178 . . . . 0.0 108.726 170.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -61.92 -48.33 80.91 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.351 0.661 . . . . 0.0 110.274 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -76.07 138.1 40.6 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.907 1.283 . . . . 0.0 108.445 170.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.58 137.59 94.9 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 118.87 -0.586 . . . . 0.0 110.367 170.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.5 144.35 63.11 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.198 2.599 . . . . 0.0 113.83 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -157.02 151.94 25.94 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.844 2.458 . . . . 0.0 105.069 169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.71 -12.72 61.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.294 1.406 . . . . 0.0 112.373 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.2 m -134.36 157.53 46.14 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.935 1.294 . . . . 0.0 107.802 -169.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -132.85 169.11 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.444 1.098 . . . . 0.0 108.452 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -128.5 136.81 51.3 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.68 1.992 . . . . 0.0 106.545 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.78 145.4 32.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.68 169.4 21.69 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.264 1.826 . . . . 0.0 108.828 -175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 t30 51.29 26.67 3.14 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.249 1.419 . . . . 0.0 112.553 -171.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.36 140.48 58.09 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -68.09 109.28 3.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 119.474 1.034 . . . . 0.0 108.455 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -63.8 -15.82 59.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.455 1.102 . . . . 0.0 113.703 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -29.3 70.01 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 120.097 1.317 . . . . 0.0 111.533 175.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.7 mm -59.25 119.56 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.774 1.23 . . . . 0.0 108.692 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.12 156.31 25.41 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.594 1.158 . . . . 0.0 108.894 172.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -43.75 67.48 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.242 1.017 . . . . 0.0 111.427 175.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.35 -43.82 96.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 110.682 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -66.22 -38.12 87.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.708 0.403 . . . . 0.0 110.342 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.51 -49.42 77.46 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.019 1.328 . . . . 0.0 109.257 174.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -58.7 -49.51 77.31 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.857 0.753 . . . . 0.0 110.161 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -60.38 -44.58 95.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.751 -179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.8 m -64.63 -46.56 82.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.087 0.858 . . . . 0.0 110.709 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.72 -52.64 64.18 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -67.49 -27.72 67.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.168 0.44 . . . . 0.0 112.112 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.33 -41.58 80.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.919 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -126.51 -38.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -170.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.98 -39.28 94.26 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.861 1.664 . . . . 0.0 110.767 175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 69.9 m -58.81 -17.94 27.93 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -66.65 -27.94 68.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.024 0.829 . . . . 0.0 111.434 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -115.51 -23.15 8.93 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 124.168 0.987 . . . . 0.0 112.007 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.94 110.74 0.46 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 105.739 -2.944 . . . . 0.0 105.739 169.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -56.71 118.31 4.76 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.727 0.775 . . . . 0.0 109.79 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.6 mt -66.42 155.52 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.967 1.707 . . . . 0.0 109.864 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.8 tp -123.04 -38.42 2.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.59 1.956 . . . . 0.0 110.337 172.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -156.6 161.84 39.91 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.678 1.127 . . . . 0.0 110.514 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 69.0 mt -139.27 143.78 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.775 1.63 . . . . 0.0 107.554 -170.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.4 t -137.36 112.1 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 124.464 1.106 . . . . 0.0 108.934 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.83 164.36 38.94 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 128.279 2.631 . . . . 0.0 106.115 169.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.9 mt -145.46 172.41 13.24 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.817 1.247 . . . . 0.0 108.76 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -69.89 -22.48 63.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.613 -0.708 . . . . 0.0 112.721 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -63.63 143.12 58.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.848 0.859 . . . . 0.0 109.295 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.8 tp -51.71 -43.59 62.89 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.426 0.69 . . . . 0.0 111.149 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -58.02 -19.69 33.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.613 1.165 . . . . 0.0 112.582 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.01 18.93 8.43 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.374 1.469 . . . . 0.0 111.07 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -106.81 -42.0 5.06 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.643 1.577 . . . . 0.0 108.148 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.11 -6.98 89.03 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.322 0.487 . . . . 0.0 112.674 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -141.38 154.88 45.88 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.286 1.834 . . . . 0.0 106.982 -176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.38 171.48 20.09 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.178 0.991 . . . . 0.0 109.486 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -135.96 156.19 49.12 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.62 138.29 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.2 mp -111.47 141.32 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 128.448 2.699 . . . . 0.0 104.072 -171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -124.74 172.5 9.25 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.255 1.022 . . . . 0.0 110.171 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -77.96 -17.57 57.03 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -153.23 147.96 26.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.299 0.954 . . . . 0.0 108.685 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 pt -62.73 -33.35 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.547 0.739 . . . . 0.0 111.82 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.74 -35.41 62.17 Favored Glycine 0 CA--C 1.528 0.854 0 O-C-N 121.318 -0.864 . . . . 0.0 110.971 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.2 m -68.26 -44.24 76.05 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.362 0.665 . . . . 0.0 109.397 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.92 73.7 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.196 0.599 . . . . 0.0 110.056 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -60.52 -42.03 95.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.057 0.543 . . . . 0.0 111.79 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -69.09 -42.23 76.42 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.727 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.77 -51.28 69.52 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.508 0.723 . . . . 0.0 109.774 172.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.81 -58.21 7.64 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.96 1.304 . . . . 0.0 109.629 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -69.82 -38.46 76.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.96 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 37.9 m -64.96 -40.58 95.23 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.67 0.668 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.9 mmm -90.74 -7.95 51.13 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -54.4 126.06 21.87 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.982 0.81 . . . . 0.0 109.623 173.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.5 0.55 31.7 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.956 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -71.28 138.25 84.2 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 119.637 1.718 . . . . 0.0 109.561 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.57 78.7 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.509 2.806 . . . . 0.0 109.965 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -57.25 -38.2 73.47 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.681 1.193 . . . . 0.0 109.657 176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -144.93 -157.3 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.186 2.594 . . . . 0.0 105.263 169.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.97 18.02 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.382 1.473 . . . . 0.0 114.245 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -137.65 137.71 22.53 Favored Pre-proline 0 C--O 1.236 0.369 0 C-N-CA 124.856 1.262 . . . . 0.0 108.184 171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -70.51 132.41 22.06 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.376 2.051 . . . . 0.0 109.059 173.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 20.2 mmm -63.81 152.29 39.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.264 0.626 . . . . 0.0 110.14 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.37 128.42 44.48 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 169.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.7 mt -137.53 149.5 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.36 11.69 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.284 1.834 . . . . 0.0 108.395 173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -67.2 162.53 22.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 m -59.01 141.09 54.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -169.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -138.11 41.03 2.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.945 2.098 . . . . 0.0 108.166 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -50.84 123.26 8.73 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.223 1.409 . . . . 0.0 109.39 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -53.34 -50.11 65.71 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.76 0.824 . . . . 0.0 112.554 -169.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.8 m -61.33 -36.0 78.95 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.665 0.386 . . . . 0.0 111.41 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.91 -46.56 35.11 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 122.91 0.484 . . . . 0.0 110.926 -176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.2 pt -65.81 -38.32 81.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.94 -46.94 95.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.08 -37.55 80.23 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.964 0.802 . . . . 0.0 111.641 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -64.78 -49.24 71.51 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.885 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.4 pt -70.79 -33.04 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 119.656 1.117 . . . . 0.0 111.831 -177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -71.69 -29.77 64.95 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.211 0.604 . . . . 0.0 111.301 175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.93 -15.38 60.75 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.946 1.26 . . . . 0.0 111.529 -176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.9 p -62.5 -10.43 11.82 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.586 1.554 . . . . 0.0 112.884 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -58.75 -27.2 64.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.276 1.03 . . . . 0.0 111.273 169.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.67 -43.22 0.83 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.543 1.137 . . . . 0.0 110.593 -176.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.4 164.79 15.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.166 0.587 . . . . 0.0 110.243 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -56.06 148.8 38.19 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.346 172.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.01 -23.4 34.24 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.579 2.186 . . . . 0.0 112.436 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -144.58 130.62 19.42 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.338 1.855 . . . . 0.0 106.934 -179.296 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -67.53 157.16 34.98 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 171.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -64.38 136.31 56.99 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.0 mp -73.68 148.19 87.38 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.302 0.641 . . . . 0.0 110.234 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.65 133.24 56.02 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.996 2.464 . . . . 0.0 112.363 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -155.36 138.91 15.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 103.065 -2.939 . . . . 0.0 103.065 169.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.0 -15.54 56.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.425 1.011 . . . . 0.0 111.782 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -120.13 145.03 47.32 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.027 1.331 . . . . 0.0 108.951 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -125.18 162.64 27.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -126.06 123.73 39.05 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 127.023 2.129 . . . . 0.0 106.163 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.6 mt -115.28 141.92 30.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -145.08 167.51 22.54 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.477 2.311 . . . . 0.0 107.768 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.9 t30 52.59 26.65 4.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.353 1.461 . . . . 0.0 112.609 -173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.13 138.49 57.11 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -66.03 110.55 2.98 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.0 -9.25 44.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.82 1.248 . . . . 0.0 113.569 -172.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -67.8 -32.25 72.68 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 120.665 1.575 . . . . 0.0 111.472 174.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.1 126.77 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.776 1.23 . . . . 0.0 108.583 -171.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.52 160.07 30.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.595 0.758 . . . . 0.0 109.507 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.93 -45.75 71.33 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.657 -0.652 . . . . 0.0 110.666 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -62.98 -38.46 91.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.475 0.31 . . . . 0.0 110.654 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -71.83 -38.94 70.08 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.971 -0.456 . . . . 0.0 110.328 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.32 -52.01 67.37 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 124.503 1.121 . . . . 0.0 109.104 171.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -57.59 -48.73 78.58 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.146 0.978 . . . . 0.0 110.235 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -58.57 -47.13 85.32 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 123.404 0.682 . . . . 0.0 110.256 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.5 m -66.81 -39.03 87.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.566 0.621 . . . . 0.0 111.698 -175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.2 mt -63.12 -47.72 81.57 Favored 'General case' 0 C--N 1.334 -0.095 0 O-C-N 121.733 -0.604 . . . . 0.0 109.659 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -63.98 -33.77 76.48 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.346 0.521 . . . . 0.0 111.499 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.16 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.596 -0.716 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.2 mt -118.29 -56.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 119.202 0.91 . . . . 0.0 110.474 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -65.14 -28.56 69.5 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.38 0.991 . . . . 0.0 111.399 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 m -59.79 -33.32 71.55 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.1 1.318 . . . . 0.0 112.483 171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -64.96 -16.12 62.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.499 1.045 . . . . 0.0 111.636 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -119.91 -6.54 10.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.325 1.05 . . . . 0.0 112.736 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.48 4.66 0.04 OUTLIER Glycine 0 CA--C 1.53 1.004 0 N-CA-C 116.675 1.43 . . . . 0.0 116.675 174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.21 102.86 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.679 2.392 . . . . 0.0 114.137 -170.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.7 mm -48.43 132.47 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.978 1.711 . . . . 0.0 111.19 174.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -110.72 -38.33 5.18 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.706 1.202 . . . . 0.0 109.715 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -158.57 162.27 37.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.436 1.017 . . . . 0.0 110.283 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.2 mt -139.2 143.93 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.116 1.766 . . . . 0.0 107.275 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.51 102.43 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.807 1.243 . . . . 0.0 108.573 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.31 166.82 23.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.462 1.905 . . . . 0.0 106.224 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.6 mt -141.52 166.3 25.13 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.496 1.119 . . . . 0.0 108.596 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -78.02 -14.8 59.38 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.695 175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -66.33 138.62 57.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.463 1.105 . . . . 0.0 108.888 174.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 63.6 tp -44.77 -55.52 5.26 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.895 1.278 . . . . 0.0 114.236 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -66.46 -43.58 85.1 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.198 0.908 . . . . 0.0 110.53 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 14.74 1.22 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.758 0.823 . . . . 0.0 112.802 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -117.03 -28.53 6.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.814 1.646 . . . . 0.0 109.97 172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.57 -12.04 73.33 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.677 1.132 . . . . 0.0 111.66 169.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -130.08 162.29 29.1 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.873 2.069 . . . . 0.0 107.972 173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.75 171.25 20.71 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.696 1.199 . . . . 0.0 108.965 172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -136.53 154.68 50.65 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.5 141.14 10.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.85 142.3 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 127.891 2.477 . . . . 0.0 105.118 -169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -124.86 172.46 9.34 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.307 1.043 . . . . 0.0 112.521 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -49.14 -46.56 45.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.852 1.661 . . . . 0.0 113.008 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.03 160.83 39.36 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 pt -58.97 -34.01 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.777 0.831 . . . . 0.0 112.372 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.93 -37.21 56.85 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.6 m -67.1 -41.65 85.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.331 0.653 . . . . 0.0 109.679 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.12 81.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.607 0.763 . . . . 0.0 110.162 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.5 m -59.02 -42.61 90.55 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.054 0.542 . . . . 0.0 111.344 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -65.67 -46.33 79.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.738 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.63 72.2 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.538 0.735 . . . . 0.0 110.102 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 tt -53.14 -59.18 4.87 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.291 1.437 . . . . 0.0 109.383 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 36.1 mtp-105 -69.86 -35.35 74.64 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.519 -172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.1 m -66.85 -40.4 87.89 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.11 0.868 . . . . 0.0 110.127 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.5 mmm -91.35 -8.62 47.55 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.896 0.478 . . . . 0.0 112.209 -172.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -55.35 123.56 14.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.348 1.059 . . . . 0.0 109.253 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.31 -0.05 50.33 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.162 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -72.88 138.25 79.72 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.618 1.709 . . . . 0.0 109.952 -174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.17 77.02 3.29 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.689 2.926 . . . . 0.0 110.215 172.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -62.2 -32.58 73.24 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.458 1.103 . . . . 0.0 110.265 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -144.9 -161.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.355 2.662 . . . . 0.0 105.316 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -66.22 18.47 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 0.0 114.071 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -138.12 138.79 23.93 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.897 1.279 . . . . 0.0 107.803 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.2 131.21 21.53 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.104 1.87 . . . . 0.0 108.629 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.1 mmm -61.95 148.19 44.5 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -126.57 125.83 42.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 103.738 -2.69 . . . . 0.0 103.738 169.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 mt -132.23 151.06 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.56 168.35 20.06 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.992 1.717 . . . . 0.0 107.931 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -78.36 145.07 35.44 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 171.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -64.93 166.5 9.1 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.583 0.706 . . . . 0.0 111.839 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -176.8 3.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.889 1.676 . . . . 0.0 108.435 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -53.31 150.38 6.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.443 1.097 . . . . 0.0 110.872 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -54.76 -45.48 74.22 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.781 0.832 . . . . 0.0 111.874 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.2 m -62.59 -36.47 82.81 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.764 0.426 . . . . 0.0 111.168 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.28 -35.54 47.85 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.258 -0.901 . . . . 0.0 111.553 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 46.5 pt -67.72 -30.91 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 O-C-N 121.4 -0.813 . . . . 0.0 110.351 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.52 -41.36 92.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 118.727 -0.654 . . . . 0.0 109.789 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 98' ' ' PHE . . . -57.47 -44.57 84.96 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 120.052 1.296 . . . . 0.0 111.314 171.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -60.75 -46.93 88.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.477 -0.773 . . . . 0.0 111.227 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.2 pt -71.08 -29.84 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.588 1.085 . . . . 0.0 111.523 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt 127.83 122.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 1 C-N-CA 132.16 4.184 . . . . 0.0 106.717 174.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.67 178.58 48.68 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.0 p -60.9 -21.89 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.564 1.146 . . . . 0.0 113.672 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' A' ' 92' ' ' ALA . 15.9 t80 -66.56 -8.1 24.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.627 1.103 . . . . 0.0 113.2 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.34 19.85 16.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.619 1.1 . . . . 0.0 111.914 169.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -129.62 -54.04 1.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.326 1.05 . . . . 0.0 109.153 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -141.8 64.38 18.06 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 125.92 1.688 . . . . 0.0 109.248 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -64.88 -38.63 28.83 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.084 1.19 . . . . 0.0 111.449 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -85.73 55.33 3.47 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.61 1.164 . . . . 0.0 108.448 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--O 1.247 0.944 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 176.041 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mtp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.809 0.338 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.94 143.42 28.48 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 169.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.5 mmt -78.58 152.21 31.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -125.14 117.56 25.52 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 126.265 1.826 . . . . 0.0 106.553 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.39 126.35 21.96 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.428 2.752 . . . . 0.0 114.896 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -161.46 153.06 19.03 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.716 2.806 . . . . 0.0 104.775 169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.44 -20.13 66.23 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.772 1.169 . . . . 0.0 112.547 -177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.6 m -105.78 142.22 35.88 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 119.454 1.024 . . . . 0.0 109.407 -172.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.6 pt -132.1 163.51 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.45 1.5 . . . . 0.0 107.641 175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -128.36 138.23 52.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 126.078 1.751 . . . . 0.0 107.684 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.3 mt -129.5 140.33 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -149.42 178.29 8.93 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 125.716 1.607 . . . . 0.0 108.418 173.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.1 t30 59.94 30.04 19.58 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.701 1.2 . . . . 0.0 111.718 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mt -61.9 146.33 50.15 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -66.99 113.97 5.41 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -52.8 -27.07 16.44 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.988 1.315 . . . . 0.0 113.226 -175.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.17 66.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.474 1.034 . . . . 0.0 113.183 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.3 mm -66.7 122.75 18.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.44 1.096 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -63.72 152.92 37.86 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.28 -35.94 78.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.602 -1.311 . . . . 0.0 112.162 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.24 -36.18 82.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.829 0.852 . . . . 0.0 111.07 173.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -72.17 -32.94 67.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.778 177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' C ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.76 -48.9 78.32 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.984 1.265 . . . . 0.0 108.319 169.768 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.32 -48.92 79.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.924 0.329 . . . . 0.0 110.114 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.95 -47.93 81.46 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.651 0.78 . . . . 0.0 110.495 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.5 m -66.23 -41.96 89.34 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.082 0.553 . . . . 0.0 111.148 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.51 -51.32 70.38 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.42 -38.23 83.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.696 0.226 . . . . 0.0 111.391 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.26 83.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.134 -0.936 . . . . 0.0 112.461 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -128.85 -41.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -59.34 -37.8 78.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.938 1.699 . . . . 0.0 111.618 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.5 m -57.53 -26.89 62.04 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.34 -8.35 31.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.952 1.251 . . . . 0.0 112.146 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.33 9.17 16.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.665 1.186 . . . . 0.0 111.949 -178.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 168.76 1.47 0.03 OUTLIER Glycine 0 CA--C 1.532 1.126 0 N-CA-C 117.562 1.785 . . . . 0.0 117.562 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 57.33 111.38 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.669 2.387 . . . . 0.0 112.972 -169.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.81 152.62 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.476 171.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.22 -40.36 3.1 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.724 2.009 . . . . 0.0 109.027 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -157.17 162.81 39.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.698 1.135 . . . . 0.0 111.281 173.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.8 mt -136.08 139.11 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.798 1.639 . . . . 0.0 106.971 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.25 94.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.584 1.153 . . . . 0.0 108.844 -175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.96 155.11 48.27 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 168.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.5 mt -139.58 163.93 31.26 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.299 1.04 . . . . 0.0 109.462 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -80.71 -8.66 59.72 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.792 0.837 . . . . 0.0 112.246 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -59.85 151.21 26.23 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.111 0.964 . . . . 0.0 109.252 178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.89 -25.82 63.71 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.244 -0.91 . . . . 0.0 112.966 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -62.56 -26.85 68.79 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.187 0.995 . . . . 0.0 112.07 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.1 mmm -130.32 11.18 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.027 1.331 . . . . 0.0 111.819 -169.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.6 tpt85 -59.98 -29.73 68.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 117.423 -1.275 . . . . 0.0 112.49 -174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.7 25.28 2.84 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.998 1.285 . . . . 0.0 112.412 -178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.82 160.27 42.01 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.034 1.334 . . . . 0.0 108.849 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.02 159.62 40.45 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.837 1.255 . . . . 0.0 110.033 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.86 150.9 42.26 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 168.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.3 p -150.89 142.63 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.87 138.4 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -122.23 164.38 17.95 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.781 1.632 . . . . 0.0 110.402 -171.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -54.77 -38.37 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.001 1.32 . . . . 0.0 113.419 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -154.94 155.78 34.88 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -60.83 -36.26 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.022 0.929 . . . . 0.0 112.545 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.87 -41.15 56.29 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.3 m -64.7 -40.86 96.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.873 0.869 . . . . 0.0 110.707 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.27 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.882 0.873 . . . . 0.0 110.037 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.1 m -60.29 -41.6 93.7 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.777 0.431 . . . . 0.0 111.253 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -63.62 -48.59 76.7 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.125 0.57 . . . . 0.0 110.823 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.84 -54.27 46.61 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.909 0.884 . . . . 0.0 110.07 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.2 -59.91 3.96 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.776 1.231 . . . . 0.0 109.715 -178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -66.41 -36.58 83.19 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 119.227 -0.416 . . . . 0.0 110.552 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.4 m -70.25 -43.09 71.26 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.453 0.57 . . . . 0.0 110.456 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.4 mmm -82.76 -9.37 59.38 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.58 125.73 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.773 0.829 . . . . 0.0 109.651 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.39 0.7 54.81 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.506 -1.164 . . . . 0.0 114.1 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -66.42 133.72 94.44 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.756 1.778 . . . . 0.0 109.636 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.38 81.6 2.44 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.484 2.789 . . . . 0.0 110.182 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -63.99 -43.64 95.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.132 0.973 . . . . 0.0 110.675 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -149.46 73.54 1.19 Allowed 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 125.805 1.642 . . . . 0.0 106.673 172.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.4 t70 66.87 -38.66 0.33 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.125 2.57 . . . . 0.0 113.874 -172.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -81.61 132.46 55.0 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.973 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.22 123.85 11.06 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.152 1.902 . . . . 0.0 108.287 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.2 mmm -59.87 138.64 57.76 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.5 123.28 49.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.34 151.67 35.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.37 21.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.47 1.508 . . . . 0.0 108.1 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -78.98 169.95 17.42 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -134.76 -173.56 3.34 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.712 1.205 . . . . 0.0 108.201 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -131.79 156.15 46.51 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -59.5 147.24 37.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.714 0.806 . . . . 0.0 109.527 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -146.92 145.78 29.91 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.625 1.17 . . . . 0.0 107.927 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -53.03 -31.72 42.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.468 1.107 . . . . 0.0 113.545 -172.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -71.4 -48.01 52.54 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.697 1.135 . . . . 0.0 111.608 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 41.4 pt -71.65 -33.02 47.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.142 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.65 -45.24 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.51 -45.3 89.06 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.224 0.92 . . . . 0.0 110.711 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -57.62 -51.01 71.25 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.195 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 pt -78.21 -34.67 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.929 0.786 . . . . 0.0 112.096 -172.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -77.59 -32.68 53.82 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.132 0.573 . . . . 0.0 110.67 -177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.62 -28.05 6.08 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.301 1.905 . . . . 0.0 111.595 169.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.0 p -146.08 163.55 34.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.711 2.004 . . . . 0.0 106.589 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -55.64 -32.78 63.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.838 0.855 . . . . 0.0 112.361 -174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 0.1 OUTLIER -133.81 138.67 45.81 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 101.626 -3.472 . . . . 0.0 101.626 168.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -58.73 120.06 8.26 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.949 1.249 . . . . 0.0 110.231 -175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.2 mmt-85 36.91 75.84 0.49 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 128.014 2.526 . . . . 0.0 110.972 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.54 -23.75 8.19 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 124.323 3.349 . . . . 0.0 117.735 -169.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -114.28 22.47 13.73 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.375 0.989 . . . . 0.0 112.238 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.5 pttm . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.09 0.556 . . . . 0.0 109.792 169.921 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.36 163.71 33.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.401 1.08 . . . . 0.0 109.69 -171.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -122.13 149.21 43.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.82 135.04 95.75 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 118.548 -0.739 . . . . 0.0 111.33 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.36 138.96 73.92 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.274 2.649 . . . . 0.0 111.869 169.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -157.91 154.03 27.23 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 169.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -70.91 -5.5 31.27 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 120.226 1.375 . . . . 0.0 112.525 -176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.6 m -138.74 152.85 48.31 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.147 1.779 . . . . 0.0 106.962 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -129.15 173.0 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -133.77 112.0 11.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.036 2.534 . . . . 0.0 105.929 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.1 mt -100.61 141.6 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -146.87 177.53 9.04 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 109.259 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.36 27.93 8.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.103 1.361 . . . . 0.0 111.822 -169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.02 130.94 41.47 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -66.91 121.61 15.88 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -58.18 -18.72 27.85 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -173.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -63.92 -34.64 78.43 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.056 0.844 . . . . 0.0 112.106 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 mm -58.77 125.24 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -73.88 160.28 31.64 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.013 0.525 . . . . 0.0 109.68 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.52 -44.18 80.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 110.685 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.06 -45.72 93.62 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.078 0.551 . . . . 0.0 110.033 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -64.02 -42.7 97.04 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.892 0.477 . . . . 0.0 110.123 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -57.49 -54.54 45.7 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.559 1.144 . . . . 0.0 109.389 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -57.72 -50.28 73.74 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.881 0.764 . . . . 0.0 110.709 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -58.21 -42.07 85.38 Favored 'General case' 0 C--N 1.337 0.06 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.328 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.2 m -63.12 -44.88 94.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.621 0.646 . . . . 0.0 111.304 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.99 -43.06 93.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.526 -0.734 . . . . 0.0 109.845 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -63.94 -30.59 71.65 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.57 -0.706 . . . . 0.0 111.801 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.33 70.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.942 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.67 -43.15 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -62.73 -41.63 99.27 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.901 1.682 . . . . 0.0 110.735 177.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.6 m -62.56 -15.14 49.36 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -72.27 -18.15 61.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -126.04 -22.06 4.19 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.021 0.928 . . . . 0.0 112.425 -171.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.5 110.11 0.43 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 105.962 -2.855 . . . . 0.0 105.962 169.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -58.58 119.36 6.9 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.837 0.827 . . . . 0.0 110.053 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.6 mt -66.45 155.18 7.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.092 1.757 . . . . 0.0 109.599 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.0 tp -122.1 -36.38 2.99 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.87 2.068 . . . . 0.0 110.109 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -158.73 162.35 37.14 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.917 1.235 . . . . 0.0 110.895 174.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mt -138.92 143.69 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.771 1.629 . . . . 0.0 107.713 -174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -140.11 113.12 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.292 1.437 . . . . 0.0 108.272 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 155.54 43.43 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.372 1.869 . . . . 0.0 106.1 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.0 tp -160.1 146.15 15.58 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -76.1 -8.91 58.08 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.0 p -58.75 147.44 33.23 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.548 1.067 . . . . 0.0 109.069 174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.99 -41.08 46.25 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.954 0.902 . . . . 0.0 112.09 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -56.35 -20.27 18.43 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.6 mmm -134.65 -6.26 2.5 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.836 1.254 . . . . 0.0 113.051 -171.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 -62.75 -26.8 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.947 1.249 . . . . 0.0 113.179 -171.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -114.98 16.56 18.11 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.68 1.133 . . . . 0.0 112.457 -174.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.02 173.68 12.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 109.569 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.06 37.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.769 1.227 . . . . 0.0 107.812 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -123.73 147.91 47.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 169.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.6 p -148.88 131.66 6.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mp -103.61 139.87 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 104.1 -2.555 . . . . 0.0 104.1 -173.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -122.51 174.15 7.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.688 1.195 . . . . 0.0 109.102 -177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.24 -23.52 59.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.644 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -156.4 151.83 26.77 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.008 0.822 . . . . 0.0 109.11 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.2 pt -64.08 -31.9 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.76 0.824 . . . . 0.0 111.768 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.18 -35.76 64.02 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.9 m -68.46 -44.66 74.38 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.3 78.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.331 0.652 . . . . 0.0 110.541 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -61.36 -42.82 99.31 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.048 0.539 . . . . 0.0 111.549 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.39 -40.22 74.06 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 119.403 -0.332 . . . . 0.0 110.996 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -52.08 66.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.674 0.789 . . . . 0.0 109.571 171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 tt -53.34 -58.1 8.27 Favored 'General case' 0 C--N 1.337 0.06 0 C-N-CA 124.659 1.184 . . . . 0.0 109.584 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 mtp-105 -67.39 -38.75 85.18 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.75 -173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.0 m -65.87 -37.44 86.16 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.128 0.876 . . . . 0.0 110.155 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.8 mmm -93.5 -7.39 44.46 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.156 0.582 . . . . 0.0 112.256 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -56.95 122.56 12.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.045 0.938 . . . . 0.0 109.163 175.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.67 3.06 65.97 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.658 -1.079 . . . . 0.0 114.139 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -64.89 132.9 95.59 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 119.535 1.667 . . . . 0.0 109.62 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.78 99.27 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.508 2.139 . . . . 0.0 109.493 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.07 -54.59 39.21 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.064 0.546 . . . . 0.0 110.456 -172.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -151.56 -63.73 0.18 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.956 1.302 . . . . 0.0 108.336 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.87 -22.12 13.55 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.669 0.788 . . . . 0.0 112.105 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -136.68 151.35 72.47 Favored Pre-proline 0 C--N 1.344 0.354 0 C-N-CA 123.069 0.547 . . . . 0.0 112.172 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -71.01 129.78 16.8 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.796 2.331 . . . . 0.0 108.939 169.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 30.9 mtp -65.94 146.79 54.3 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.829 0.851 . . . . 0.0 108.997 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -125.05 130.35 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mt -137.82 147.47 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -169.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.57 -179.57 7.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.291 1.837 . . . . 0.0 108.156 172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -71.06 158.83 35.81 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.671 -0.643 . . . . 0.0 110.24 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.8 m -60.19 159.51 9.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.723 1.209 . . . . 0.0 112.82 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 59.9 16.24 5.57 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.996 1.718 . . . . 0.0 113.557 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.3 m -69.36 -42.01 75.8 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.531 1.059 . . . . 0.0 111.427 176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -167.82 -178.71 3.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.566 1.546 . . . . 0.0 108.005 -169.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.2 m 60.55 -69.94 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 128.908 2.883 . . . . 0.0 112.418 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.27 -44.88 90.36 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.034 0.834 . . . . 0.0 111.117 -171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.4 pt -65.43 -40.86 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.279 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.7 t -66.64 -45.85 87.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.92 -38.91 83.71 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.248 0.619 . . . . 0.0 110.804 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.37 -53.0 49.8 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 118.765 -0.636 . . . . 0.0 110.602 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.7 pt -70.17 -34.52 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.86 0.754 . . . . 0.0 111.623 -174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -71.23 -48.12 53.15 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.276 0.489 . . . . 0.0 110.22 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.46 -23.1 4.32 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.549 1.071 . . . . 0.0 111.841 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 m -52.63 -21.41 3.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.663 1.585 . . . . 0.0 113.748 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.7 -32.55 65.58 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.324 -0.86 . . . . 0.0 111.866 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.82 1.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.436 1.094 . . . . 0.0 113.508 -170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -137.84 165.28 26.86 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.721 1.608 . . . . 0.0 108.745 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -59.41 141.88 87.35 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-O 118.142 -0.932 . . . . 0.0 109.719 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.15 -40.42 60.14 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.097 2.531 . . . . 0.0 113.868 175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -155.54 150.6 26.68 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.205 1.402 . . . . 0.0 108.02 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--O 1.247 0.964 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 172.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -125.13 -15.37 6.33 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.906 0.882 . . . . 0.0 111.489 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -78.94 41.69 0.44 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.368 2.267 . . . . 0.0 113.153 -170.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.3 mp -80.84 122.38 81.96 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.043 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -55.47 125.22 18.42 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.384 2.723 . . . . 0.0 115.338 -176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -163.73 153.89 15.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.781 2.832 . . . . 0.0 104.593 169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -65.91 -16.51 63.92 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.967 1.258 . . . . 0.0 112.497 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.4 m -119.64 145.15 46.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.662 1.119 . . . . 0.0 109.681 -169.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.64 163.25 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.883 1.273 . . . . 0.0 108.032 176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -128.2 124.18 36.13 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.647 1.979 . . . . 0.0 106.831 -171.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.0 mt -112.48 138.81 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.12 168.64 19.26 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.03 2.132 . . . . 0.0 108.099 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 45.7 t30 52.31 27.28 4.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 112.356 -171.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.8 137.21 53.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -65.92 114.08 4.86 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -68.63 -9.41 49.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.531 1.133 . . . . 0.0 113.728 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -69.43 -24.84 63.88 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 120.181 1.355 . . . . 0.0 112.221 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.3 mm -70.52 125.25 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.328 1.051 . . . . 0.0 108.293 -171.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -68.65 164.62 21.12 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.562 0.745 . . . . 0.0 110.199 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -56.77 -44.58 81.97 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.154 0.582 . . . . 0.0 110.591 174.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -59.13 -46.7 87.66 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.984 0.913 . . . . 0.0 109.886 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -69.22 -39.62 78.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.301 0.641 . . . . 0.0 110.518 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.4 -52.47 65.5 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 124.683 1.193 . . . . 0.0 109.176 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -59.09 -48.34 81.97 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.592 0.757 . . . . 0.0 109.985 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.05 -48.78 79.05 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 123.152 0.581 . . . . 0.0 109.94 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 m -64.76 -43.04 94.59 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.398 0.544 . . . . 0.0 111.514 -175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.23 -51.46 69.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.46 -26.47 65.51 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 119.818 -0.753 . . . . 0.0 112.07 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.4 -32.86 68.91 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.773 -1.108 . . . . 0.0 112.323 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 pt -133.09 -43.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -60.8 -40.09 91.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.11 1.777 . . . . 0.0 111.155 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.5 m -59.26 -35.77 74.32 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.505 1.048 . . . . 0.0 112.096 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -74.56 0.34 15.2 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 118.867 0.758 . . . . 0.0 111.79 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -123.62 4.83 8.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 112.277 173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -179.79 11.61 0.03 OUTLIER Glycine 0 CA--C 1.533 1.208 0 N-CA-C 118.064 1.986 . . . . 0.0 118.064 177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 35.99 101.61 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.784 2.834 . . . . 0.0 115.658 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.6 153.27 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.428 1.491 . . . . 0.0 110.841 174.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.68 -37.26 2.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.069 2.548 . . . . 0.0 109.464 171.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -157.29 162.51 39.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.712 1.142 . . . . 0.0 110.974 175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 143.77 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.466 1.906 . . . . 0.0 106.969 -172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.5 t -138.31 101.02 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 124.445 1.098 . . . . 0.0 109.3 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.23 162.83 34.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.374 2.269 . . . . 0.0 105.321 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.6 mt -140.74 160.62 39.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -69.14 -23.51 63.97 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.669 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -58.57 133.19 55.63 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.973 0.806 . . . . 0.0 109.037 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 50.6 tp -49.39 -39.85 33.96 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.584 1.154 . . . . 0.0 112.013 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -54.55 -21.56 10.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.9 1.28 . . . . 0.0 112.843 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.5 mmm -126.61 31.9 5.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.812 1.245 . . . . 0.0 111.261 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.5 mtm-85 -117.28 -28.9 6.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.283 1.033 . . . . 0.0 109.731 168.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.23 -12.21 84.81 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-N 118.758 0.708 . . . . 0.0 112.633 170.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -149.86 160.73 43.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.251 1.821 . . . . 0.0 108.047 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 171.84 19.48 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.669 1.588 . . . . 0.0 108.861 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.86 157.83 45.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.5 146.44 14.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 mp -121.55 141.24 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -170.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -128.79 165.67 20.51 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.322 1.449 . . . . 0.0 109.872 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.82 -23.31 60.75 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.83 149.81 36.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.427 1.012 . . . . 0.0 108.901 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.5 pt -67.49 -32.95 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.632 0.773 . . . . 0.0 112.344 -175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.98 64.96 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 m -64.62 -40.69 95.93 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.695 0.798 . . . . 0.0 110.684 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.62 85.45 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.243 0.617 . . . . 0.0 110.759 172.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -62.07 -38.66 89.65 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.696 0.398 . . . . 0.0 111.151 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -69.68 -40.02 76.62 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 118.95 -0.547 . . . . 0.0 111.604 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.37 70.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.634 0.774 . . . . 0.0 109.321 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 tt -52.45 -56.15 17.03 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.245 1.018 . . . . 0.0 109.205 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -60.36 -50.0 75.35 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.804 0.442 . . . . 0.0 111.12 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.6 m -65.86 -37.01 85.02 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -172.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.1 mmm -89.9 -7.52 53.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.868 0.467 . . . . 0.0 111.882 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -57.51 121.84 11.26 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.018 0.927 . . . . 0.0 109.448 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.69 2.15 49.29 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 118.816 -0.991 . . . . 0.0 114.057 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -73.01 137.89 79.35 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 119.525 1.663 . . . . 0.0 109.748 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.16 78.09 3.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.637 2.892 . . . . 0.0 110.285 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -58.72 -35.76 73.19 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.683 1.193 . . . . 0.0 110.212 175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.39 -158.63 0.91 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.217 2.607 . . . . 0.0 105.217 169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.03 20.82 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.387 1.475 . . . . 0.0 113.978 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -138.76 139.2 23.33 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 124.98 1.312 . . . . 0.0 108.033 170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.88 130.91 20.01 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.248 1.965 . . . . 0.0 108.788 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.5 mmm -63.06 152.06 38.12 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.068 0.547 . . . . 0.0 109.607 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -129.74 127.5 40.54 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.139 -2.541 . . . . 0.0 104.139 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.62 149.46 29.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -169.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.18 166.23 25.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.739 1.616 . . . . 0.0 108.541 172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -69.51 174.98 4.39 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.434 0.694 . . . . 0.0 109.927 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.4 m -137.43 158.07 45.21 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.044 0.938 . . . . 0.0 109.135 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.23 32.96 1.52 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.349 1.46 . . . . 0.0 108.681 170.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 m -136.53 24.32 3.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 111.499 -169.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.25 -47.13 69.31 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.497 0.719 . . . . 0.0 111.415 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -61.06 -33.06 72.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.962 0.505 . . . . 0.0 111.727 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -77.77 -43.49 30.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 121.85 -0.531 . . . . 0.0 111.121 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 44.5 pt -65.06 -36.93 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 118.492 0.587 . . . . 0.0 109.979 175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.57 -46.05 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.41 -38.64 77.81 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.839 1.199 . . . . 0.0 111.942 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -67.75 -44.69 76.91 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.891 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.0 pt -76.65 -28.33 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.744 1.156 . . . . 0.0 111.613 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -88.47 -143.1 0.13 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.376 1.47 . . . . 0.0 107.673 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -147.04 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.529 0.92 0 CA-C-N 119.826 1.194 . . . . 0.0 114.184 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.4 p -72.74 -49.08 33.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.428 1.614 . . . . 0.0 109.808 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.9 t80 166.55 -39.37 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 130.164 3.386 . . . . 0.0 107.588 -169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -145.24 -5.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.184 0.993 . . . . 0.0 113.512 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.78 -173.92 3.69 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.45 1.9 . . . . 0.0 106.428 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.1 ttt-85 -137.29 143.42 41.48 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.34 105.31 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 105.897 -2.386 . . . . 0.0 105.897 169.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -53.44 113.06 1.03 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.265 1.026 . . . . 0.0 110.625 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 tptt . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -129.62 172.65 11.38 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.146 0.978 . . . . 0.0 108.771 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -71.44 140.11 49.93 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.625 0.77 . . . . 0.0 111.461 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.75 97.34 17.29 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 103.853 -2.647 . . . . 0.0 103.853 169.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.41 109.37 0.29 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 124.019 3.146 . . . . 0.0 112.556 -174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -149.84 0.43 0.47 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 84.35 -9.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.306 2.242 . . . . 0.0 113.206 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -134.51 153.88 51.72 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.545 1.066 . . . . 0.0 108.85 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.0 pt -132.4 164.0 36.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -120.68 132.86 55.31 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.353 2.261 . . . . 0.0 105.661 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.2 mt -121.18 139.47 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -175.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -146.62 175.68 10.41 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.061 1.344 . . . . 0.0 109.233 176.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.6 t30 59.99 25.11 14.29 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.122 1.369 . . . . 0.0 111.033 -168.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -71.55 137.75 48.3 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.621 1.568 . . . . 0.0 107.337 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -66.99 114.75 6.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.257 0.481 . . . . 0.0 109.737 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.42 -11.03 5.68 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -67.97 -23.89 65.09 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.421 1.464 . . . . 0.0 112.144 172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.31 112.48 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -69.51 168.76 13.93 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.626 0.77 . . . . 0.0 110.686 172.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.68 -47.93 73.02 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.302 1.041 . . . . 0.0 110.902 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.93 -42.63 99.32 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.76 -35.77 72.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 119.401 -0.333 . . . . 0.0 110.665 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -50.07 75.29 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.434 1.094 . . . . 0.0 109.232 172.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -59.76 -49.82 76.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -58.44 -45.59 88.21 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.29 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.9 m -64.01 -45.71 87.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.751 0.705 . . . . 0.0 111.025 -177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.91 -51.91 68.0 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.909 0.484 . . . . 0.0 109.912 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.31 -31.75 72.41 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.593 0.633 . . . . 0.0 111.915 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.54 78.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.73 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 pt -128.14 -37.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 -170.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -62.94 -38.28 90.41 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.702 1.592 . . . . 0.0 111.117 176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.4 m -56.81 -20.23 21.52 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -66.62 -26.58 67.15 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.893 0.77 . . . . 0.0 111.57 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -119.24 -21.25 7.63 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.217 1.007 . . . . 0.0 111.812 -169.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.1 109.21 0.4 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 105.304 -3.119 . . . . 0.0 105.304 169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -57.08 122.81 13.25 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 175.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.9 mt -71.13 154.59 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 125.781 1.633 . . . . 0.0 109.253 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -122.24 -37.75 2.78 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.826 2.05 . . . . 0.0 110.061 172.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -157.35 162.13 39.07 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.8 1.182 . . . . 0.0 110.73 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 61.4 mt -139.82 143.57 30.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.717 1.607 . . . . 0.0 107.593 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.44 115.87 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.202 1.001 . . . . 0.0 109.566 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.47 166.82 27.98 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.543 2.337 . . . . 0.0 106.372 169.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.0 mt -140.35 169.69 17.2 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.611 1.564 . . . . 0.0 108.707 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -71.9 -30.29 65.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 118.72 -0.657 . . . . 0.0 111.669 174.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 p -60.75 134.66 57.31 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.08 0.952 . . . . 0.0 109.023 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.0 tp -53.13 -42.75 66.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.196 0.598 . . . . 0.0 111.805 -171.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -58.92 -21.91 58.75 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.303 0.641 . . . . 0.0 112.389 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.1 21.59 9.69 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.551 1.54 . . . . 0.0 110.703 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -118.39 -38.91 3.09 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 125.03 1.332 . . . . 0.0 109.674 171.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.73 -5.36 88.41 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.233 0.92 . . . . 0.0 111.764 169.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.26 157.36 46.41 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.474 1.91 . . . . 0.0 106.91 174.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.09 170.98 19.84 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.606 1.162 . . . . 0.0 109.27 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -132.7 153.92 50.67 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.36 139.22 14.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.2 mp -112.52 142.7 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 128.396 2.678 . . . . 0.0 104.181 -172.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -123.4 173.58 7.9 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.282 1.033 . . . . 0.0 110.918 -172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -65.74 -29.41 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.515 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -153.07 157.1 39.93 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -173.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.13 -35.03 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.084 0.954 . . . . 0.0 111.56 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.7 77.66 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 m -61.94 -44.44 96.75 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.083 0.942 . . . . 0.0 110.515 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.55 -46.37 90.43 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 122.442 0.297 . . . . 0.0 110.626 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.0 m -61.65 -44.86 96.17 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.016 0.526 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -69.26 -40.71 77.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.515 0.326 . . . . 0.0 110.915 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.24 -51.55 69.3 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 173.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tt -53.87 -52.9 59.0 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.151 0.981 . . . . 0.0 110.53 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -72.74 -33.13 66.18 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 118.751 -0.642 . . . . 0.0 111.424 -173.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -72.74 -36.57 67.77 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.24 0.927 . . . . 0.0 111.104 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mmm -98.51 -13.78 20.32 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -169.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -58.69 134.59 56.94 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.469 1.486 . . . . 0.0 109.827 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.4 -6.24 31.4 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.573 -1.126 . . . . 0.0 114.093 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.41 137.55 88.76 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.752 1.776 . . . . 0.0 109.471 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.63 78.21 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.492 2.794 . . . . 0.0 109.962 172.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -56.95 -38.59 73.14 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.678 1.191 . . . . 0.0 109.605 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -144.99 -157.22 0.77 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 128.07 2.548 . . . . 0.0 105.228 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.09 20.66 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.246 1.419 . . . . 0.0 114.04 -178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -138.46 139.49 25.05 Favored Pre-proline 0 C--O 1.235 0.329 0 C-N-CA 125.029 1.332 . . . . 0.0 108.217 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -70.06 133.95 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 23.1 mmm -64.37 153.2 39.25 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.199 0.6 . . . . 0.0 110.107 176.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -131.16 133.61 45.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.2 mt -140.39 144.01 28.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -169.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.61 176.28 9.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.566 1.546 . . . . 0.0 108.333 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -63.84 151.61 41.91 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.2 m -63.92 150.9 44.01 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.418 0.687 . . . . 0.0 112.157 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -140.72 152.93 45.68 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.565 1.946 . . . . 0.0 106.342 176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.9 m -56.63 142.03 41.27 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.082 0.953 . . . . 0.0 111.965 -169.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -151.58 146.28 25.74 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.752 1.621 . . . . 0.0 107.078 170.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 m -54.22 -32.92 57.11 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.984 0.913 . . . . 0.0 113.131 -173.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.93 -35.88 37.12 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.571 1.078 . . . . 0.0 111.967 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 45.0 pt -71.75 -34.63 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.784 0.72 . . . . 0.0 110.241 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.66 -45.69 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.74 -35.01 75.28 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.502 -0.749 . . . . 0.0 111.663 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.76 -42.72 90.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.839 0.855 . . . . 0.0 112.117 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 pt -74.6 -31.05 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.85 0.75 . . . . 0.0 110.612 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.37 -172.84 1.89 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.136 0.974 . . . . 0.0 108.741 169.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -89.95 -13.27 60.95 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 121.286 -0.884 . . . . 0.0 111.901 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 p -65.43 -8.03 16.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.972 1.386 . . . . 0.0 114.521 -169.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -64.33 -20.37 66.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.603 1.092 . . . . 0.0 111.633 169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -136.73 -33.36 0.79 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 124.137 0.975 . . . . 0.0 112.429 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.59 153.93 42.84 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -61.21 153.72 66.05 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.004 0.922 . . . . 0.0 109.824 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.2 -36.3 55.57 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.189 2.593 . . . . 0.0 113.189 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -152.95 157.14 40.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.979 1.712 . . . . 0.0 107.827 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.246 0.905 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 173.115 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.43 164.72 35.17 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.258 1.423 . . . . 0.0 108.32 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -65.08 152.65 42.97 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.334 0.654 . . . . 0.0 111.266 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.3 mt -123.94 145.83 49.1 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.422 1.089 . . . . 0.0 108.74 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.6 130.82 42.56 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.165 2.577 . . . . 0.0 114.175 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 8' ' ' THR . 37.2 t30 -161.32 145.08 12.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 127.296 2.239 . . . . 0.0 105.518 169.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -69.36 -12.33 61.57 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.673 1.124 . . . . 0.0 113.147 -170.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.402 ' H ' ' ND2' ' A' ' 6' ' ' ASN . 23.9 m -124.74 143.84 50.56 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.379 1.471 . . . . 0.0 108.483 -177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 164.45 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.555 1.142 . . . . 0.0 108.086 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -128.5 131.75 48.32 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.144 2.178 . . . . 0.0 106.504 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.32 144.17 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 125.892 1.677 . . . . 0.0 106.492 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.09 171.26 16.14 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.3 1.84 . . . . 0.0 108.628 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.0 t30 52.79 27.84 5.78 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.312 1.445 . . . . 0.0 112.437 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.26 141.96 54.28 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -66.84 112.83 4.48 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.103 0.865 . . . . 0.0 108.829 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -57.17 -23.23 46.11 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.788 1.235 . . . . 0.0 114.082 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -62.9 -30.66 71.71 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.781 1.173 . . . . 0.0 111.566 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 mm -61.96 132.14 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.28 1.032 . . . . 0.0 108.633 -173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -80.21 166.92 20.94 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.535 1.134 . . . . 0.0 109.177 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -57.89 -46.03 85.51 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.694 -0.629 . . . . 0.0 110.84 177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -62.85 -42.92 99.93 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -66.37 -42.29 88.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.954 0.502 . . . . 0.0 110.012 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.2 -50.74 71.92 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.672 1.189 . . . . 0.0 109.389 172.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -60.52 -49.52 77.22 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.889 0.476 . . . . 0.0 110.199 -175.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -61.07 -42.97 99.5 Favored 'General case' 0 C--O 1.227 -0.093 0 CA-C-O 118.622 -0.704 . . . . 0.0 110.294 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.5 m -64.26 -44.56 91.38 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.041 0.837 . . . . 0.0 111.281 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.4 -49.53 76.93 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -65.11 -25.94 67.99 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.61 -40.86 33.28 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.924 0.784 . . . . 0.0 112.382 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.64 -39.38 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -60.73 -36.36 78.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.594 1.543 . . . . 0.0 110.007 172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.7 m -50.74 -32.16 18.83 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 174.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.93 -10.85 60.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.103 0.561 . . . . 0.0 111.746 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -128.68 -22.58 3.26 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.363 1.065 . . . . 0.0 112.273 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.54 107.67 0.33 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 106.204 -2.758 . . . . 0.0 106.204 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 134.35 56.96 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 122.327 1.06 . . . . 0.0 109.641 177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 34.1 mm -68.81 150.33 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 126.777 2.031 . . . . 0.0 109.601 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.48 -38.45 2.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.863 1.265 . . . . 0.0 109.579 169.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -158.73 164.85 35.5 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.465 1.029 . . . . 0.0 110.378 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -139.53 145.37 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.475 1.91 . . . . 0.0 107.357 -173.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.12 106.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.843 1.257 . . . . 0.0 108.484 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.34 170.22 16.43 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.53 2.332 . . . . 0.0 106.146 169.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 tp -150.18 160.13 43.91 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.559 0.744 . . . . 0.0 109.664 -176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -70.11 -22.3 63.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.577 0.751 . . . . 0.0 112.454 -176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 p -65.05 144.06 57.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 109.358 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.8 tp -47.04 -45.67 21.66 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.458 1.103 . . . . 0.0 111.058 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -54.74 -21.96 12.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.167 1.387 . . . . 0.0 113.136 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 47.6 mmm -132.49 29.16 4.27 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 120.046 1.294 . . . . 0.0 112.659 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -129.34 -18.05 3.68 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.149 0.979 . . . . 0.0 110.611 168.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.53 88.12 Favored Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 167.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -153.7 162.47 41.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.327 2.651 . . . . 0.0 107.432 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 173.77 14.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.307 1.443 . . . . 0.0 109.02 -173.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -138.05 158.59 44.01 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 169.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -154.25 148.22 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.38 141.12 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.101 2.56 . . . . 0.0 104.328 -170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.21 172.41 9.55 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.403 1.081 . . . . 0.0 111.409 -169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -57.99 -38.3 75.85 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 119.257 -0.401 . . . . 0.0 111.843 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 161.5 41.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.79 0.836 . . . . 0.0 109.194 -171.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 pt -63.11 -31.69 53.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.901 0.88 . . . . 0.0 111.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.87 -40.07 64.19 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 m -63.28 -44.23 95.65 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.609 0.764 . . . . 0.0 109.832 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.26 88.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -59.7 -46.16 89.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.884 0.474 . . . . 0.0 110.95 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -68.42 -40.96 81.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.56 33.18 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.926 0.89 . . . . 0.0 110.086 172.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 tt -54.04 -57.38 11.27 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.565 1.146 . . . . 0.0 109.385 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -64.44 -40.14 95.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 118.611 -0.709 . . . . 0.0 111.14 -173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 m -68.68 -42.5 77.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.363 0.983 . . . . 0.0 110.624 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.2 mmm -85.11 -8.52 58.61 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.82 0.448 . . . . 0.0 112.092 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.8 121.99 9.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.51 0.91 50.4 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 118.765 -1.02 . . . . 0.0 114.003 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -73.01 138.72 79.37 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.712 . . . . 0.0 109.79 -175.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.9 77.95 2.98 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.659 2.906 . . . . 0.0 110.372 172.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -58.72 -35.37 72.56 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.604 1.162 . . . . 0.0 110.1 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -145.66 -159.63 1.03 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.21 2.604 . . . . 0.0 105.168 169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.46 20.46 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.437 1.495 . . . . 0.0 114.113 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -138.35 139.91 26.64 Favored Pre-proline 0 C--O 1.235 0.328 0 C-N-CA 124.855 1.262 . . . . 0.0 108.261 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.88 131.04 20.26 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.241 1.96 . . . . 0.0 108.828 171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 19.5 mmm -63.18 151.25 40.84 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.178 0.591 . . . . 0.0 109.874 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -128.25 129.04 45.79 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.28 150.63 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.0 36.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.924 1.69 . . . . 0.0 108.158 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' HE3' ' A' ' 85' ' ' LYS . 26.0 p90 -84.25 138.62 32.85 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -70.54 158.12 36.68 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 170.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HE3' ' CE2' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -153.29 -32.79 0.12 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 m -61.24 123.06 16.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.142 0.883 . . . . 0.0 109.253 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -54.49 -49.46 70.09 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.85 0.86 . . . . 0.0 112.578 -169.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.6 m -62.31 -37.32 85.13 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.544 0.337 . . . . 0.0 111.007 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.61 -41.52 54.16 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.205 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 pt -66.21 -38.64 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 118.786 0.721 . . . . 0.0 110.168 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.16 -44.0 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 119.113 0.87 . . . . 0.0 109.297 175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.91 86.13 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 118.717 -0.659 . . . . 0.0 110.952 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.37 -43.66 80.87 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.911 1.232 . . . . 0.0 111.35 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 12.7 pt -74.14 -22.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.669 1.122 . . . . 0.0 112.215 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -113.04 2.21 15.64 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.964 1.256 . . . . 0.0 114.023 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.76 -131.56 1.74 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 119.533 1.061 . . . . 0.0 110.462 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 30.0 p -135.07 -59.75 0.78 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.687 0.795 . . . . 0.0 110.678 -173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -139.89 20.58 2.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.459 1.904 . . . . 0.0 108.946 175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -151.76 147.17 26.36 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.672 2.789 . . . . 0.0 103.72 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.05 33.17 0.27 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.242 0.928 . . . . 0.0 112.496 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -142.37 151.41 57.95 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 125.928 1.691 . . . . 0.0 107.163 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -52.32 -35.85 66.05 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.262 2.641 . . . . 0.0 113.287 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -148.5 147.36 29.01 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.084 -177.854 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -144.23 -55.91 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.455 0.702 . . . . 0.0 109.21 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -65.79 164.44 14.7 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.781 1.232 . . . . 0.0 111.417 172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.6 mt -122.52 130.66 24.57 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -48.69 132.49 25.85 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 114.037 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -159.16 153.54 24.02 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.348 2.259 . . . . 0.0 105.61 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -70.15 -12.25 61.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.85 1.204 . . . . 0.0 112.094 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.9 m -132.95 146.28 51.65 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.577 1.151 . . . . 0.0 108.851 -169.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.1 pt -127.18 168.58 20.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.919 1.288 . . . . 0.0 107.933 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -135.01 115.26 13.31 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.402 1.881 . . . . 0.0 106.066 -172.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.4 mt -98.99 138.75 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 104.574 -2.38 . . . . 0.0 104.574 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -139.4 14.3 2.57 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -145.6 44.58 1.29 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.312 0.96 . . . . 0.0 112.045 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.0 148.86 48.66 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -66.74 123.15 19.32 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -48.98 -33.0 10.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.098 1.759 . . . . 0.0 113.142 -175.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.75 -23.98 67.42 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.6 mm -71.36 119.95 18.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.026 0.931 . . . . 0.0 108.805 -170.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -69.07 165.54 20.04 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.719 0.807 . . . . 0.0 110.008 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.66 -46.75 70.71 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.691 0.796 . . . . 0.0 110.425 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.84 -43.26 98.51 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.188 0.995 . . . . 0.0 110.223 -178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -70.63 -37.41 73.79 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.851 0.461 . . . . 0.0 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -51.98 67.37 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 124.002 0.921 . . . . 0.0 109.262 174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -66.96 -39.14 87.18 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.656 1.116 . . . . 0.0 110.923 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -56.48 -50.98 70.18 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.292 0.637 . . . . 0.0 110.073 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.2 m -66.84 -41.82 86.77 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.306 0.503 . . . . 0.0 111.348 -174.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.33 -51.41 69.92 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.16 0.584 . . . . 0.0 110.204 175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.97 -36.65 82.08 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.809 0.277 . . . . 0.0 111.146 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.47 97.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.887 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -128.52 -42.69 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -171.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -59.33 -36.87 76.47 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 121.3 1.864 . . . . 0.0 111.714 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 m -58.63 -30.6 67.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.087 0.858 . . . . 0.0 112.809 174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -66.29 -10.79 46.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.607 1.094 . . . . 0.0 112.003 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -119.97 6.74 10.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.883 1.273 . . . . 0.0 111.972 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 177.34 11.41 0.02 OUTLIER Glycine 0 CA--C 1.531 1.072 0 N-CA-C 117.723 1.849 . . . . 0.0 117.723 174.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 38.45 102.64 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.14 2.576 . . . . 0.0 114.67 -171.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 90.6 mt -59.59 151.7 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.288 174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 64.3 tp -119.18 -36.26 3.43 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.124 2.169 . . . . 0.0 110.059 173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.877 1.217 . . . . 0.0 111.027 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.8 141.8 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.047 1.739 . . . . 0.0 107.541 -172.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -141.97 117.48 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.259 1.024 . . . . 0.0 109.233 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.71 173.51 12.69 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.651 1.98 . . . . 0.0 106.703 169.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -151.61 153.53 34.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.36 -15.35 58.79 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.331 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 p -62.49 147.79 47.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.364 0.984 . . . . 0.0 108.832 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 42.0 tp -51.66 -39.19 57.74 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 112.248 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -55.2 -26.68 40.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.893 0.877 . . . . 0.0 112.605 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 99.3 mmm -121.07 7.71 10.34 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.999 1.319 . . . . 0.0 110.99 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -82.99 51.47 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.381 -1.45 . . . . 0.0 109.67 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.54 -11.31 0.21 Allowed Glycine 0 CA--C 1.527 0.828 0 O-C-N 121.67 -0.644 . . . . 0.0 112.596 -169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -142.33 155.95 45.22 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.248 1.024 . . . . 0.0 109.966 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 165.3 36.58 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.824 1.249 . . . . 0.0 109.231 -171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -122.68 150.05 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.8 138.54 13.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.14 140.63 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 128.236 2.614 . . . . 0.0 104.869 -169.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -124.96 174.96 7.64 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.283 1.033 . . . . 0.0 112.003 -170.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -45.03 69.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 125.641 1.576 . . . . 0.0 112.221 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -157.69 155.6 30.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.5 -34.76 59.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 112.979 -175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.81 -39.33 59.87 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.1 m -67.45 -40.34 85.42 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.859 0.864 . . . . 0.0 110.373 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.75 78.85 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.743 0.817 . . . . 0.0 110.26 171.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 m -60.1 -40.67 90.44 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.729 0.412 . . . . 0.0 111.122 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -66.67 -43.41 84.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.266 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.21 -51.04 71.71 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.571 0.749 . . . . 0.0 109.702 175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.86 -54.37 35.42 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.844 1.258 . . . . 0.0 109.62 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -61.52 -48.56 80.51 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.398 0.679 . . . . 0.0 111.084 -177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.1 m -71.57 -27.67 63.31 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.247 -171.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mmm -100.81 -16.21 17.37 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.03 -0.986 . . . . 0.0 113.102 -174.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -59.16 137.62 57.89 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.866 1.666 . . . . 0.0 109.484 172.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.12 -8.75 22.3 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.421 -1.211 . . . . 0.0 114.38 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -66.71 134.92 94.28 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 120.05 1.925 . . . . 0.0 109.548 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.38 78.59 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.5 2.8 . . . . 0.0 110.277 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -64.78 -41.42 95.85 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.874 0.87 . . . . 0.0 111.071 -169.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -146.03 66.12 1.2 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 169.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 65.71 -34.99 0.2 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.801 2.841 . . . . 0.0 114.172 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -69.38 127.36 92.87 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.284 176.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.64 121.98 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.964 1.776 . . . . 0.0 107.81 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 24.9 mmm -59.88 148.35 35.19 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.01 0.524 . . . . 0.0 110.081 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -126.54 129.52 48.75 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 103.606 -2.738 . . . . 0.0 103.606 171.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 mt -142.38 148.14 20.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.1 171.04 15.06 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.432 1.893 . . . . 0.0 108.255 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -75.12 146.01 41.73 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.8 p -76.88 -15.43 59.7 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.497 -0.752 . . . . 0.0 112.57 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -56.74 -29.61 62.72 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.201 1.401 . . . . 0.0 113.417 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 p -76.26 44.57 0.34 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.17 1.788 . . . . 0.0 111.255 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.9 -50.02 58.25 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.415 1.486 . . . . 0.0 112.929 -169.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.2 m -65.0 -30.82 71.84 Favored 'General case' 0 CA--C 1.537 0.442 0 O-C-N 121.788 -0.57 . . . . 0.0 111.979 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.56 -47.41 40.88 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.49 -0.756 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.8 pt -64.99 -34.15 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 O-C-N 122.193 -0.317 . . . . 0.0 110.393 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 37.9 t -64.91 -40.52 89.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 118.62 0.646 . . . . 0.0 110.241 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.12 -31.1 72.16 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.408 -0.808 . . . . 0.0 111.425 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.59 -48.13 64.96 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.789 1.177 . . . . 0.0 111.42 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.4 pt -88.17 -20.25 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -169.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -123.51 -57.69 1.64 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.832 1.196 . . . . 0.0 109.442 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.92 -52.57 0.7 Allowed Glycine 0 N--CA 1.465 0.625 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.4 m -58.23 148.79 25.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.244 1.418 . . . . 0.0 109.215 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -59.88 -34.53 73.29 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.336 0.654 . . . . 0.0 111.856 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -122.36 157.28 32.18 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 169.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -82.59 80.31 8.76 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -130.59 157.1 78.62 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 126.674 1.99 . . . . 0.0 106.492 174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.65 -57.39 2.3 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.858 2.372 . . . . 0.0 113.92 -170.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -150.08 38.36 0.73 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.107 1.363 . . . . 0.0 110.151 -175.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--O 1.248 0.983 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -171.441 . . . . . . . . 0 0 . 1 stop_ save_